<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:4b848cb4-f489-49f5-8bbf-053fe4e49d76,g:1bb8b48b-af3d-4a62-9c44-d36ac7093e22-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Cover" xlink:type="simple" xlink:href="inpha-20251231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a263b63e-5d77-437e-8572-67168e9f46b8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_e21ddaad-474f-46fc-a6ac-3d2262b03386" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a263b63e-5d77-437e-8572-67168e9f46b8" xlink:to="loc_dei_EntityAddressesTable_e21ddaad-474f-46fc-a6ac-3d2262b03386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_b2246957-8a1b-4938-9f43-d0675f249895" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_e21ddaad-474f-46fc-a6ac-3d2262b03386" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_b2246957-8a1b-4938-9f43-d0675f249895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_7bd5692c-fe80-47f9-b8a3-85f3f9a1b79a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_b2246957-8a1b-4938-9f43-d0675f249895" xlink:to="loc_dei_AddressTypeDomain_7bd5692c-fe80-47f9-b8a3-85f3f9a1b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_96e77c4f-3362-4ce0-9b39-822f2c1fa193" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_7bd5692c-fe80-47f9-b8a3-85f3f9a1b79a" xlink:to="loc_dei_BusinessContactMember_96e77c4f-3362-4ce0-9b39-822f2c1fa193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_d2f9488f-47b4-4430-95ce-2e8d0bc52b65" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_e21ddaad-474f-46fc-a6ac-3d2262b03386" xlink:to="loc_dei_EntityListingsExchangeAxis_d2f9488f-47b4-4430-95ce-2e8d0bc52b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_ba2f052d-12c2-406c-b163-0dff480c4cc4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_d2f9488f-47b4-4430-95ce-2e8d0bc52b65" xlink:to="loc_dei_ExchangeDomain_ba2f052d-12c2-406c-b163-0dff480c4cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AmericanDepositorySharesMember_0d0e50df-fcdb-446a-aff3-2b8cd3ead57a" xlink:href="inpha-20251231.xsd#inpha_AmericanDepositorySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_ba2f052d-12c2-406c-b163-0dff480c4cc4" xlink:to="loc_inpha_AmericanDepositorySharesMember_0d0e50df-fcdb-446a-aff3-2b8cd3ead57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_e21ddaad-474f-46fc-a6ac-3d2262b03386" xlink:to="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5a485167-d9a2-4572-946d-fabfd60e4201" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentType_5a485167-d9a2-4572-946d-fabfd60e4201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_336b99bb-614b-4eb6-9163-a88d88804959" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentRegistrationStatement_336b99bb-614b-4eb6-9163-a88d88804959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_ac23376e-5efc-40d5-89d2-556fdee5d9a1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentAnnualReport_ac23376e-5efc-40d5-89d2-556fdee5d9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_080484cc-4dc2-4008-8838-0ac86e8e3e37" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentPeriodEndDate_080484cc-4dc2-4008-8838-0ac86e8e3e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7b957f2a-d736-46b5-8e49-94cea124ebe4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_CurrentFiscalYearEndDate_7b957f2a-d736-46b5-8e49-94cea124ebe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_263b626d-5cd6-4149-b0f7-d9ad700ee0cb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentTransitionReport_263b626d-5cd6-4149-b0f7-d9ad700ee0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_dd05577c-7349-4210-9e35-4307f70e8a6f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentShellCompanyReport_dd05577c-7349-4210-9e35-4307f70e8a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_62e42b9c-6d14-4e91-bfbf-ed91d65d0dbd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityFileNumber_62e42b9c-6d14-4e91-bfbf-ed91d65d0dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bddd7cc8-172d-4ada-9d49-14ad02939bef" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityRegistrantName_bddd7cc8-172d-4ada-9d49-14ad02939bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4477c7fd-7f73-4bc8-b518-9ed5ac6eb7eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4477c7fd-7f73-4bc8-b518-9ed5ac6eb7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_23f0b4ec-6a31-4599-a7b2-e7b5e5f8f52b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityAddressAddressLine1_23f0b4ec-6a31-4599-a7b2-e7b5e5f8f52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8f4fceda-779c-4bc6-97c6-b8ff59ee5eb2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityAddressPostalZipCode_8f4fceda-779c-4bc6-97c6-b8ff59ee5eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_adaa8269-082a-4785-a50b-e247f7bd7d3b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityAddressCityOrTown_adaa8269-082a-4785-a50b-e247f7bd7d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_9cdbe0ac-85ee-4570-a654-5c969c12370a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityAddressCountry_9cdbe0ac-85ee-4570-a654-5c969c12370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_1d3074db-a809-4c65-8a6d-74471be09a77" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_ContactPersonnelName_1d3074db-a809-4c65-8a6d-74471be09a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f1cfe32c-7050-4f7a-834b-8516b662dea2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_CityAreaCode_f1cfe32c-7050-4f7a-834b-8516b662dea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_fa55046b-d892-4f1a-854b-aff1f3ace998" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_LocalPhoneNumber_fa55046b-d892-4f1a-854b-aff1f3ace998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_edc45db6-d985-4c8e-8c86-65e78cd44e73" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_Security12bTitle_edc45db6-d985-4c8e-8c86-65e78cd44e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_28dcb10d-5f3f-4003-979c-e8bb824fe18d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_TradingSymbol_28dcb10d-5f3f-4003-979c-e8bb824fe18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d0d4f187-c4b3-4b28-85a5-3d2bca538aea" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_SecurityExchangeName_d0d4f187-c4b3-4b28-85a5-3d2bca538aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fceb1f50-ca89-4c1c-9345-579b799214db" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fceb1f50-ca89-4c1c-9345-579b799214db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_97dacff5-bc5b-44ea-879e-4c8ffcad7cee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_97dacff5-bc5b-44ea-879e-4c8ffcad7cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a921ee8d-766d-4348-ac4b-68d6bc5ef3b1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityVoluntaryFilers_a921ee8d-766d-4348-ac4b-68d6bc5ef3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8acd9094-1d77-4d3f-bc7c-70bc09bd4239" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityCurrentReportingStatus_8acd9094-1d77-4d3f-bc7c-70bc09bd4239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f1d39649-f97b-4bca-b29a-2da886cac585" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityInteractiveDataCurrent_f1d39649-f97b-4bca-b29a-2da886cac585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bdea28d1-bcf3-4336-bd87-de0f7ee39f5d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityFilerCategory_bdea28d1-bcf3-4336-bd87-de0f7ee39f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_39c7473d-f0ee-4e06-85c7-dab8c0066051" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityEmergingGrowthCompany_39c7473d-f0ee-4e06-85c7-dab8c0066051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_499bc5d8-3652-4eca-a019-603a4bd4c9ab" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_IcfrAuditorAttestationFlag_499bc5d8-3652-4eca-a019-603a4bd4c9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_e0309d37-4b90-4ce3-b6f8-570f7b3e0bb4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_e0309d37-4b90-4ce3-b6f8-570f7b3e0bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_11d7b1ca-bdc0-4abb-9d2a-a0388d95e290" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_11d7b1ca-bdc0-4abb-9d2a-a0388d95e290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_6466d591-3a02-4af6-ad8f-c285f4ea813d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentAccountingStandard_6466d591-3a02-4af6-ad8f-c285f4ea813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f01bd334-25ce-45e7-8131-71be45718605" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityShellCompany_f01bd334-25ce-45e7-8131-71be45718605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_618ae483-3910-40da-9624-1263195e200e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_EntityCentralIndexKey_618ae483-3910-40da-9624-1263195e200e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dcf76b2a-3f90-440b-8944-bf04488a5668" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_AmendmentFlag_dcf76b2a-3f90-440b-8944-bf04488a5668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_63e47adf-8e1d-4077-b808-69d77d418b92" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentFiscalPeriodFocus_63e47adf-8e1d-4077-b808-69d77d418b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d996579c-3113-475c-98cd-528d1fe0ceee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_28b33845-0195-434b-8516-1a59d2fc0b42" xlink:to="loc_dei_DocumentFiscalYearFocus_d996579c-3113-475c-98cd-528d1fe0ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AuditInformation" xlink:type="simple" xlink:href="inpha-20251231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AuditorInformationAbstract_336dda86-317b-45ff-a9a0-0dd9d59a7d62" xlink:href="inpha-20251231.xsd#inpha_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorTable_4a2b8197-574c-496b-b1bf-b8362aeb077f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorInformationAbstract_336dda86-317b-45ff-a9a0-0dd9d59a7d62" xlink:to="loc_dei_AuditorTable_4a2b8197-574c-496b-b1bf-b8362aeb077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9d0bdde6-18bb-4fe5-bbed-d7e9c693e63a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_4a2b8197-574c-496b-b1bf-b8362aeb077f" xlink:to="loc_srt_CounterpartyNameAxis_9d0bdde6-18bb-4fe5-bbed-d7e9c693e63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_85e77edf-447a-425d-a6ca-84d6091c1678" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9d0bdde6-18bb-4fe5-bbed-d7e9c693e63a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_85e77edf-447a-425d-a6ca-84d6091c1678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PricewaterhouseCoopersMember_9fe5965a-d017-49aa-9935-d27071d03f65" xlink:href="inpha-20251231.xsd#inpha_PricewaterhouseCoopersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_85e77edf-447a-425d-a6ca-84d6091c1678" xlink:to="loc_inpha_PricewaterhouseCoopersMember_9fe5965a-d017-49aa-9935-d27071d03f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_aad6c289-b69d-4571-a01f-f7b6896596ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorTable_4a2b8197-574c-496b-b1bf-b8362aeb077f" xlink:to="loc_dei_AuditorLineItems_aad6c289-b69d-4571-a01f-f7b6896596ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_e4e677fb-9ef4-45b0-af2c-7f49fe7f2fb7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_aad6c289-b69d-4571-a01f-f7b6896596ca" xlink:to="loc_dei_AuditorName_e4e677fb-9ef4-45b0-af2c-7f49fe7f2fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_e2fee4e9-5d71-4389-b8b7-0cbccb805506" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_aad6c289-b69d-4571-a01f-f7b6896596ca" xlink:to="loc_dei_AuditorFirmId_e2fee4e9-5d71-4389-b8b7-0cbccb805506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_79a196c5-73cd-4d71-8f94-5df60faca8a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_aad6c289-b69d-4571-a01f-f7b6896596ca" xlink:to="loc_dei_AuditorLocation_79a196c5-73cd-4d71-8f94-5df60faca8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementsofFinancialPosition" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementsofFinancialPosition"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementsofFinancialPosition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_4f8fbc66-5835-4178-8616-fbae3b59fe27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_37700fdc-7ab3-4eeb-96ab-9cddca26faff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_4f8fbc66-5835-4178-8616-fbae3b59fe27" xlink:to="loc_ifrs-full_AssetsAbstract_37700fdc-7ab3-4eeb-96ab-9cddca26faff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_37700fdc-7ab3-4eeb-96ab-9cddca26faff" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_48872b7c-6345-4e16-85f9-e68e3530d029" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_48872b7c-6345-4e16-85f9-e68e3530d029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_b0be6f97-c4cf-4ff3-b541-abd3d325680c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_b0be6f97-c4cf-4ff3-b541-abd3d325680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_ec63a95f-56f4-4b34-9df1-5f041626568e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_ec63a95f-56f4-4b34-9df1-5f041626568e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_1a821364-3186-49c3-a84d-c99a054c391b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_1a821364-3186-49c3-a84d-c99a054c391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivables_5036b667-76b0-4e76-bd12-526060343a4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_NoncurrentReceivables_5036b667-76b0-4e76-bd12-526060343a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_3f5f4693-ab30-4214-bdff-1bd4f3f3f8fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_3251b4bc-a35b-4ddc-8120-25d3120f3a55" xlink:to="loc_ifrs-full_NoncurrentAssets_3f5f4693-ab30-4214-bdff-1bd4f3f3f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_37700fdc-7ab3-4eeb-96ab-9cddca26faff" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_97aac253-208c-4540-94fe-b21ffff2332e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:to="loc_ifrs-full_CashAndCashEquivalents_97aac253-208c-4540-94fe-b21ffff2332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssets_22fe7c00-36c1-4ced-83bf-86abab8c1140" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:to="loc_ifrs-full_CurrentFinancialAssets_22fe7c00-36c1-4ced-83bf-86abab8c1140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_901e83bb-0f0f-47ef-a1cc-0cdf3089e879" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_901e83bb-0f0f-47ef-a1cc-0cdf3089e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_428f7cb3-71ae-4530-88c8-3ad05b8dddda" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_a7551c13-c3a2-4887-96ea-1c5dce7a96cb" xlink:to="loc_ifrs-full_CurrentAssets_428f7cb3-71ae-4530-88c8-3ad05b8dddda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_0829fb79-302c-4b1d-9261-da0714386f2f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_37700fdc-7ab3-4eeb-96ab-9cddca26faff" xlink:to="loc_ifrs-full_Assets_0829fb79-302c-4b1d-9261-da0714386f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_4f8fbc66-5835-4178-8616-fbae3b59fe27" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:to="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_f68434cc-4879-4cf5-99a1-1e4229dcfa6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_IssuedCapital_f68434cc-4879-4cf5-99a1-1e4229dcfa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_a53688e1-fe71-4b96-a0f3-47dce54c37a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_SharePremium_a53688e1-fe71-4b96-a0f3-47dce54c37a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_09d0348c-54fb-4359-af70-ca0748ad8530" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_09d0348c-54fb-4359-af70-ca0748ad8530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_ec60fa57-6186-4131-a528-8f2675d40f48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_OtherReserves_ec60fa57-6186-4131-a528-8f2675d40f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_af1d68e0-0320-4d7e-9dc4-0d8f9df75081" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_af1d68e0-0320-4d7e-9dc4-0d8f9df75081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_63069204-216a-4df8-8f60-3e9a6063ec8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_7247b7dd-fe81-4eaf-8b57-bb09fbf1bbee" xlink:to="loc_ifrs-full_Equity_63069204-216a-4df8-8f60-3e9a6063ec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesNonCurrent_f1213bc1-f0e4-4974-b77c-7e5f464574b9" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilitiesNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_inpha_CollaborationLiabilitiesNonCurrent_f1213bc1-f0e4-4974-b77c-7e5f464574b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities_6550beb0-5314-48c6-85b3-731435e9701d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilities_6550beb0-5314-48c6-85b3-731435e9701d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_c5d3daf9-41b0-49af-9276-0b709a0f9bd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_c5d3daf9-41b0-49af-9276-0b709a0f9bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_1194b404-d490-4d74-a240-c5b77b8e29bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_1194b404-d490-4d74-a240-c5b77b8e29bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_19b8aedd-df4d-4c83-b145-4dacec9ea1c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_ifrs-full_NoncurrentProvisions_19b8aedd-df4d-4c83-b145-4dacec9ea1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_eec2320b-4d5b-484a-a631-e718e7895d16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_9a9c1ed6-de84-4028-acdd-5a1f65845d6d" xlink:to="loc_ifrs-full_NoncurrentLiabilities_eec2320b-4d5b-484a-a631-e718e7895d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_4a39f548-8542-41e4-9bab-0e8aadd231bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_4a39f548-8542-41e4-9bab-0e8aadd231bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesCurrent_2f43c27c-9079-467e-b233-62b6d9dc8a67" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_inpha_CollaborationLiabilitiesCurrent_2f43c27c-9079-467e-b233-62b6d9dc8a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities_87905be9-3a43-452a-a44a-417180c94a7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_ifrs-full_CurrentFinancialLiabilities_87905be9-3a43-452a-a44a-417180c94a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_3981ef61-4dd3-404e-b69d-6845d7b8c24b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_3981ef61-4dd3-404e-b69d-6845d7b8c24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentProvisions_3dea6326-778f-40bd-bc63-44055d4cff23" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_ifrs-full_CurrentProvisions_3dea6326-778f-40bd-bc63-44055d4cff23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_a5713681-a3ff-45c1-8426-98f996485d2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_1b7a8de1-8d64-4f49-9873-da0a30e17ee3" xlink:to="loc_ifrs-full_CurrentLiabilities_a5713681-a3ff-45c1-8426-98f996485d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_d2e92ca4-e34f-4add-835f-c4f6dcb0a0c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17177103-8d83-418b-af1e-09033fab9791" xlink:to="loc_ifrs-full_EquityAndLiabilities_d2e92ca4-e34f-4add-835f-c4f6dcb0a0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementsofIncomeLoss" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementsofIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementsofIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:href="inpha-20251231.xsd#inpha_RevenueAndOtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_267fbece-7c22-4b11-ae86-9a91a18c06d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_267fbece-7c22-4b11-ae86-9a91a18c06d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GovernmentFinancingForResearchExpenditures_adcdf6f6-01b6-4d4a-928c-619df1dc2686" xlink:href="inpha-20251231.xsd#inpha_GovernmentFinancingForResearchExpenditures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:to="loc_inpha_GovernmentFinancingForResearchExpenditures_adcdf6f6-01b6-4d4a-928c-619df1dc2686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_dac4677c-66c9-487b-af90-cb6e7a58990c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:to="loc_ifrs-full_OtherIncome_dac4677c-66c9-487b-af90-cb6e7a58990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_2bff90b6-fddc-4672-98b5-1c096bb0809b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_RevenueAndOtherIncome_8ad10b54-c2f1-4825-9582-0aa6fcdeb122" xlink:to="loc_ifrs-full_Revenue_2bff90b6-fddc-4672-98b5-1c096bb0809b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:href="inpha-20251231.xsd#inpha_OperatingExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_746c045c-3ddb-4fbe-b695-91aff2545070" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_746c045c-3ddb-4fbe-b695-91aff2545070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_9e8177ca-bd86-4ade-a9f8-fd9efbd610ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_9e8177ca-bd86-4ade-a9f8-fd9efbd610ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e41319c7-298a-44bd-9e32-70992202363a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e41319c7-298a-44bd-9e32-70992202363a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_4f0244f7-c43b-49eb-b26c-2f67d64d3146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_OperatingExpenseAbstract_0234d712-4070-46af-b8a4-287d5d1b7240" xlink:to="loc_ifrs-full_OperatingExpense_4f0244f7-c43b-49eb-b26c-2f67d64d3146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_6aafff94-d56c-42f2-9362-1242d4077d1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_6aafff94-d56c-42f2-9362-1242d4077d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_b304078e-0e8d-48e1-acc6-e9ec8b19ccc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_FinanceIncome_b304078e-0e8d-48e1-acc6-e9ec8b19ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_420dcfdb-f053-4213-953c-e9cd65573c5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_FinanceCosts_420dcfdb-f053-4213-953c-e9cd65573c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_d5b63a27-7a4e-4cb0-b766-45314c936b84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_FinanceIncomeCost_d5b63a27-7a4e-4cb0-b766-45314c936b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_65d6cd19-f356-4055-b3ce-af249d3db975" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_65d6cd19-f356-4055-b3ce-af249d3db975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b6f3db9b-f49c-4b05-98ba-5e8f969a2691" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_b6f3db9b-f49c-4b05-98ba-5e8f969a2691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_e7980ec2-34a1-496f-86ff-65ce8fc01e0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_e7980ec2-34a1-496f-86ff-65ce8fc01e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_e18fd72d-e4fb-456b-9333-d0657cfb8409" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_ProfitLoss_e18fd72d-e4fb-456b-9333-d0657cfb8409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_06711848-b376-4ff5-be4c-44868d6637a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_06711848-b376-4ff5-be4c-44868d6637a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_228c9d58-2393-433b-a1ae-c28d474c1378" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_228c9d58-2393-433b-a1ae-c28d474c1378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0994dde3-581d-4699-adaf-72d91ffa472c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0994dde3-581d-4699-adaf-72d91ffa472c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_6ab7f9bf-06b0-4757-8a11-569107972122" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_6ab7f9bf-06b0-4757-8a11-569107972122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_ba2554c4-7148-41da-b062-904a9ccb4d1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_ba2554c4-7148-41da-b062-904a9ccb4d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_e9c2ccc2-9f49-410f-bd51-9aa8e681e1c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_8cf51614-88cc-4e1e-88cb-b6244ddb54b2" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_e9c2ccc2-9f49-410f-bd51-9aa8e681e1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_ba0350a6-63f5-4e16-aaec-4b16125793a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:to="loc_ifrs-full_ProfitLoss_ba0350a6-63f5-4e16-aaec-4b16125793a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_150a4788-ddd8-4e37-aa62-d37110d65507" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_150a4788-ddd8-4e37-aa62-d37110d65507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome_423cf4a8-bb43-4a84-85b6-6509298eec52" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_150a4788-ddd8-4e37-aa62-d37110d65507" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome_423cf4a8-bb43-4a84-85b6-6509298eec52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_be612a6b-fe67-42a2-86c2-dcdd0a80270c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_150a4788-ddd8-4e37-aa62-d37110d65507" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_be612a6b-fe67-42a2-86c2-dcdd0a80270c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_4b4b380b-b1c3-4994-a1ee-8d186522b28b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_4b4b380b-b1c3-4994-a1ee-8d186522b28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_4a56fb44-a52d-441f-875c-cb63a2b036dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_4b4b380b-b1c3-4994-a1ee-8d186522b28b" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_4a56fb44-a52d-441f-875c-cb63a2b036dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_de921523-b2b7-464c-83bc-267abe149974" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_de921523-b2b7-464c-83bc-267abe149974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_0a773c2b-2c8f-41df-8c34-90c900770ea0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_13803707-e3a4-42ba-b72d-1e193e97b882" xlink:to="loc_ifrs-full_ComprehensiveIncome_0a773c2b-2c8f-41df-8c34-90c900770ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlows" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementofCashFlows"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_8ea2826e-f57e-48c5-8d1e-7b5c9407f109" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_ProfitLoss_8ea2826e-f57e-48c5-8d1e-7b5c9407f109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_beaa624f-89d8-47b5-a0cb-0820042c7310" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_beaa624f-89d8-47b5-a0cb-0820042c7310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_6f9ed077-837f-4575-b501-3ee4a4e6ecb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_6f9ed077-837f-4575-b501-3ee4a4e6ecb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForProvisions_d467c10d-1da7-45b6-a2cf-4a45eea2dcb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForProvisions_d467c10d-1da7-45b6-a2cf-4a45eea2dcb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_150c0975-cd45-43a1-8664-18eae16bca58" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_150c0975-cd45-43a1-8664-18eae16bca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_0bed7441-dac4-490f-8f55-ced8d39c0a7c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_0bed7441-dac4-490f-8f55-ced8d39c0a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_2efc2280-c621-40bd-8e2e-5ccb73c4b0f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_2efc2280-c621-40bd-8e2e-5ccb73c4b0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_6274a977-5119-4140-81c2-48069210bf6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_6274a977-5119-4140-81c2-48069210bf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_74e490da-ef31-47f7-94d3-01040cb0b2aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncome_74e490da-ef31-47f7-94d3-01040cb0b2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_b1f57321-be3c-4a6e-8976-ed4be9ec7d1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_b1f57321-be3c-4a6e-8976-ed4be9ec7d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_68474f79-78f1-408c-994a-8a2758e020a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_68474f79-78f1-408c-994a-8a2758e020a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_83fa6343-6073-4794-9619-3e5a04049112" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_83fa6343-6073-4794-9619-3e5a04049112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_6e27329c-859c-438d-a6da-d98d7eb57a5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_826bc715-32ba-47b3-ab9f-7e50c223624d" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_6e27329c-859c-438d-a6da-d98d7eb57a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_983f45cf-1843-47c9-9e65-69fed64b7e88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_983f45cf-1843-47c9-9e65-69fed64b7e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_81c90c8b-982b-4aa2-896d-f69bf21628e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_81c90c8b-982b-4aa2-896d-f69bf21628e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_dff51213-7187-479f-80e6-24a8dde1508e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_dff51213-7187-479f-80e6-24a8dde1508e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3bded778-f2f9-4e36-844a-1c121a0ebb97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_3bded778-f2f9-4e36-844a-1c121a0ebb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_62c92ecc-eab9-4b72-a9d1-d1033e1199fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_62c92ecc-eab9-4b72-a9d1-d1033e1199fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_8eec4a6a-6972-4869-bc76-0708b065825c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_8eec4a6a-6972-4869-bc76-0708b065825c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterests_45ac6ae1-489a-4d34-9531-60d16ec159d3" xlink:href="inpha-20251231.xsd#inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterests_45ac6ae1-489a-4d34-9531-60d16ec159d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisposalOfNonCurrentFinancialInstruments_41d1cfb6-2722-41c2-9f6e-91a34cb80838" xlink:href="inpha-20251231.xsd#inpha_DisposalOfNonCurrentFinancialInstruments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_inpha_DisposalOfNonCurrentFinancialInstruments_41d1cfb6-2722-41c2-9f6e-91a34cb80838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019d2a59-6f69-79b2-a4fe-53e978d8263f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019d2a59-6f69-79b2-a4fe-53e978d8263f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_c97ef853-b882-4a99-a3e7-0bea817f3a95" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_c97ef853-b882-4a99-a3e7-0bea817f3a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_2bda8b5d-a616-4dda-b6ca-565c086c40d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_2bda8b5d-a616-4dda-b6ca-565c086c40d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_6d0cd6ed-860c-4e46-a1dc-6a3ed0a976aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_6d0cd6ed-860c-4e46-a1dc-6a3ed0a976aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_3144f8db-9ddc-40a5-ab61-324debc0796f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_3144f8db-9ddc-40a5-ab61-324debc0796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_3706ca21-4018-444b-a160-ebf5bb797efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_3706ca21-4018-444b-a160-ebf5bb797efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_da8488d3-478a-4ad3-b37c-c299e9746f41" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_da8488d3-478a-4ad3-b37c-c299e9746f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_daaa98fd-8991-4059-a27c-8791a475f3f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_CashAndCashEquivalents_daaa98fd-8991-4059-a27c-8791a475f3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_b08f741f-6b34-4b69-8660-a803a48d9fcc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_ifrs-full_CashAndCashEquivalents_b08f741f-6b34-4b69-8660-a803a48d9fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:href="inpha-20251231.xsd#inpha_SummaryOfChangesInWorkingCapitalAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_5be5c592-b4fd-46c9-a41c-6e30f646d484" xlink:to="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_e7e97cdd-8c02-40de-96b8-8fe393296d57" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_e7e97cdd-8c02-40de-96b8-8fe393296d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_fff4048f-b09c-4403-afac-0699f9447eaf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_fff4048f-b09c-4403-afac-0699f9447eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayables_dde5a221-8141-4fc1-a2d7-725d80aa08f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_TradeAndOtherPayables_dde5a221-8141-4fc1-a2d7-725d80aa08f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_6e59a5ba-fab6-4df5-80b6-9277df567e63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_6e59a5ba-fab6-4df5-80b6-9277df567e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilities_ac670b7b-1fb3-4adf-a1aa-88f17aa84fc7" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_CollaborationLiabilities_ac670b7b-1fb3-4adf-a1aa-88f17aa84fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities_31056c0a-05e9-40a2-be63-eb0f34138436" xlink:href="inpha-20251231.xsd#inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities_31056c0a-05e9-40a2-be63-eb0f34138436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_1921de3f-6bc2-4f4f-b889-f37404987203" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_1921de3f-6bc2-4f4f-b889-f37404987203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_07ef6c79-48d7-4764-b5ce-c480b38b30cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_07ef6c79-48d7-4764-b5ce-c480b38b30cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ChangeInWorkingCapital_cb064b22-18eb-4652-8b8f-25094de6a30a" xlink:href="inpha-20251231.xsd#inpha_ChangeInWorkingCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_ChangeInWorkingCapital_cb064b22-18eb-4652-8b8f-25094de6a30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInWorkingCapitalBeforeAdjustments_131b6b5d-9954-43fd-b0c3-bc10b7d44dc1" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInWorkingCapitalBeforeAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_IncreaseDecreaseInWorkingCapitalBeforeAdjustments_131b6b5d-9954-43fd-b0c3-bc10b7d44dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxCreditRetentionsCIR_64b14e82-5d43-48dc-af0e-fe4d27bc8b4b" xlink:href="inpha-20251231.xsd#inpha_TaxCreditRetentionsCIR"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_TaxCreditRetentionsCIR_64b14e82-5d43-48dc-af0e-fe4d27bc8b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdjustmentsForIncreaseDecreaseTaxCreditRetentionsCIR_465ddfd6-4b52-41c7-8a32-9dd24b8aa2ec" xlink:href="inpha-20251231.xsd#inpha_AdjustmentsForIncreaseDecreaseTaxCreditRetentionsCIR"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_AdjustmentsForIncreaseDecreaseTaxCreditRetentionsCIR_465ddfd6-4b52-41c7-8a32-9dd24b8aa2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ChangeInWorkingCapitalAdjusted_d73eefbb-7fa1-43f0-86fc-54d5f2e86f53" xlink:href="inpha-20251231.xsd#inpha_ChangeInWorkingCapitalAdjusted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_inpha_ChangeInWorkingCapitalAdjusted_d73eefbb-7fa1-43f0-86fc-54d5f2e86f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_c6412534-3dc2-4c91-9cea-981c708bdd3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_640889fa-7959-4d9a-8212-17dd4732e5bc" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_c6412534-3dc2-4c91-9cea-981c708bdd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlowsParenthetical" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_bc772d41-e006-4af6-81cf-0564cabc43b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_bc772d41-e006-4af6-81cf-0564cabc43b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_16a8eb67-2c4f-426a-84c5-27f9bcea1678" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_16a8eb67-2c4f-426a-84c5-27f9bcea1678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfPreFinancedCIRCollected_7f514d2a-c845-4a41-9bc1-e250f6679a2b" xlink:href="inpha-20251231.xsd#inpha_PercentageOfPreFinancedCIRCollected"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_inpha_PercentageOfPreFinancedCIRCollected_7f514d2a-c845-4a41-9bc1-e250f6679a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WithholdingRateCIR_6ba8626d-ab98-42ed-9bda-cf0fd5ebb999" xlink:href="inpha-20251231.xsd#inpha_WithholdingRateCIR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_inpha_WithholdingRateCIR_6ba8626d-ab98-42ed-9bda-cf0fd5ebb999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CumulativeTaxCreditRetentionsCIR_019d3df4-6d92-7f44-a2a0-f0bbd7a149d8" xlink:href="inpha-20251231.xsd#inpha_CumulativeTaxCreditRetentionsCIR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_inpha_CumulativeTaxCreditRetentionsCIR_019d3df4-6d92-7f44-a2a0-f0bbd7a149d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxCreditRetentions2025CIR_019d3e30-94a5-7be6-9248-ab069dc1c895" xlink:href="inpha-20251231.xsd#inpha_TaxCreditRetentions2025CIR"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_inpha_TaxCreditRetentions2025CIR_019d3e30-94a5-7be6-9248-ab069dc1c895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxCreditRetentions2024CIR_019d3e30-e30e-7a15-b3f4-b21b03b26d15" xlink:href="inpha-20251231.xsd#inpha_TaxCreditRetentions2024CIR"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_070c1909-b18e-4501-9185-2bdc61bc01c0" xlink:to="loc_inpha_TaxCreditRetentions2024CIR_019d3e30-e30e-7a15-b3f4-b21b03b26d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="simple" xlink:href="inpha-20251231.xsd#ConsolidatedStatementofChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_3a6b5abb-d2c1-4161-aa7e-b3ea57539b2c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_8a277bc5-01fc-4771-b468-161988a362d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_3a6b5abb-d2c1-4161-aa7e-b3ea57539b2c" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_8a277bc5-01fc-4771-b468-161988a362d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_b7aa26bc-dbad-4014-abf8-785b501058e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_8a277bc5-01fc-4771-b468-161988a362d2" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_b7aa26bc-dbad-4014-abf8-785b501058e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_b7aa26bc-dbad-4014-abf8-785b501058e6" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_ee9d9431-333f-47ac-9062-29cbbc6abebc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:to="loc_ifrs-full_IssuedCapitalMember_ee9d9431-333f-47ac-9062-29cbbc6abebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_b1fa13dd-7dcb-42a0-9a82-addd4c5297cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:to="loc_ifrs-full_SharePremiumMember_b1fa13dd-7dcb-42a0-9a82-addd4c5297cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_019b9e2d-f839-7027-ae44-2a8d79afe130" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_019b9e2d-f839-7027-ae44-2a8d79afe130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_92e2274b-a054-47b3-8279-2bcb1d7e46e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:to="loc_ifrs-full_OtherReservesMember_92e2274b-a054-47b3-8279-2bcb1d7e46e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_019b9e2b-d0b1-7e55-9b40-28b3a11880f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_7f71928a-e57c-41e4-88ce-98207d59b45c" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_019b9e2b-d0b1-7e55-9b40-28b3a11880f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019d2539-756e-742e-ba25-a9b77b24562b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_8a277bc5-01fc-4771-b468-161988a362d2" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019d2539-756e-742e-ba25-a9b77b24562b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019d2539-756e-774c-99b1-04763b46b6df" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019d2539-756e-742e-ba25-a9b77b24562b" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019d2539-756e-774c-99b1-04763b46b6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PreferenceSharesMember_019d2539-81de-7701-a776-31f0250c1b2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PreferenceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019d2539-756e-774c-99b1-04763b46b6df" xlink:to="loc_ifrs-full_PreferenceSharesMember_019d2539-81de-7701-a776-31f0250c1b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019d3df9-82fd-73d3-b75d-878c6c81b38e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019d2539-756e-774c-99b1-04763b46b6df" xlink:to="loc_ifrs-full_OrdinarySharesMember_019d3df9-82fd-73d3-b75d-878c6c81b38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_8a277bc5-01fc-4771-b468-161988a362d2" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_d23e4051-e3b5-4e27-8f5a-c4e6d3e863f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_NumberOfSharesIssued_d23e4051-e3b5-4e27-8f5a-c4e6d3e863f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_561b3b64-c1cd-46d3-897c-155745e5a790" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_Equity_561b3b64-c1cd-46d3-897c-155745e5a790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_706e752e-63cc-4840-a46d-b009f72a4d47" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_ProfitLoss_706e752e-63cc-4840-a46d-b009f72a4d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_a31aa641-1aed-446c-89ec-60f55369f6a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_a31aa641-1aed-446c-89ec-60f55369f6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_d96ca097-9367-4d2d-bdeb-a58fb3c65c3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_d96ca097-9367-4d2d-bdeb-a58fb3c65c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_980a6a94-4706-48f7-bf28-a153352f76c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_ComprehensiveIncome_980a6a94-4706-48f7-bf28-a153352f76c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_019b9e25-53ab-72f0-bc86-c2919cb23a23" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_019b9e25-53ab-72f0-bc86-c2919cb23a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_297e0fb3-31cc-46b4-b717-60f9d7796139" xlink:href="inpha-20251231.xsd#inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_297e0fb3-31cc-46b4-b717-60f9d7796139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_d2837f9a-dd8c-45b9-94cd-cffdfe1afcfb" xlink:href="inpha-20251231.xsd#inpha_ExerciseAndSubscriptionOfEquityInstruments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_d2837f9a-dd8c-45b9-94cd-cffdfe1afcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseCapitalNetInShares_55ebb75c-af15-436d-bf6b-08c783e78c72" xlink:href="inpha-20251231.xsd#inpha_IncreaseCapitalNetInShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_inpha_IncreaseCapitalNetInShares_55ebb75c-af15-436d-bf6b-08c783e78c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_0ab7c079-10ab-4dd1-867a-b18a20ce7a07" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_IssueOfEquity_0ab7c079-10ab-4dd1-867a-b18a20ce7a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_bb110e22-528e-45de-919d-8fe417639149" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_bb110e22-528e-45de-919d-8fe417639149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_5377c3a5-f3b1-4a92-9fe4-723ca651ac0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_NumberOfSharesIssued_5377c3a5-f3b1-4a92-9fe4-723ca651ac0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ca8d1c21-0e70-444d-bd9e-30e25dec3462" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c937417d-8151-4ab4-accf-086981ff4663" xlink:to="loc_ifrs-full_Equity_ca8d1c21-0e70-444d-bd9e-30e25dec3462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Thecompany" xlink:type="simple" xlink:href="inpha-20251231.xsd#Thecompany"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Thecompany" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_0029564e-04ce-45d1-a726-f2b1ff808bf7" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfCompanySignificantContractsAndKeyEventsTextBlock_c2c48f31-fbf3-40d1-be06-295021bd5003" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfCompanySignificantContractsAndKeyEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_0029564e-04ce-45d1-a726-f2b1ff808bf7" xlink:to="loc_inpha_DisclosureOfCompanySignificantContractsAndKeyEventsTextBlock_c2c48f31-fbf3-40d1-be06-295021bd5003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Accountingpoliciesandstatementofcompliance" xlink:type="simple" xlink:href="inpha-20251231.xsd#Accountingpoliciesandstatementofcompliance"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Accountingpoliciesandstatementofcompliance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_e9bf849f-8c48-4142-90e0-598a4786d972" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_3cf053d8-2267-44a5-a7ff-f16c31cd2b63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_e9bf849f-8c48-4142-90e0-598a4786d972" xlink:to="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_3cf053d8-2267-44a5-a7ff-f16c31cd2b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Managementoffinancialrisksandfairvalue" xlink:type="simple" xlink:href="inpha-20251231.xsd#Managementoffinancialrisksandfairvalue"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Managementoffinancialrisksandfairvalue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_7421a7ca-6c8a-455c-b756-01b7d6d15294" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_f4b95c1c-ff36-4211-a690-102567a9ef4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_7421a7ca-6c8a-455c-b756-01b7d6d15294" xlink:to="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_f4b95c1c-ff36-4211-a690-102567a9ef4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Cashcashequivalentsandfinancialassets" xlink:type="simple" xlink:href="inpha-20251231.xsd#Cashcashequivalentsandfinancialassets"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Cashcashequivalentsandfinancialassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract_0961f6fb-56c1-409b-9db3-3b61c7d566a8" xlink:href="inpha-20251231.xsd#inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_39e435d0-37f2-4626-8c01-e8f56b9a2a4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract_0961f6fb-56c1-409b-9db3-3b61c7d566a8" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_39e435d0-37f2-4626-8c01-e8f56b9a2a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Tradereceivablesandothers" xlink:type="simple" xlink:href="inpha-20251231.xsd#Tradereceivablesandothers"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Tradereceivablesandothers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_ca460bf3-2d62-4a3b-93d0-de7129fdf234" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1fc5dd8c-a5f9-48f5-8632-4f71856f9ddb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_ca460bf3-2d62-4a3b-93d0-de7129fdf234" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1fc5dd8c-a5f9-48f5-8632-4f71856f9ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Intangibleassets" xlink:type="simple" xlink:href="inpha-20251231.xsd#Intangibleassets"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Intangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_4e2f345d-9baa-4b21-b95e-f7e939a20208" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_344affb2-9368-4f8a-8981-422503ee191c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_4e2f345d-9baa-4b21-b95e-f7e939a20208" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_344affb2-9368-4f8a-8981-422503ee191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Propertyandequipment" xlink:type="simple" xlink:href="inpha-20251231.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_98eb1a7e-ec11-4a5d-a8c5-4e49ff481fa3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_ce0100aa-834c-4de2-8434-63e64b82cade" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_98eb1a7e-ec11-4a5d-a8c5-4e49ff481fa3" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_ce0100aa-834c-4de2-8434-63e64b82cade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Tradepayablesandothers" xlink:type="simple" xlink:href="inpha-20251231.xsd#Tradepayablesandothers"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Tradepayablesandothers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_a4ab44b5-f590-4b18-ae71-bfdbc4d73de8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_23ecaee4-7a66-4f63-8776-795096f1d69e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_a4ab44b5-f590-4b18-ae71-bfdbc4d73de8" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_23ecaee4-7a66-4f63-8776-795096f1d69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Financialliabilities" xlink:type="simple" xlink:href="inpha-20251231.xsd#Financialliabilities"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Financialliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ce43071b-ad2e-4177-9e36-816c02289bd2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_e2d97e31-e3cc-4f46-9905-b21348eb7bf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_ce43071b-ad2e-4177-9e36-816c02289bd2" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_e2d97e31-e3cc-4f46-9905-b21348eb7bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Employeebenefits" xlink:type="simple" xlink:href="inpha-20251231.xsd#Employeebenefits"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Employeebenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_8c7d9f3e-b8f5-46e7-99c7-7892856d6361" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_5c9d8656-433d-4200-9a3b-5c0188e166fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_8c7d9f3e-b8f5-46e7-99c7-7892856d6361" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_5c9d8656-433d-4200-9a3b-5c0188e166fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Sharecapitalandsharebasedpayments" xlink:type="simple" xlink:href="inpha-20251231.xsd#Sharecapitalandsharebasedpayments"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Sharecapitalandsharebasedpayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_67b9f9d4-357e-4218-ab5e-c3de24963390" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_16fbd34b-1f4d-4072-a60a-d83364a1baea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_67b9f9d4-357e-4218-ab5e-c3de24963390" xlink:to="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_16fbd34b-1f4d-4072-a60a-d83364a1baea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement" xlink:type="simple" xlink:href="inpha-20251231.xsd#Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_cf4227ab-ad8f-4080-b8b7-8f430c833fbf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_603ea71b-817d-4c1a-b63c-afe6296564cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_cf4227ab-ad8f-4080-b8b7-8f430c833fbf" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_603ea71b-817d-4c1a-b63c-afe6296564cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Revenueandgovernmentfinancingforresearchexpenditures" xlink:type="simple" xlink:href="inpha-20251231.xsd#Revenueandgovernmentfinancingforresearchexpenditures"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Revenueandgovernmentfinancingforresearchexpenditures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_a5e9e5aa-a9e2-4eac-8d93-9c7d0fac4076" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_cc930ccc-d951-4b8e-a448-10f85ec4b712" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_a5e9e5aa-a9e2-4eac-8d93-9c7d0fac4076" xlink:to="loc_ifrs-full_DisclosureOfRevenueExplanatory_cc930ccc-d951-4b8e-a448-10f85ec4b712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Operatingexpenses" xlink:type="simple" xlink:href="inpha-20251231.xsd#Operatingexpenses"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Operatingexpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1f0e3d00-dee5-49ba-b1fe-9736be27ac90" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesExplanatory_05bd0376-2451-41d9-bd77-77317a0eb93f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1f0e3d00-dee5-49ba-b1fe-9736be27ac90" xlink:to="loc_ifrs-full_DisclosureOfExpensesExplanatory_05bd0376-2451-41d9-bd77-77317a0eb93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Netfinancialincomeloss" xlink:type="simple" xlink:href="inpha-20251231.xsd#Netfinancialincomeloss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Netfinancialincomeloss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_07605c5a-b12e-4dc0-978c-989fd459821d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_c155fa68-2b3b-4ae6-9829-8d4d7b14f9bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_07605c5a-b12e-4dc0-978c-989fd459821d" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_c155fa68-2b3b-4ae6-9829-8d4d7b14f9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomeTax" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_58fa8a68-77ff-4621-9c3b-e96fbe31eb48" xlink:href="inpha-20251231.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_31ceb78e-1220-4829-9406-6dd60153e842" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_58fa8a68-77ff-4621-9c3b-e96fbe31eb48" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_31ceb78e-1220-4829-9406-6dd60153e842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigations" xlink:type="simple" xlink:href="inpha-20251231.xsd#Commitmentscontingenciesandlitigations"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_79d933b8-697d-42dd-90d6-3694477f6c1e" xlink:href="inpha-20251231.xsd#inpha_CommitmentsContingenciesAndLitigationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_052102c8-8b62-4ee7-8bba-8c23d3a50343" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_79d933b8-697d-42dd-90d6-3694477f6c1e" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_052102c8-8b62-4ee7-8bba-8c23d3a50343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="inpha-20251231.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_56cac500-3673-4991-ab50-6387ca10acae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_0bb15c81-9ca3-487c-be0d-21a36599eade" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_56cac500-3673-4991-ab50-6387ca10acae" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_0bb15c81-9ca3-487c-be0d-21a36599eade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Incomelosspershare" xlink:type="simple" xlink:href="inpha-20251231.xsd#Incomelosspershare"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Incomelosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_14c1c3db-b0d3-4ade-94c1-ecfefb66c63e" xlink:href="inpha-20251231.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_408638df-d8d0-4c3b-92d2-c5cc8edc1728" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_14c1c3db-b0d3-4ade-94c1-ecfefb66c63e" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_408638df-d8d0-4c3b-92d2-c5cc8edc1728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Eventsafterthereportingdate" xlink:type="simple" xlink:href="inpha-20251231.xsd#Eventsafterthereportingdate"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Eventsafterthereportingdate" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_ac5d0fec-1ade-4eae-812b-81a68a26aaf1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_83b05bce-b8ec-4be9-86a8-d78d4825f328" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_ac5d0fec-1ade-4eae-812b-81a68a26aaf1" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_83b05bce-b8ec-4be9-86a8-d78d4825f328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcompliancePolicies" xlink:type="simple" xlink:href="inpha-20251231.xsd#AccountingpoliciesandstatementofcompliancePolicies"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcompliancePolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForBasisOfPreparationPolicyTextBlock_6cb6a8e3-4902-4ed5-95cd-502b1a4ffa6f" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForBasisOfPreparationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForBasisOfPreparationPolicyTextBlock_6cb6a8e3-4902-4ed5-95cd-502b1a4ffa6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfStatementOfCompliancePolicyTextBlock_906610a2-7a01-4326-be76-0fffea342489" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfStatementOfCompliancePolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfStatementOfCompliancePolicyTextBlock_906610a2-7a01-4326-be76-0fffea342489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForNewIFRSReleasesPolicyTextBlock_6c960bf0-c90c-4add-a7a0-76e765731c0e" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForNewIFRSReleasesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForNewIFRSReleasesPolicyTextBlock_6c960bf0-c90c-4add-a7a0-76e765731c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForChangeInAccountingPoliciesPolicyTextBlock_67401e7b-2ab2-4ae6-a3b7-91e2570d9d01" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForChangeInAccountingPoliciesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForChangeInAccountingPoliciesPolicyTextBlock_67401e7b-2ab2-4ae6-a3b7-91e2570d9d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2c3126ad-56e9-46ed-ac8f-62ac17d7e1a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_2c3126ad-56e9-46ed-ac8f-62ac17d7e1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForConsolidationMethodPolicyTextBlock_45b6b0ca-8c01-427c-8969-9032d3769245" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForConsolidationMethodPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForConsolidationMethodPolicyTextBlock_45b6b0ca-8c01-427c-8969-9032d3769245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_7341460b-13d8-4663-80f0-b1c795d71c11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_7341460b-13d8-4663-80f0-b1c795d71c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_d8a3afbe-5501-41ff-9602-a6378b8dfc88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_d8a3afbe-5501-41ff-9602-a6378b8dfc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_9e35f2c1-74fd-476b-bf5f-209392e223ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_9e35f2c1-74fd-476b-bf5f-209392e223ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_22dc695b-255c-483f-8560-0f8f5f3d9f75" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_22dc695b-255c-483f-8560-0f8f5f3d9f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f6d188ab-45d8-4e35-9513-a36eb063a1f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_f6d188ab-45d8-4e35-9513-a36eb063a1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2ab90b62-27b3-4ec2-a055-0320f3c8454e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_2ab90b62-27b3-4ec2-a055-0320f3c8454e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_9e5aa353-5363-40d0-8f03-62d4fec97f78" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_9e5aa353-5363-40d0-8f03-62d4fec97f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_ea3cb590-989a-43d5-8359-7a029df2b1c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_ea3cb590-989a-43d5-8359-7a029df2b1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_6aa46448-e016-4adf-a552-d28bbd9e37bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_6aa46448-e016-4adf-a552-d28bbd9e37bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0eccf46f-289a-40f5-a8e2-276b370eecd7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0eccf46f-289a-40f5-a8e2-276b370eecd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_08a9b2f3-9279-45e4-9245-70dc624c5194" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_08a9b2f3-9279-45e4-9245-70dc624c5194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_d283b457-8924-428c-a6e0-b34cb3706bbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_d283b457-8924-428c-a6e0-b34cb3706bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_e8badc2e-9dde-44aa-91ca-102fb1df4ae0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_e8badc2e-9dde-44aa-91ca-102fb1df4ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForOtherComprehensiveIncomePolicyTextBlock_663a5556-6039-4f97-a383-03661f9c9eca" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForOtherComprehensiveIncomePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForOtherComprehensiveIncomePolicyTextBlock_663a5556-6039-4f97-a383-03661f9c9eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_905ffa91-7442-47a1-b72b-fdbe0531310d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_905ffa91-7442-47a1-b72b-fdbe0531310d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_8d83107a-064e-48b4-90e1-8382506e9daf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_8d83107a-064e-48b4-90e1-8382506e9daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DescriptionOfAccountingPolicyForAccountingEstimatesAndAssumptionsPolicyTextBlock_cf516d84-1309-423b-8dde-2ab5a1d24887" xlink:href="inpha-20251231.xsd#inpha_DescriptionOfAccountingPolicyForAccountingEstimatesAndAssumptionsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_f8f290b4-a0b0-4c7e-9894-e15afeea4ef1" xlink:to="loc_inpha_DescriptionOfAccountingPolicyForAccountingEstimatesAndAssumptionsPolicyTextBlock_cf516d84-1309-423b-8dde-2ab5a1d24887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_019b9e4e-2bf7-7da1-85aa-ce862e3508b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_019b9e4d-8360-7a8d-8aec-f37990d3d9ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_019b9e4e-2bf7-7da1-85aa-ce862e3508b9" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_019b9e4d-8360-7a8d-8aec-f37990d3d9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#AccountingpoliciesandstatementofcomplianceTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_4c855a9b-8ad5-41f3-a9ca-f88ccabb4fdc" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_a5a37a91-fef2-4745-90c7-d234043d083b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_4c855a9b-8ad5-41f3-a9ca-f88ccabb4fdc" xlink:to="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_a5a37a91-fef2-4745-90c7-d234043d083b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfDepreciationPeriodsTableTextBlock_ea828cff-f3c5-4074-85aa-6c74d02ccaac" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfDepreciationPeriodsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_4c855a9b-8ad5-41f3-a9ca-f88ccabb4fdc" xlink:to="loc_inpha_DisclosureOfDepreciationPeriodsTableTextBlock_ea828cff-f3c5-4074-85aa-6c74d02ccaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#CashcashequivalentsandfinancialassetsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract_b9b19d93-09d0-4f99-ae80-5a388c810172" xlink:href="inpha-20251231.xsd#inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock_a46c57eb-5fbc-4fa6-9896-35aee601203d" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract_b9b19d93-09d0-4f99-ae80-5a388c810172" xlink:to="loc_inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock_a46c57eb-5fbc-4fa6-9896-35aee601203d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory_41ac5808-c107-4562-91fb-e78d2e3d2ba5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CashAndCashEquivalentsAndFinancialAssetsAbstract_b9b19d93-09d0-4f99-ae80-5a388c810172" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory_41ac5808-c107-4562-91fb-e78d2e3d2ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradereceivablesandothersTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#TradereceivablesandothersTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradereceivablesandothersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_be3c911b-4703-4376-b2ad-0163e2aa87c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock_45de9f39-3dd3-4a65-bafa-0097f41b478d" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_be3c911b-4703-4376-b2ad-0163e2aa87c4" xlink:to="loc_inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock_45de9f39-3dd3-4a65-bafa-0097f41b478d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IntangibleassetsTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#IntangibleassetsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IntangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_19e32e87-37f1-4306-a131-277e46b5a3c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_61542e6e-ad57-4410-a6c4-1dda7213a757" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_19e32e87-37f1-4306-a131-277e46b5a3c3" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_61542e6e-ad57-4410-a6c4-1dda7213a757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_dee4fa5d-f2db-4130-ae4a-4d3a2844898f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_5af44de3-1834-45e4-885a-f4e0a7cad52c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_dee4fa5d-f2db-4130-ae4a-4d3a2844898f" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_5af44de3-1834-45e4-885a-f4e0a7cad52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradepayablesandothersTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#TradepayablesandothersTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradepayablesandothersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_9ed1b751-9305-486c-b3aa-fc07b36ed8b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradePayablesAndOthersTextBlock_e12445a2-fbe9-4dc2-b7dd-6d39d07e04ac" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfTradePayablesAndOthersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_9ed1b751-9305-486c-b3aa-fc07b36ed8b1" xlink:to="loc_inpha_DisclosureOfTradePayablesAndOthersTextBlock_e12445a2-fbe9-4dc2-b7dd-6d39d07e04ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_50f139e6-bfb2-4149-9837-ad0e5cbf9f4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock_a103d12c-2253-43ff-83d4-db39907322f2" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_50f139e6-bfb2-4149-9837-ad0e5cbf9f4f" xlink:to="loc_inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock_a103d12c-2253-43ff-83d4-db39907322f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfFinancialLiabilitiesClassifiedTableTextBlock_f8035027-265c-4541-84d4-e0216eecd296" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfFinancialLiabilitiesClassifiedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_50f139e6-bfb2-4149-9837-ad0e5cbf9f4f" xlink:to="loc_inpha_DisclosureOfFinancialLiabilitiesClassifiedTableTextBlock_f8035027-265c-4541-84d4-e0216eecd296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_566df01e-954c-421c-8b57-fde6d9620057" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_50f139e6-bfb2-4149-9837-ad0e5cbf9f4f" xlink:to="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_566df01e-954c-421c-8b57-fde6d9620057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitsTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#EmployeebenefitsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_1884a130-3c54-4c50-b4eb-0f17d2005e64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_ae73cf92-e127-47b0-a03d-b4c090bb0e6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_1884a130-3c54-4c50-b4eb-0f17d2005e64" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_ae73cf92-e127-47b0-a03d-b4c090bb0e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfActuarialAssumptionsForDefinedBenefitPlansTextBlock_874519bb-d6d8-4847-b5d4-8d5a76984d9e" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfActuarialAssumptionsForDefinedBenefitPlansTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_1884a130-3c54-4c50-b4eb-0f17d2005e64" xlink:to="loc_inpha_DisclosureOfActuarialAssumptionsForDefinedBenefitPlansTextBlock_874519bb-d6d8-4847-b5d4-8d5a76984d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_a6d7dae7-57d0-4019-a120-14e15f2168b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_1884a130-3c54-4c50-b4eb-0f17d2005e64" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_a6d7dae7-57d0-4019-a120-14e15f2168b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_30576e50-e524-48db-87d6-7ec34638c5ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_30576e50-e524-48db-87d6-7ec34638c5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_303eeceb-10d9-40a5-8a42-8b364d711142" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_303eeceb-10d9-40a5-8a42-8b364d711142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_57333583-4f05-4b04-b7e7-c4c0585f9c7d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_57333583-4f05-4b04-b7e7-c4c0585f9c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfChangeInNumberOfOtherEquityInstrumentsOutstandingTableTextBlock_cc6c5e1c-963d-47b5-b113-f0984da24bae" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfChangeInNumberOfOtherEquityInstrumentsOutstandingTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_inpha_DisclosureOfChangeInNumberOfOtherEquityInstrumentsOutstandingTableTextBlock_cc6c5e1c-963d-47b5-b113-f0984da24bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfClosingBalanceOfShareBasedPaymentArrangementsTableTextBlock_cb5e4501-63e4-43b0-b15e-21094241646e" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfClosingBalanceOfShareBasedPaymentArrangementsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_inpha_DisclosureOfClosingBalanceOfShareBasedPaymentArrangementsTableTextBlock_cb5e4501-63e4-43b0-b15e-21094241646e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_af9ed264-216a-4dce-9b3e-270a3360488a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0873e797-05ab-4184-b708-f53d7b4994e2" xlink:to="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss_af9ed264-216a-4dce-9b3e-270a3360488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_6d6b286e-2167-4eb8-8526-65b00af5c640" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_85b85671-f5ae-4bde-aab8-508aea096242" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_6d6b286e-2167-4eb8-8526-65b00af5c640" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_85b85671-f5ae-4bde-aab8-508aea096242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_01322895-6757-4249-a547-b512eafeefef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_3eb390cc-f022-413d-89c9-d415a7f3776c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_01322895-6757-4249-a547-b512eafeefef" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_3eb390cc-f022-413d-89c9-d415a7f3776c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory_44fb67f8-e834-4ab5-a884-fe13507e77f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_01322895-6757-4249-a547-b512eafeefef" xlink:to="loc_ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory_44fb67f8-e834-4ab5-a884-fe13507e77f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock_7c11d973-8c30-4188-a1ac-b316d0320653" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_01322895-6757-4249-a547-b512eafeefef" xlink:to="loc_inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock_7c11d973-8c30-4188-a1ac-b316d0320653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock_b267d62a-6955-4f41-905c-5ed75a36ad31" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_01322895-6757-4249-a547-b512eafeefef" xlink:to="loc_inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock_b267d62a-6955-4f41-905c-5ed75a36ad31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#OperatingexpensesTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f2f9e707-1e35-438a-986c-ecc155c719d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_d6d5283c-ff43-4bb2-ba89-56dfd875f574" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f2f9e707-1e35-438a-986c-ecc155c719d1" xlink:to="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_d6d5283c-ff43-4bb2-ba89-56dfd875f574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfAuditAndNonAuditFeesTableTextBlock_f24d8539-784c-4c3a-b85a-a380a16f2c38" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfAuditAndNonAuditFeesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f2f9e707-1e35-438a-986c-ecc155c719d1" xlink:to="loc_inpha_DisclosureOfAuditAndNonAuditFeesTableTextBlock_f24d8539-784c-4c3a-b85a-a380a16f2c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/NetfinancialincomelossTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#NetfinancialincomelossTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/NetfinancialincomelossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9656dbdd-214b-48ab-9122-8f1a25263637" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock_6a1b9caa-ca46-44a8-ae35-d0fd8fd456a4" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_9656dbdd-214b-48ab-9122-8f1a25263637" xlink:to="loc_inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock_6a1b9caa-ca46-44a8-ae35-d0fd8fd456a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomeTaxTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomeTaxTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomeTaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_c669b529-5407-47b2-a0c9-e5fb572a7383" xlink:href="inpha-20251231.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_fa9411db-3371-4f6b-a05c-2c5c2fd10f90" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_c669b529-5407-47b2-a0c9-e5fb572a7383" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_fa9411db-3371-4f6b-a05c-2c5c2fd10f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTaxRateReconciliationTextBlock_4af1e7e9-a111-48cb-8e42-9aeffe09fad7" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfTaxRateReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_c669b529-5407-47b2-a0c9-e5fb572a7383" xlink:to="loc_inpha_DisclosureOfTaxRateReconciliationTextBlock_4af1e7e9-a111-48cb-8e42-9aeffe09fad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#RelatedpartytransactionsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_d642adcb-478e-4482-941e-c3efdf2e1665" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock_8742749a-2cdc-4940-b7ce-d41f5abe0ac3" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_d642adcb-478e-4482-941e-c3efdf2e1665" xlink:to="loc_inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock_8742749a-2cdc-4940-b7ce-d41f5abe0ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0475f185-ba45-4406-8870-cf246f838bca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_d642adcb-478e-4482-941e-c3efdf2e1665" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0475f185-ba45-4406-8870-cf246f838bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareTables" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomelosspershareTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_913e828f-a652-46b0-af38-d9c9a37c80a7" xlink:href="inpha-20251231.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_d965b8db-7ce3-4639-98bb-8e3f737a0662" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_913e828f-a652-46b0-af38-d9c9a37c80a7" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_d965b8db-7ce3-4639-98bb-8e3f737a0662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_ce12334a-3317-4d17-a23b-6bd916b72110" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationTable_019d2a57-15f9-7337-b685-1ae2ffcb4bff" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_ce12334a-3317-4d17-a23b-6bd916b72110" xlink:to="loc_inpha_CompanyInformationTable_019d2a57-15f9-7337-b685-1ae2ffcb4bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationTable_019d2a57-15f9-7337-b685-1ae2ffcb4bff" xlink:to="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfTherapeuticApproaches_4ef09bba-36c9-4c9d-923b-950cc3d3747c" xlink:href="inpha-20251231.xsd#inpha_NumberOfTherapeuticApproaches"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:to="loc_inpha_NumberOfTherapeuticApproaches_4ef09bba-36c9-4c9d-923b-950cc3d3747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_3c792f4c-7b63-4bf6-9dc3-b5e95fd0100f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:to="loc_ifrs-full_ProfitLoss_3c792f4c-7b63-4bf6-9dc3-b5e95fd0100f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_99f8b6fc-d746-4d78-93dc-19281cc7a405" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:to="loc_ifrs-full_Equity_99f8b6fc-d746-4d78-93dc-19281cc7a405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfWhollyOwnedSubsidiaries_2ea7b8aa-e056-4843-8673-04ffacf8f4dd" xlink:href="inpha-20251231.xsd#inpha_NumberOfWhollyOwnedSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationLineItems_019d2a57-15f9-751f-9dfd-af087134cd2a" xlink:to="loc_inpha_NumberOfWhollyOwnedSubsidiaries_2ea7b8aa-e056-4843-8673-04ffacf8f4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Thecompany2014NovoNordiskASmonalizumabagreementDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#Thecompany2014NovoNordiskASmonalizumabagreementDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Thecompany2014NovoNordiskASmonalizumabagreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_61083f4a-9e0e-4d2c-84b3-daef5b0e4135" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_8175c2ca-5e25-4bf4-94e0-1987d2a5e5de" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_61083f4a-9e0e-4d2c-84b3-daef5b0e4135" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_8175c2ca-5e25-4bf4-94e0-1987d2a5e5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_5712db12-42f8-4608-a29f-3602aeb6a7ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_8175c2ca-5e25-4bf4-94e0-1987d2a5e5de" xlink:to="loc_ifrs-full_TypesOfContractsAxis_5712db12-42f8-4608-a29f-3602aeb6a7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_82d217ce-5400-4774-8bca-98c703b1e781" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_5712db12-42f8-4608-a29f-3602aeb6a7ce" xlink:to="loc_ifrs-full_TypesOfContractsDomain_82d217ce-5400-4774-8bca-98c703b1e781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2014NovoNordiskASMonalizumabAgreementMember_c93c1e7a-cac8-427f-a0a7-726f0495aa03" xlink:href="inpha-20251231.xsd#inpha_A2014NovoNordiskASMonalizumabAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_82d217ce-5400-4774-8bca-98c703b1e781" xlink:to="loc_inpha_A2014NovoNordiskASMonalizumabAgreementMember_c93c1e7a-cac8-427f-a0a7-726f0495aa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_8175c2ca-5e25-4bf4-94e0-1987d2a5e5de" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0b884070-560b-4dfd-a3f9-ab1f56b60db3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0b884070-560b-4dfd-a3f9-ab1f56b60db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SharesIssuedForTheAcquisitionOfC5aRIntangibleAssetInShares_90b30ccb-ad08-4128-b920-09d8c97ec6f9" xlink:href="inpha-20251231.xsd#inpha_SharesIssuedForTheAcquisitionOfC5aRIntangibleAssetInShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_inpha_SharesIssuedForTheAcquisitionOfC5aRIntangibleAssetInShares_90b30ccb-ad08-4128-b920-09d8c97ec6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareIssuedPricePerShare_22da6364-bddf-4bb6-b821-4ca306c5ff49" xlink:href="inpha-20251231.xsd#inpha_ShareIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_inpha_ShareIssuedPricePerShare_22da6364-bddf-4bb6-b821-4ca306c5ff49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IssueSharesForLicenses_8ae1e4eb-0fa8-4cdf-9353-a0393ade2ba5" xlink:href="inpha-20251231.xsd#inpha_IssueSharesForLicenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_inpha_IssueSharesForLicenses_8ae1e4eb-0fa8-4cdf-9353-a0393ade2ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumPotentialRegulatoryMilestonesAndSingleDigitTieredRoyaltiesOnSaleOfProducts_8481eec6-72f0-4977-9bdf-2ec2b4ce36ba" xlink:href="inpha-20251231.xsd#inpha_MaximumPotentialRegulatoryMilestonesAndSingleDigitTieredRoyaltiesOnSaleOfProducts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_inpha_MaximumPotentialRegulatoryMilestonesAndSingleDigitTieredRoyaltiesOnSaleOfProducts_8481eec6-72f0-4977-9bdf-2ec2b4ce36ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_9d4b5b99-e984-41a8-b3f6-9dceed211c14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_ifrs-full_FinancialLiabilities_9d4b5b99-e984-41a8-b3f6-9dceed211c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PotentialAdditionalMilestonePayments_a1f479a3-83dc-4b08-9440-f22204e69167" xlink:href="inpha-20251231.xsd#inpha_PotentialAdditionalMilestonePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_inpha_PotentialAdditionalMilestonePayments_a1f479a3-83dc-4b08-9440-f22204e69167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_07a99d30-7b0c-40f0-87a4-cf8c3f24264c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_061d6eb4-d133-4bbe-9ff2-9b715a61e851" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_07a99d30-7b0c-40f0-87a4-cf8c3f24264c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Thecompany2015AstraZenecamonalizumabagreementsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#Thecompany2015AstraZenecamonalizumabagreementsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Thecompany2015AstraZenecamonalizumabagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_7e895226-922f-4bff-9677-1cb7cd1822c8" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3fb26273-2334-40a6-8d1e-9c83747ba3fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_7e895226-922f-4bff-9677-1cb7cd1822c8" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3fb26273-2334-40a6-8d1e-9c83747ba3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_6f950325-4b5a-497e-ac74-e9dd227b78fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3fb26273-2334-40a6-8d1e-9c83747ba3fe" xlink:to="loc_ifrs-full_TypesOfContractsAxis_6f950325-4b5a-497e-ac74-e9dd227b78fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_0510caf4-8da6-4e9e-97d2-280424b10024" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_6f950325-4b5a-497e-ac74-e9dd227b78fe" xlink:to="loc_ifrs-full_TypesOfContractsDomain_0510caf4-8da6-4e9e-97d2-280424b10024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_861763d2-7c40-410c-a993-d0ecd6fc59c5" xlink:href="inpha-20251231.xsd#inpha_A2015AstraZenecaMonalizumabAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_0510caf4-8da6-4e9e-97d2-280424b10024" xlink:to="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_861763d2-7c40-410c-a993-d0ecd6fc59c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3fb26273-2334-40a6-8d1e-9c83747ba3fe" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement_6e74f61b-6723-445e-a1a6-46af8697c0c8" xlink:href="inpha-20251231.xsd#inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement_6e74f61b-6723-445e-a1a6-46af8697c0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReceiptsFromCodevelopmentAgreement_aafaecef-c4aa-45b0-98c9-7e313c0ec66a" xlink:href="inpha-20251231.xsd#inpha_ReceiptsFromCodevelopmentAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_ReceiptsFromCodevelopmentAgreement_aafaecef-c4aa-45b0-98c9-7e313c0ec66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReceiptsFromOptionAgreement_e0806307-c37c-425e-872b-32697af06169" xlink:href="inpha-20251231.xsd#inpha_ReceiptsFromOptionAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_ReceiptsFromOptionAgreement_e0806307-c37c-425e-872b-32697af06169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProceedsFromExerciseOfOptionAgreement_87c530a1-cc8c-4164-aa6f-3615dcb85473" xlink:href="inpha-20251231.xsd#inpha_ProceedsFromExerciseOfOptionAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_ProceedsFromExerciseOfOptionAgreement_87c530a1-cc8c-4164-aa6f-3615dcb85473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumPotentialRegulatoryMilestones_a78da73e-61e2-4669-b4ba-33d908126384" xlink:href="inpha-20251231.xsd#inpha_MaximumPotentialRegulatoryMilestones"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_MaximumPotentialRegulatoryMilestones_a78da73e-61e2-4669-b4ba-33d908126384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_7cd8d365-bc3d-4e23-a735-7a78e5734660" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_7cd8d365-bc3d-4e23-a735-7a78e5734660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdditionalMilestonesPaymentReceivable_0fee015d-fe23-43ab-ae21-fceec91bd996" xlink:href="inpha-20251231.xsd#inpha_AdditionalMilestonesPaymentReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_AdditionalMilestonesPaymentReceivable_0fee015d-fe23-43ab-ae21-fceec91bd996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdditionalMilestonesPaymentReceivableNotEligible_87592727-6d70-4f2c-808b-7aa3cc2636b3" xlink:href="inpha-20251231.xsd#inpha_AdditionalMilestonesPaymentReceivableNotEligible"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_AdditionalMilestonesPaymentReceivableNotEligible_87592727-6d70-4f2c-808b-7aa3cc2636b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_4358ea60-3511-40bc-8b65-b1b2dded2f68" xlink:href="inpha-20251231.xsd#inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_4358ea60-3511-40bc-8b65-b1b2dded2f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DevelopmentAndRegulatoryMilestones_41dc7344-8bc0-4926-83a0-016530133b24" xlink:href="inpha-20251231.xsd#inpha_DevelopmentAndRegulatoryMilestones"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_DevelopmentAndRegulatoryMilestones_41dc7344-8bc0-4926-83a0-016530133b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommercializationMilestones_ae83948c-b317-4dbf-96f4-57dd5f285a1c" xlink:href="inpha-20251231.xsd#inpha_CommercializationMilestones"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_CommercializationMilestones_ae83948c-b317-4dbf-96f4-57dd5f285a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CoFundPercentageOfTrialsOfLicensedProduct_b1bc6868-2c26-4555-9211-ecf4a8d3354a" xlink:href="inpha-20251231.xsd#inpha_CoFundPercentageOfTrialsOfLicensedProduct"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_CoFundPercentageOfTrialsOfLicensedProduct_b1bc6868-2c26-4555-9211-ecf4a8d3354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfProfitsInEurope_6ea99691-2aaf-4dbd-83db-052cdf6e824d" xlink:href="inpha-20251231.xsd#inpha_PercentageOfProfitsInEurope"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0ef2ff07-d383-4efd-bafa-8854a6870ee3" xlink:to="loc_inpha_PercentageOfProfitsInEurope_6ea99691-2aaf-4dbd-83db-052cdf6e824d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoIPH5201withAstraZenecaDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyAgreementrelatedtoIPH5201withAstraZenecaDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoIPH5201withAstraZenecaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_dadbdd3f-ce06-49d3-aaba-71e6abb035c1" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d09b1bc9-7957-4e8d-b2a4-feee842ebd1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_dadbdd3f-ce06-49d3-aaba-71e6abb035c1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d09b1bc9-7957-4e8d-b2a4-feee842ebd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_166487f5-0e5b-4aaa-b672-b20afe9372a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d09b1bc9-7957-4e8d-b2a4-feee842ebd1e" xlink:to="loc_ifrs-full_TypesOfContractsAxis_166487f5-0e5b-4aaa-b672-b20afe9372a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_86abeff7-ef2c-4159-8cea-4f9338ba7d49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_166487f5-0e5b-4aaa-b672-b20afe9372a7" xlink:to="loc_ifrs-full_TypesOfContractsDomain_86abeff7-ef2c-4159-8cea-4f9338ba7d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_8de40b9b-77e8-4a44-8aa3-7eea8a7943be" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_86abeff7-ef2c-4159-8cea-4f9338ba7d49" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_8de40b9b-77e8-4a44-8aa3-7eea8a7943be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaInitialPaymentMember_4a549460-024c-4d1d-939d-35117e54b53c" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaInitialPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_86abeff7-ef2c-4159-8cea-4f9338ba7d49" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaInitialPaymentMember_4a549460-024c-4d1d-939d-35117e54b53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMilestonePaymentMember_96d5e4a7-866c-4e64-9569-7c9ff7ea3fb0" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaMilestonePaymentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_86abeff7-ef2c-4159-8cea-4f9338ba7d49" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMilestonePaymentMember_96d5e4a7-866c-4e64-9569-7c9ff7ea3fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d09b1bc9-7957-4e8d-b2a4-feee842ebd1e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement_49120ed1-0d63-4398-8cf2-6dac3af563d7" xlink:href="inpha-20251231.xsd#inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_ReceiptsFromCodevelopmentAgreementAndOptionAgreement_49120ed1-0d63-4398-8cf2-6dac3af563d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_dda0461b-f940-49b7-a91e-02f178d76625" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_dda0461b-f940-49b7-a91e-02f178d76625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainDevelopmentMilestones_2a354bab-7cf6-4ad1-9ff4-f9933d5ea13d" xlink:href="inpha-20251231.xsd#inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainDevelopmentMilestones"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainDevelopmentMilestones_2a354bab-7cf6-4ad1-9ff4-f9933d5ea13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OptionExerciseFeePayableByCounterParty_3f5ce849-f916-4472-bfe7-11c0ee48a206" xlink:href="inpha-20251231.xsd#inpha_OptionExerciseFeePayableByCounterParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_OptionExerciseFeePayableByCounterParty_3f5ce849-f916-4472-bfe7-11c0ee48a206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_8a36ed08-a696-40fc-8cd7-3b0599040dfb" xlink:href="inpha-20251231.xsd#inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_8a36ed08-a696-40fc-8cd7-3b0599040dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DevelopmentAndRegulatoryMilestones_63cd5825-47d1-4da6-9762-1fd5a40c7e80" xlink:href="inpha-20251231.xsd#inpha_DevelopmentAndRegulatoryMilestones"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_DevelopmentAndRegulatoryMilestones_63cd5825-47d1-4da6-9762-1fd5a40c7e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommercializationMilestones_51c9370c-3062-42e0-b62f-a1c5bbe2bd1b" xlink:href="inpha-20251231.xsd#inpha_CommercializationMilestones"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_CommercializationMilestones_51c9370c-3062-42e0-b62f-a1c5bbe2bd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfProfitsInEurope_b861eee6-d514-400b-868c-eccc75e325e4" xlink:href="inpha-20251231.xsd#inpha_PercentageOfProfitsInEurope"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_PercentageOfProfitsInEurope_b861eee6-d514-400b-868c-eccc75e325e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_6ba2a83a-567c-46f2-90f2-04deb345cd85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_6ba2a83a-567c-46f2-90f2-04deb345cd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CoFundPercentageOfTrialsOfLicensedProduct_6bd3e6d1-a949-455d-b420-aa524f05ee9a" xlink:href="inpha-20251231.xsd#inpha_CoFundPercentageOfTrialsOfLicensedProduct"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_06763841-94c6-489e-9f26-da83532474c0" xlink:to="loc_inpha_CoFundPercentageOfTrialsOfLicensedProduct_6bd3e6d1-a949-455d-b420-aa524f05ee9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoadditionalpreclinicalmoleculeswithAstraZenecaDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyAgreementrelatedtoadditionalpreclinicalmoleculeswithAstraZenecaDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoadditionalpreclinicalmoleculeswithAstraZenecaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_d9b99d68-d40e-49ca-bc3e-ef121e6338eb" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_76ba7ae1-9db9-4058-9077-634e682dd9ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_d9b99d68-d40e-49ca-bc3e-ef121e6338eb" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_76ba7ae1-9db9-4058-9077-634e682dd9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_bbb5313e-a0d6-4726-879f-4c2cdc59eeb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_76ba7ae1-9db9-4058-9077-634e682dd9ed" xlink:to="loc_ifrs-full_TypesOfContractsAxis_bbb5313e-a0d6-4726-879f-4c2cdc59eeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_58020ac6-9a82-43f1-8dc2-9593ec19bff0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_bbb5313e-a0d6-4726-879f-4c2cdc59eeb0" xlink:to="loc_ifrs-full_TypesOfContractsDomain_58020ac6-9a82-43f1-8dc2-9593ec19bff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToAdditionalPreclinicalMoleculesWithAstraZenecaMember_9ea9b0e8-1082-42f1-83bd-b3369e940f0b" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToAdditionalPreclinicalMoleculesWithAstraZenecaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_58020ac6-9a82-43f1-8dc2-9593ec19bff0" xlink:to="loc_inpha_AgreementRelatedToAdditionalPreclinicalMoleculesWithAstraZenecaMember_9ea9b0e8-1082-42f1-83bd-b3369e940f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_76ba7ae1-9db9-4058-9077-634e682dd9ed" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfExclusiveOptionsGranted_c21aebbb-a417-41d0-b44c-1cf0dd7b65b3" xlink:href="inpha-20251231.xsd#inpha_NumberOfExclusiveOptionsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:to="loc_inpha_NumberOfExclusiveOptionsGranted_c21aebbb-a417-41d0-b44c-1cf0dd7b65b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_4ff61a07-9182-4f80-bc8f-7e7657aca776" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_4ff61a07-9182-4f80-bc8f-7e7657aca776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfPreclinicalMolecules_4f72ff04-e653-42bf-b995-2fd3f0ee82a7" xlink:href="inpha-20251231.xsd#inpha_NumberOfPreclinicalMolecules"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:to="loc_inpha_NumberOfPreclinicalMolecules_4f72ff04-e653-42bf-b995-2fd3f0ee82a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_24597c62-3f23-474b-aa71-603e554b1bf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_72f947f1-2c39-4ed1-9838-88a8ac1d9c99" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_24597c62-3f23-474b-aa71-603e554b1bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyAgreementsrelatedtoavdoralimabwithNovoNordiskandwithAstraZenecaDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyAgreementsrelatedtoavdoralimabwithNovoNordiskandwithAstraZenecaDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyAgreementsrelatedtoavdoralimabwithNovoNordiskandwithAstraZenecaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_543cc33e-d52b-48ce-b939-c9063488808f" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_bfbefb45-45d5-4dde-a763-d33653cfac4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_543cc33e-d52b-48ce-b939-c9063488808f" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_bfbefb45-45d5-4dde-a763-d33653cfac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_233228f4-22f3-4e65-a305-729fcd09df85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_bfbefb45-45d5-4dde-a763-d33653cfac4c" xlink:to="loc_ifrs-full_TypesOfContractsAxis_233228f4-22f3-4e65-a305-729fcd09df85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_fd643228-f193-4b76-82b7-093d5222e8ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_233228f4-22f3-4e65-a305-729fcd09df85" xlink:to="loc_ifrs-full_TypesOfContractsDomain_fd643228-f193-4b76-82b7-093d5222e8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2017AvdoralimabInLicensingAgreementWithNovoNordiskASMember_892b17c0-c393-41db-aed2-51a6232ea729" xlink:href="inpha-20251231.xsd#inpha_A2017AvdoralimabInLicensingAgreementWithNovoNordiskASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_fd643228-f193-4b76-82b7-093d5222e8ed" xlink:to="loc_inpha_A2017AvdoralimabInLicensingAgreementWithNovoNordiskASMember_892b17c0-c393-41db-aed2-51a6232ea729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2018AvdoralimabAstraZenecaAgreementMember_6267b97d-b4e3-4048-be50-26dbcbfc0ee3" xlink:href="inpha-20251231.xsd#inpha_A2018AvdoralimabAstraZenecaAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_fd643228-f193-4b76-82b7-093d5222e8ed" xlink:to="loc_inpha_A2018AvdoralimabAstraZenecaAgreementMember_6267b97d-b4e3-4048-be50-26dbcbfc0ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_bfbefb45-45d5-4dde-a763-d33653cfac4c" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UpfrontPayment_676e111b-a628-4c53-88b6-3b2479055caa" xlink:href="inpha-20251231.xsd#inpha_UpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_UpfrontPayment_676e111b-a628-4c53-88b6-3b2479055caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UpfrontPaymentSharesIssued_cb772773-2f36-46f6-b673-2505c0dd3e81" xlink:href="inpha-20251231.xsd#inpha_UpfrontPaymentSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_UpfrontPaymentSharesIssued_cb772773-2f36-46f6-b673-2505c0dd3e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UpfrontPaymentCash_37dc6b80-897a-416b-9c02-5c3ebeb421d5" xlink:href="inpha-20251231.xsd#inpha_UpfrontPaymentCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_UpfrontPaymentCash_37dc6b80-897a-416b-9c02-5c3ebeb421d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PaymentsForMilestone_f48c8994-747d-47f7-b480-d430c7ea775b" xlink:href="inpha-20251231.xsd#inpha_PaymentsForMilestone"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_PaymentsForMilestone_f48c8994-747d-47f7-b480-d430c7ea775b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumPaymentsToCounterPartyUponAchievementOfCertainMilestones_5a046f17-d92a-4ce2-9023-947333a85206" xlink:href="inpha-20251231.xsd#inpha_MaximumPaymentsToCounterPartyUponAchievementOfCertainMilestones"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_MaximumPaymentsToCounterPartyUponAchievementOfCertainMilestones_5a046f17-d92a-4ce2-9023-947333a85206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfPartnersSponsoringTrialCosts_7ee5cff9-45dc-4d33-b261-2ade566232f2" xlink:href="inpha-20251231.xsd#inpha_NumberOfPartnersSponsoringTrialCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_NumberOfPartnersSponsoringTrialCosts_7ee5cff9-45dc-4d33-b261-2ade566232f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfCohortsOfTheTrialThatDidNotMeetPrimaryEndpoints_438c235d-69d9-46eb-9f39-e458d0216cc3" xlink:href="inpha-20251231.xsd#inpha_NumberOfCohortsOfTheTrialThatDidNotMeetPrimaryEndpoints"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0e75e5ba-5bb7-4b85-857b-6e7c63e69264" xlink:to="loc_inpha_NumberOfCohortsOfTheTrialThatDidNotMeetPrimaryEndpoints_438c235d-69d9-46eb-9f39-e458d0216cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyCollaborationandlicenseagreementsconcludedwithSanofiforthedevelopmentofNKCellengagesinoncologyDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyCollaborationandlicenseagreementsconcludedwithSanofiforthedevelopmentofNKCellengagesinoncologyDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyCollaborationandlicenseagreementsconcludedwithSanofiforthedevelopmentofNKCellengagesinoncologyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_49bfc168-3561-464b-b94a-f54439d44e72" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3746de4e-9728-4c53-b08d-65b01b8d4739" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_49bfc168-3561-464b-b94a-f54439d44e72" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3746de4e-9728-4c53-b08d-65b01b8d4739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_81dc2f44-9115-4bb8-88ba-47515846ecf5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3746de4e-9728-4c53-b08d-65b01b8d4739" xlink:to="loc_ifrs-full_TypesOfContractsAxis_81dc2f44-9115-4bb8-88ba-47515846ecf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_d394bbde-a8bf-427a-8fcb-e1ea29e63d6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_81dc2f44-9115-4bb8-88ba-47515846ecf5" xlink:to="loc_ifrs-full_TypesOfContractsDomain_d394bbde-a8bf-427a-8fcb-e1ea29e63d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_f9c5fc59-04ae-44a0-b6e0-f36b9b3b49fe" xlink:href="inpha-20251231.xsd#inpha_AgreementsWithSanofiForNKCellEngagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_d394bbde-a8bf-427a-8fcb-e1ea29e63d6e" xlink:to="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_f9c5fc59-04ae-44a0-b6e0-f36b9b3b49fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_520ad8ae-50b8-4bef-bccb-b04ec5f28b31" xlink:href="inpha-20251231.xsd#inpha_AgreementsWithGenzymeForNKCellEngagesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_d394bbde-a8bf-427a-8fcb-e1ea29e63d6e" xlink:to="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_520ad8ae-50b8-4bef-bccb-b04ec5f28b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_bcb62940-4674-47fa-93a7-063f6cf77eb9" xlink:href="inpha-20251231.xsd#inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_d394bbde-a8bf-427a-8fcb-e1ea29e63d6e" xlink:to="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_bcb62940-4674-47fa-93a7-063f6cf77eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3746de4e-9728-4c53-b08d-65b01b8d4739" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfSpecifiedTargets_7a55445f-c41d-4d3f-9b54-4de6afffbf76" xlink:href="inpha-20251231.xsd#inpha_NumberOfSpecifiedTargets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_NumberOfSpecifiedTargets_7a55445f-c41d-4d3f-9b54-4de6afffbf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_7419fd3a-3e8e-4111-bce4-3fc3f6233687" xlink:href="inpha-20251231.xsd#inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_MaximumAmountReceivableFromCounterPartyUponAchievementOfCertainMilestones_7419fd3a-3e8e-4111-bce4-3fc3f6233687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_da0559d0-091d-4e3b-9a20-94ee4ed2e81d" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_da0559d0-091d-4e3b-9a20-94ee4ed2e81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfAdditionalTargets_a06fc623-6379-4f58-8bd2-60083b643acd" xlink:href="inpha-20251231.xsd#inpha_NumberOfAdditionalTargets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_NumberOfAdditionalTargets_a06fc623-6379-4f58-8bd2-60083b643acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfExclusiveOptionsGranted_877873e3-855a-4a21-a539-3bdea70fd938" xlink:href="inpha-20251231.xsd#inpha_NumberOfExclusiveOptionsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_NumberOfExclusiveOptionsGranted_877873e3-855a-4a21-a539-3bdea70fd938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExercisePeriodTerms_e47261d3-eb71-4879-9c23-d437fea69fe9" xlink:href="inpha-20251231.xsd#inpha_ExercisePeriodTerms"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_ExercisePeriodTerms_e47261d3-eb71-4879-9c23-d437fea69fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfOptionsExcercisedForLicenses_019b9e3c-1cc4-7076-976b-38dc60f65895" xlink:href="inpha-20251231.xsd#inpha_NumberOfOptionsExcercisedForLicenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_NumberOfOptionsExcercisedForLicenses_019b9e3c-1cc4-7076-976b-38dc60f65895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfPreclinicalMolecules_e871ea2e-3c0d-48a2-a6dd-5e2488426d54" xlink:href="inpha-20251231.xsd#inpha_NumberOfPreclinicalMolecules"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_NumberOfPreclinicalMolecules_e871ea2e-3c0d-48a2-a6dd-5e2488426d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TerminationNoticePeriod_61e48c0c-f792-45b0-8f8a-0bc72541f52b" xlink:href="inpha-20251231.xsd#inpha_TerminationNoticePeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_20d5bc66-3f87-4a15-a62b-79381a9d7440" xlink:to="loc_inpha_TerminationNoticePeriod_61e48c0c-f792-45b0-8f8a-0bc72541f52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ThecompanyKeyeventsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ThecompanyKeyeventsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ThecompanyKeyeventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_80e77c26-cce1-4697-9199-7c3845be274a" xlink:href="inpha-20251231.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_80e77c26-cce1-4697-9199-7c3845be274a" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b9e42-5d11-79fd-8f27-1f6ab83f7de3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_srt_RangeAxis_019b9e42-5d11-79fd-8f27-1f6ab83f7de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b9e42-5d11-7fee-b36d-495d838e73da" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019b9e42-5d11-79fd-8f27-1f6ab83f7de3" xlink:to="loc_srt_RangeMember_019b9e42-5d11-7fee-b36d-495d838e73da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b9e42-7297-72ab-be09-b519cf95cdbb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b9e42-5d11-7fee-b36d-495d838e73da" xlink:to="loc_srt_MaximumMember_019b9e42-7297-72ab-be09-b519cf95cdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019b9e42-94e2-7038-9d08-ae6541dee895" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_ifrs-full_CounterpartiesAxis_019b9e42-94e2-7038-9d08-ae6541dee895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019b9e42-94e2-7e75-8be9-6e6dd04327a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_019b9e42-94e2-7038-9d08-ae6541dee895" xlink:to="loc_ifrs-full_CounterpartiesDomain_019b9e42-94e2-7e75-8be9-6e6dd04327a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiAventisMember_019b9e42-df2a-789a-92ca-df6560846096" xlink:href="inpha-20251231.xsd#inpha_SanofiAventisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e42-94e2-7e75-8be9-6e6dd04327a0" xlink:to="loc_inpha_SanofiAventisMember_019b9e42-df2a-789a-92ca-df6560846096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_019b9e43-07b7-7ce2-8fac-41c2bf652a61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_ifrs-full_TypesOfContractsAxis_019b9e43-07b7-7ce2-8fac-41c2bf652a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_019b9e43-07b7-79a0-8136-a7fad26162db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_019b9e43-07b7-7ce2-8fac-41c2bf652a61" xlink:to="loc_ifrs-full_TypesOfContractsDomain_019b9e43-07b7-79a0-8136-a7fad26162db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019b9e43-332b-7db6-8453-1dc89484790e" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019b9e43-07b7-79a0-8136-a7fad26162db" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019b9e43-332b-7db6-8453-1dc89484790e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019b9e47-195e-7a48-ba86-440bd22f98a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019b9e47-195e-7a48-ba86-440bd22f98a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019b9e47-195e-7b40-826a-78a929fbe37b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019b9e47-195e-7a48-ba86-440bd22f98a7" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019b9e47-195e-7b40-826a-78a929fbe37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019b9e47-4e1b-7134-9258-fbf00f3c8b5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019b9e47-195e-7b40-826a-78a929fbe37b" xlink:to="loc_ifrs-full_IssuedCapitalMember_019b9e47-4e1b-7134-9258-fbf00f3c8b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_019b9e47-b7f8-7917-9ee0-109a6f5331f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019b9e47-195e-7b40-826a-78a929fbe37b" xlink:to="loc_ifrs-full_SharePremiumMember_019b9e47-b7f8-7917-9ee0-109a6f5331f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019b9e49-5fb9-751a-9a39-f062472f66b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019b9e49-5fb9-751a-9a39-f062472f66b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019b9e49-5fb9-7042-9f1e-1e893c74e8db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019b9e49-5fb9-751a-9a39-f062472f66b0" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019b9e49-5fb9-7042-9f1e-1e893c74e8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019b9e49-9bbf-747b-a56f-73fdb65ab3b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019b9e49-5fb9-7042-9f1e-1e893c74e8db" xlink:to="loc_ifrs-full_OrdinarySharesMember_019b9e49-9bbf-747b-a56f-73fdb65ab3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2016PreferredSharesMember_019b9e4a-720f-7428-b66f-26a27151511e" xlink:href="inpha-20251231.xsd#inpha_A2016PreferredSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019b9e49-5fb9-7042-9f1e-1e893c74e8db" xlink:to="loc_inpha_A2016PreferredSharesMember_019b9e4a-720f-7428-b66f-26a27151511e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2017PreferredSharesMember_019b9e4a-de47-77c0-bb99-16e8c39cd5bd" xlink:href="inpha-20251231.xsd#inpha_A2017PreferredSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019b9e49-5fb9-7042-9f1e-1e893c74e8db" xlink:to="loc_inpha_A2017PreferredSharesMember_019b9e4a-de47-77c0-bb99-16e8c39cd5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1a46e91a-2416-4c15-8ef3-1d272aedb5b2" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy_019b9e40-243a-73d4-99c7-6a05078ed35e" xlink:href="inpha-20251231.xsd#inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy_019b9e40-243a-73d4-99c7-6a05078ed35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019b9e42-3415-7d57-a8a5-9f10ff4dae56" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_ifrs-full_IssueOfEquity_019b9e42-3415-7d57-a8a5-9f10ff4dae56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_019b9e43-bdae-7900-9b24-b625296022ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_019b9e43-bdae-7900-9b24-b625296022ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IssueOfEquitySharePrice_019b9e44-76f8-7264-bbf1-a41e9d4c569d" xlink:href="inpha-20251231.xsd#inpha_IssueOfEquitySharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_inpha_IssueOfEquitySharePrice_019b9e44-76f8-7264-bbf1-a41e9d4c569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019b9e48-b461-7a99-af93-96377c826dd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_ifrs-full_IssuedCapital_019b9e48-b461-7a99-af93-96377c826dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019b9e49-3c24-7a73-ac18-71d985f9253e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019b9e49-3c24-7a73-ac18-71d985f9253e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedDecreaseInNumberOfEmployeesPercentage_019b9e5b-43aa-7a4d-99ec-44a9292e5558" xlink:href="inpha-20251231.xsd#inpha_ExpectedDecreaseInNumberOfEmployeesPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019b9e40-243a-7a74-a817-9861c9470eaf" xlink:to="loc_inpha_ExpectedDecreaseInNumberOfEmployeesPercentage_019b9e5b-43aa-7a4d-99ec-44a9292e5558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TheCompanySummaryofthecompanysshareholdinginformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#TheCompanySummaryofthecompanysshareholdinginformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TheCompanySummaryofthecompanysshareholdinginformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatisticalDisclosureForBanksAbstract_019b9e4f-91d4-74c2-b843-0b4fcc931cfa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatisticalDisclosureForBanksAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019b9e57-b94f-7486-a388-d2f912d2d400" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatisticalDisclosureForBanksAbstract_019b9e4f-91d4-74c2-b843-0b4fcc931cfa" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019b9e57-b94f-7486-a388-d2f912d2d400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019b9e57-b94f-7da5-a343-f568522b9e35" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019b9e57-b94f-7486-a388-d2f912d2d400" xlink:to="loc_ifrs-full_CounterpartiesAxis_019b9e57-b94f-7da5-a343-f568522b9e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_019b9e57-b94f-7da5-a343-f568522b9e35" xlink:to="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NovoNordiskASMember_019b9e57-b94f-75c7-b7e4-699316ea83e3" xlink:href="inpha-20251231.xsd#inpha_NovoNordiskASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_NovoNordiskASMember_019b9e57-b94f-75c7-b7e4-699316ea83e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiAventisParticipationsMember_019b9e57-b94f-7408-8510-5fa9b2399a48" xlink:href="inpha-20251231.xsd#inpha_SanofiAventisParticipationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_SanofiAventisParticipationsMember_019b9e57-b94f-7408-8510-5fa9b2399a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MedimmuneLimitedMember_019b9e57-b94f-76e5-9a53-d3b43aa7973c" xlink:href="inpha-20251231.xsd#inpha_MedimmuneLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_MedimmuneLimitedMember_019b9e57-b94f-76e5-9a53-d3b43aa7973c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BpifranceParticipationsMember_019b9e57-b94f-7179-93e1-b7b83d9c39d2" xlink:href="inpha-20251231.xsd#inpha_BpifranceParticipationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_BpifranceParticipationsMember_019b9e57-b94f-7179-93e1-b7b83d9c39d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MembersOfTheExecutiveBoardSupervisoryBoardAndLeadershipTeamMember_019b9e57-b94f-77b9-a936-9dff692bcc89" xlink:href="inpha-20251231.xsd#inpha_MembersOfTheExecutiveBoardSupervisoryBoardAndLeadershipTeamMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_MembersOfTheExecutiveBoardSupervisoryBoardAndLeadershipTeamMember_019b9e57-b94f-77b9-a936-9dff692bcc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InnatePharmaTreasuryStockMember_019b9e57-b94f-7abd-a734-6967f54cdaa0" xlink:href="inpha-20251231.xsd#inpha_InnatePharmaTreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_InnatePharmaTreasuryStockMember_019b9e57-b94f-7abd-a734-6967f54cdaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherIndividualShareholdersMember_019b9e57-b94f-771c-991e-80ea5ede465e" xlink:href="inpha-20251231.xsd#inpha_OtherIndividualShareholdersMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019b9e57-b94f-7854-90dd-e1612bcccc5d" xlink:to="loc_inpha_OtherIndividualShareholdersMember_019b9e57-b94f-771c-991e-80ea5ede465e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_019b9e57-b94f-7486-a388-d2f912d2d400" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019b9e57-b94f-75d7-b3f1-3ffd6a34ba0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019b9e57-b94f-75d7-b3f1-3ffd6a34ba0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfShareholdingInTheCompany_019b9e57-b94f-77a3-8dbe-965209e334a0" xlink:href="inpha-20251231.xsd#inpha_PercentageOfShareholdingInTheCompany"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:to="loc_inpha_PercentageOfShareholdingInTheCompany_019b9e57-b94f-77a3-8dbe-965209e334a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfVotingRightsHeld_019b9e57-b94f-7824-b88a-3da16452bdaf" xlink:href="inpha-20251231.xsd#inpha_NumberOfVotingRightsHeld"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:to="loc_inpha_NumberOfVotingRightsHeld_019b9e57-b94f-7824-b88a-3da16452bdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProportionOfVotingRightsHeldInTheCompany_019b9e57-b94f-776d-9af9-56c222fa39e2" xlink:href="inpha-20251231.xsd#inpha_ProportionOfVotingRightsHeldInTheCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019b9e57-b94f-7df0-8f18-a641d127e273" xlink:to="loc_inpha_ProportionOfVotingRightsHeldInTheCompany_019b9e57-b94f-776d-9af9-56c222fa39e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#AccountingpoliciesandstatementofcomplianceAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_1bb6d454-cf27-45fc-8d0f-1b634e227c8c" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_1bb6d454-cf27-45fc-8d0f-1b634e227c8c" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_41430678-244d-4962-8f9e-761506e37022" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_41430678-244d-4962-8f9e-761506e37022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_a27109e8-188f-4fe7-b801-5c85e064c47a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_41430678-244d-4962-8f9e-761506e37022" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_a27109e8-188f-4fe7-b801-5c85e064c47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_a1e26e94-de1b-4a6a-96a7-773817b56bf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_a27109e8-188f-4fe7-b801-5c85e064c47a" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_a1e26e94-de1b-4a6a-96a7-773817b56bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_0f5e04be-7d24-4b08-91a9-c2c858bb35f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:to="loc_ifrs-full_RangeAxis_0f5e04be-7d24-4b08-91a9-c2c858bb35f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_37b7e462-963e-4cf9-8b77-fae986361a2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_0f5e04be-7d24-4b08-91a9-c2c858bb35f7" xlink:to="loc_ifrs-full_RangeDomain_37b7e462-963e-4cf9-8b77-fae986361a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_e08a10a3-b522-4f72-b642-efde37608a6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_37b7e462-963e-4cf9-8b77-fae986361a2a" xlink:to="loc_ifrs-full_BottomOfRangeMember_e08a10a3-b522-4f72-b642-efde37608a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_7ba610fa-f8a2-4bbe-8a48-1042d661d61e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_37b7e462-963e-4cf9-8b77-fae986361a2a" xlink:to="loc_ifrs-full_TopOfRangeMember_7ba610fa-f8a2-4bbe-8a48-1042d661d61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_80b140fc-1376-4389-90cc-8b6294b0bf2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:to="loc_ifrs-full_TypesOfContractsAxis_80b140fc-1376-4389-90cc-8b6294b0bf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_5539265a-c141-4ea3-98df-d6c0f9c275f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_80b140fc-1376-4389-90cc-8b6294b0bf2d" xlink:to="loc_ifrs-full_TypesOfContractsDomain_5539265a-c141-4ea3-98df-d6c0f9c275f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_082e086c-594d-444d-852f-26c93fa362b6" xlink:href="inpha-20251231.xsd#inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_5539265a-c141-4ea3-98df-d6c0f9c275f4" xlink:to="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_082e086c-594d-444d-852f-26c93fa362b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_9cc2e176-85ef-475d-9abf-399d261b78e9" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_701ea535-2365-4931-8371-c6e51f54f8b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_701ea535-2365-4931-8371-c6e51f54f8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DefinedContributionPlanContributionPercentage_fec438cd-399a-4bf7-a790-b0bce273360d" xlink:href="inpha-20251231.xsd#inpha_DefinedContributionPlanContributionPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_DefinedContributionPlanContributionPercentage_fec438cd-399a-4bf7-a790-b0bce273360d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DefinedContributionPlanContributionPercentageByEmployer_a21d4184-eb55-4280-89cb-2f5af968742c" xlink:href="inpha-20251231.xsd#inpha_DefinedContributionPlanContributionPercentageByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_DefinedContributionPlanContributionPercentageByEmployer_a21d4184-eb55-4280-89cb-2f5af968742c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DefinedContributionPlanContributionPercentageByEmployee_e8a25f60-c330-41be-baf1-1598b1f35ae4" xlink:href="inpha-20251231.xsd#inpha_DefinedContributionPlanContributionPercentageByEmployee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_DefinedContributionPlanContributionPercentageByEmployee_e8a25f60-c330-41be-baf1-1598b1f35ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne_32a5e183-2605-4953-bbab-a204a185938a" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne_32a5e183-2605-4953-bbab-a204a185938a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo_bc45c1be-f071-42c9-baf5-8462774744b4" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo_bc45c1be-f071-42c9-baf5-8462774744b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree_74e702f6-344d-4672-b5d7-d45194fe41e8" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree_74e702f6-344d-4672-b5d7-d45194fe41e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_42553488-62ff-4854-85b8-84daa46caae5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_42553488-62ff-4854-85b8-84daa46caae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e4e8fb54-f09b-44b7-b310-669ebee180cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_b929b4a4-e558-4fef-aa9f-ebd34148c2fd" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_e4e8fb54-f09b-44b7-b310-669ebee180cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofEffectofChangesinForeignExchangeRatesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#AccountingpoliciesandstatementofcomplianceDisclosureofEffectofChangesinForeignExchangeRatesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofEffectofChangesinForeignExchangeRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_b6b6f61d-640a-46b6-bed1-dd81b2715331" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_ab6a0a76-98ac-4083-9b91-a3d39a51fb08" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_b6b6f61d-640a-46b6-bed1-dd81b2715331" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_ab6a0a76-98ac-4083-9b91-a3d39a51fb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_80ac6b00-451e-4ed2-b861-5d41abc17b22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_b6b6f61d-640a-46b6-bed1-dd81b2715331" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_80ac6b00-451e-4ed2-b861-5d41abc17b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofDepreciationPeriodsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#AccountingpoliciesandstatementofcomplianceDisclosureofDepreciationPeriodsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofDepreciationPeriodsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_6bcf03fb-0c27-4c2e-91fe-795742e40d00" xlink:href="inpha-20251231.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_b0db3f32-bdaf-45ce-ab93-ad909046cc20" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_6bcf03fb-0c27-4c2e-91fe-795742e40d00" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_b0db3f32-bdaf-45ce-ab93-ad909046cc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_827ac3c4-fcb6-44d7-9b00-a272c4e1634b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_b0db3f32-bdaf-45ce-ab93-ad909046cc20" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_827ac3c4-fcb6-44d7-9b00-a272c4e1634b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_827ac3c4-fcb6-44d7-9b00-a272c4e1634b" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BuildingsMember_b8de9274-238f-4536-8934-f3f649c03d97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:to="loc_ifrs-full_BuildingsMember_b8de9274-238f-4536-8934-f3f649c03d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InstallationsMember_75695910-795d-4dfa-ace6-7870f68d833c" xlink:href="inpha-20251231.xsd#inpha_InstallationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:to="loc_inpha_InstallationsMember_75695910-795d-4dfa-ace6-7870f68d833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TechnicalInstallationsAndEquipmentMember_4e7c56c6-a925-4318-9be0-5525cf71be71" xlink:href="inpha-20251231.xsd#inpha_TechnicalInstallationsAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:to="loc_inpha_TechnicalInstallationsAndEquipmentMember_4e7c56c6-a925-4318-9be0-5525cf71be71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OfficeEquipmentMember_f56f2996-c6d9-470e-9d0d-240e78392125" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:to="loc_ifrs-full_OfficeEquipmentMember_f56f2996-c6d9-470e-9d0d-240e78392125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_d5c14fe1-339d-45a1-93cc-66ab7a007957" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc10a008-00fc-416a-a764-74e96c781e68" xlink:to="loc_ifrs-full_ComputerEquipmentMember_d5c14fe1-339d-45a1-93cc-66ab7a007957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_b746d42f-fcca-42c1-8ca4-a19ae18309c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_b0db3f32-bdaf-45ce-ab93-ad909046cc20" xlink:to="loc_ifrs-full_RangeAxis_b746d42f-fcca-42c1-8ca4-a19ae18309c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_2ffed493-22c8-445d-8f4b-275fc1058061" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_b746d42f-fcca-42c1-8ca4-a19ae18309c5" xlink:to="loc_ifrs-full_RangeDomain_2ffed493-22c8-445d-8f4b-275fc1058061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_447b0350-e347-4141-b283-3c42160632ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_2ffed493-22c8-445d-8f4b-275fc1058061" xlink:to="loc_ifrs-full_BottomOfRangeMember_447b0350-e347-4141-b283-3c42160632ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_098218b3-d15c-45dd-83f6-86065483376a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_2ffed493-22c8-445d-8f4b-275fc1058061" xlink:to="loc_ifrs-full_TopOfRangeMember_098218b3-d15c-45dd-83f6-86065483376a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_ac1f1ffa-0ffc-4051-98c3-69eca64d663c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_b0db3f32-bdaf-45ce-ab93-ad909046cc20" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_ac1f1ffa-0ffc-4051-98c3-69eca64d663c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_ed9db5e6-a23a-4ce4-bfd1-f6eb02bb8b72" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_ac1f1ffa-0ffc-4051-98c3-69eca64d663c" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_ed9db5e6-a23a-4ce4-bfd1-f6eb02bb8b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ManagementoffinancialrisksandfairvalueDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#ManagementoffinancialrisksandfairvalueDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ManagementoffinancialrisksandfairvalueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_dbe71265-aac5-47d9-98cc-bea1d005b8e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_33f950de-11a8-4624-ad74-4f91babcd8bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_dbe71265-aac5-47d9-98cc-bea1d005b8e1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_33f950de-11a8-4624-ad74-4f91babcd8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_ee5ad2c9-05c1-4993-b59d-31a39df37b5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_33f950de-11a8-4624-ad74-4f91babcd8bb" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_ee5ad2c9-05c1-4993-b59d-31a39df37b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_a5a529fd-f817-469e-aa64-62698b9e359f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_ee5ad2c9-05c1-4993-b59d-31a39df37b5a" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_a5a529fd-f817-469e-aa64-62698b9e359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StateGuaranteedLoansMember_39235316-a258-4230-abd3-3df3654850c0" xlink:href="inpha-20251231.xsd#inpha_StateGuaranteedLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_a5a529fd-f817-469e-aa64-62698b9e359f" xlink:to="loc_inpha_StateGuaranteedLoansMember_39235316-a258-4230-abd3-3df3654850c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_33f950de-11a8-4624-ad74-4f91babcd8bb" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_1a7548fd-71d5-4243-b8dc-4b16eccc9c08" xlink:href="inpha-20251231.xsd#inpha_CashCashEquivalentsAndShortTermInvestmentsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:to="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_1a7548fd-71d5-4243-b8dc-4b16eccc9c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfRevenueDenominatedInUSDollars_ef7779ae-515f-4a1d-8f2e-7713920fa960" xlink:href="inpha-20251231.xsd#inpha_PercentageOfRevenueDenominatedInUSDollars"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:to="loc_inpha_PercentageOfRevenueDenominatedInUSDollars_ef7779ae-515f-4a1d-8f2e-7713920fa960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfPaymentsInUSDollars_40fd368d-2cd9-4e9d-9f49-5e17932f363c" xlink:href="inpha-20251231.xsd#inpha_PercentageOfPaymentsInUSDollars"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:to="loc_inpha_PercentageOfPaymentsInUSDollars_40fd368d-2cd9-4e9d-9f49-5e17932f363c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_081102d1-86f3-4ba1-8506-82afe8c11162" xlink:href="inpha-20251231.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5fd080ab-2c83-4b40-8f80-a3239c9b8239" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_081102d1-86f3-4ba1-8506-82afe8c11162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofCashCashEquivalentsandFinancialAssetsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#CashcashequivalentsandfinancialassetsDisclosureofCashCashEquivalentsandFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofCashCashEquivalentsandFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_bd163c0b-f1c1-4285-83b0-c410510903ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:to="loc_ifrs-full_CashAndCashEquivalents_bd163c0b-f1c1-4285-83b0-c410510903ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssets_cc9762b1-a895-4fe0-9103-34b099f68380" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:to="loc_ifrs-full_CurrentFinancialAssets_cc9762b1-a895-4fe0-9103-34b099f68380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_69a94c3d-31e7-44c3-82ed-30821152031a" xlink:href="inpha-20251231.xsd#inpha_CashCashEquivalentsAndShortTermInvestmentsAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:to="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_69a94c3d-31e7-44c3-82ed-30821152031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_52e8557b-55d2-4539-b0f1-0f1848fe3044" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_52e8557b-55d2-4539-b0f1-0f1848fe3044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_f9527c91-3720-4ee6-ad9f-975189d77746" xlink:href="inpha-20251231.xsd#inpha_TotalCashCashEquivalentsAndFinancialAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_e0ab24d8-e4ce-43cc-8b6c-d5b94103ecfc" xlink:to="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_f9527c91-3720-4ee6-ad9f-975189d77746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#CashcashequivalentsandfinancialassetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7e7f2be5-e0af-4a8c-9389-6ea99c620a64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_7e9f059f-e627-461a-a9f0-fac31a04cd51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_7e7f2be5-e0af-4a8c-9389-6ea99c620a64" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_7e9f059f-e627-461a-a9f0-fac31a04cd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_339fee4f-0eb2-470a-8d84-30f89ba6b2f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_7e9f059f-e627-461a-a9f0-fac31a04cd51" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_339fee4f-0eb2-470a-8d84-30f89ba6b2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_8cce0d59-f321-4595-9a56-cce91b7201cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_339fee4f-0eb2-470a-8d84-30f89ba6b2f3" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_8cce0d59-f321-4595-9a56-cce91b7201cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember_a27c96d0-5566-4964-b01c-963b0faa849c" xlink:href="inpha-20251231.xsd#inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_8cce0d59-f321-4595-9a56-cce91b7201cd" xlink:to="loc_inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember_a27c96d0-5566-4964-b01c-963b0faa849c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_92a88e52-2f69-45ed-a708-7c1514b4e639" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_7e9f059f-e627-461a-a9f0-fac31a04cd51" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_92a88e52-2f69-45ed-a708-7c1514b4e639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_1677fa7f-2cc2-4c1e-86ae-cc1d84a5b286" xlink:href="inpha-20251231.xsd#inpha_TotalCashCashEquivalentsAndFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_92a88e52-2f69-45ed-a708-7c1514b4e639" xlink:to="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_1677fa7f-2cc2-4c1e-86ae-cc1d84a5b286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofReconciliationofChangesinLossAllowanceandExplanationofChangesinGrossCarryingAmountforFinancialInstrumentsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#CashcashequivalentsandfinancialassetsDisclosureofReconciliationofChangesinLossAllowanceandExplanationofChangesinGrossCarryingAmountforFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofReconciliationofChangesinLossAllowanceandExplanationofChangesinGrossCarryingAmountforFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentInvestments_7708ba08-0b5a-4ecc-9682-f202a79f75d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_ifrs-full_CurrentInvestments_7708ba08-0b5a-4ecc-9682-f202a79f75d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAcquisitions_931b7d98-cad8-412b-a291-d460e99e48b0" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentsAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_ShortTermInvestmentsAcquisitions_931b7d98-cad8-412b-a291-d460e99e48b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionShortTermInvestment_dd8ae546-5e47-4981-a18a-abf635342352" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughDerecognitionShortTermInvestment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_DecreaseThroughDerecognitionShortTermInvestment_dd8ae546-5e47-4981-a18a-abf635342352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_0f2a9d9d-69f6-4ddb-aa00-094075441b72" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_0f2a9d9d-69f6-4ddb-aa00-094075441b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_7fe99c79-2788-4cd8-984f-ad07a5530823" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_7fe99c79-2788-4cd8-984f-ad07a5530823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsForeignCurrencyEffect_c42e84f4-0c94-40e8-b4d7-90b162763ba0" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentsForeignCurrencyEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_ShortTermInvestmentsForeignCurrencyEffect_c42e84f4-0c94-40e8-b4d7-90b162763ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentInvestments_74899a8b-95b7-4ac4-b215-17b480b2b129" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_ifrs-full_CurrentInvestments_74899a8b-95b7-4ac4-b215-17b480b2b129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_9483518f-1579-46b9-8a8b-90e568b8f989" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_9483518f-1579-46b9-8a8b-90e568b8f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsAcquisitions_55833614-54cf-4b69-a2f7-aa9658970777" xlink:href="inpha-20251231.xsd#inpha_NonCurrentFinancialAssetsAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_NonCurrentFinancialAssetsAcquisitions_55833614-54cf-4b69-a2f7-aa9658970777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets_dbd63410-699b-467e-9992-0317e08addf0" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets_dbd63410-699b-467e-9992-0317e08addf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_2ab455d4-0778-4f96-86d8-4c9ea2473a46" xlink:href="inpha-20251231.xsd#inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_2ab455d4-0778-4f96-86d8-4c9ea2473a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_6725d9c3-687d-4686-9273-33c2d665b1fc" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_6725d9c3-687d-4686-9273-33c2d665b1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsForeignCurrencyEffect_78d0099f-416b-45b9-b2cc-9d5824a3e32a" xlink:href="inpha-20251231.xsd#inpha_NonCurrentFinancialAssetsForeignCurrencyEffect"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_NonCurrentFinancialAssetsForeignCurrencyEffect_78d0099f-416b-45b9-b2cc-9d5824a3e32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_2faf3ce2-0b28-4c9c-a09f-01b0b91f2510" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_2faf3ce2-0b28-4c9c-a09f-01b0b91f2510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_005e6e62-ad25-4af7-8f7c-aeffbb78d6ec" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_005e6e62-ad25-4af7-8f7c-aeffbb78d6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalAcquisitions_c60f6824-1ead-4312-978c-c9d9c868d07e" xlink:href="inpha-20251231.xsd#inpha_TotalAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_TotalAcquisitions_c60f6824-1ead-4312-978c-c9d9c868d07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets_c7080bf0-0817-40a1-913a-5807e52e9f4f" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets_c7080bf0-0817-40a1-913a-5807e52e9f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_27d31b2e-fa88-4566-8439-84b313943cc0" xlink:href="inpha-20251231.xsd#inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_27d31b2e-fa88-4566-8439-84b313943cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_6960517a-1f29-4353-a445-bec111e8738e" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_6960517a-1f29-4353-a445-bec111e8738e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalForeignCurrencyEffect_06809c19-ff37-45a3-b547-5db90958e553" xlink:href="inpha-20251231.xsd#inpha_TotalForeignCurrencyEffect"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_TotalForeignCurrencyEffect_06809c19-ff37-45a3-b547-5db90958e553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_409e804b-bd03-4294-8a10-827d8a8d95de" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_d19b63f7-3acd-4f04-a102-6ded1e4f84f8" xlink:to="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_409e804b-bd03-4294-8a10-827d8a8d95de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradereceivablesandothersDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#TradereceivablesandothersDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradereceivablesandothersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_dff5107f-b224-4404-8eb9-eb10cb634ee9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_dff5107f-b224-4404-8eb9-eb10cb634ee9" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis_562fbbd6-a7db-48e4-9458-04cfc5a6476a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsAxis_562fbbd6-a7db-48e4-9458-04cfc5a6476a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_41a9e168-21b3-449a-ab1d-e0f9027d7800" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_562fbbd6-a7db-48e4-9458-04cfc5a6476a" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_41a9e168-21b3-449a-ab1d-e0f9027d7800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GuaranteesMember_c62883cd-7fe4-489a-8ac3-726d57551d83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_41a9e168-21b3-449a-ab1d-e0f9027d7800" xlink:to="loc_ifrs-full_GuaranteesMember_c62883cd-7fe4-489a-8ac3-726d57551d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_b0e779e9-b89f-4687-bd56-85fd6c198e7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_b0e779e9-b89f-4687-bd56-85fd6c198e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_73f78193-6464-4ed7-8539-a10189befa3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_b0e779e9-b89f-4687-bd56-85fd6c198e7f" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_73f78193-6464-4ed7-8539-a10189befa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_999861f3-3442-414c-a251-1949d816d969" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_73f78193-6464-4ed7-8539-a10189befa3c" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_999861f3-3442-414c-a251-1949d816d969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_71d268a4-8636-4420-afe7-8abd144df0a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:to="loc_ifrs-full_TypesOfContractsAxis_71d268a4-8636-4420-afe7-8abd144df0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_2146d007-5e9d-4783-a903-589db140c2c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_71d268a4-8636-4420-afe7-8abd144df0a0" xlink:to="loc_ifrs-full_TypesOfContractsDomain_2146d007-5e9d-4783-a903-589db140c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_913c0638-a236-4b96-aabf-fc10f462774e" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2146d007-5e9d-4783-a903-589db140c2c6" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_913c0638-a236-4b96-aabf-fc10f462774e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_95334ce4-0f52-442d-abf4-6fee83b5417e" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentReceivables_7d74030b-58b3-475c-aae0-02a551238270" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_OtherCurrentReceivables_7d74030b-58b3-475c-aae0-02a551238270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchTaxCreditReceivableCurrent_406c03cb-f7ad-49d3-8740-43046dc1c8f4" xlink:href="inpha-20251231.xsd#inpha_ResearchTaxCreditReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_ResearchTaxCreditReceivableCurrent_406c03cb-f7ad-49d3-8740-43046dc1c8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherCurrentTaxCreditsReceivables_76027d82-cffe-4204-b57e-f1ade5bb7391" xlink:href="inpha-20251231.xsd#inpha_OtherCurrentTaxCreditsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_OtherCurrentTaxCreditsReceivables_76027d82-cffe-4204-b57e-f1ade5bb7391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_c24381d8-cc10-4399-8461-b94bdf9c3402" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_c24381d8-cc10-4399-8461-b94bdf9c3402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_7d5e8390-1170-4390-af41-7f544b518df5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_7d5e8390-1170-4390-af41-7f544b518df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_bbeee151-c0bd-46b4-9665-86d4cfd60c31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_CurrentTradeReceivables_bbeee151-c0bd-46b4-9665-86d4cfd60c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_5ffbea12-9392-4692-8cd9-4b13f0f5fbb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvancesToSuppliers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_5ffbea12-9392-4692-8cd9-4b13f0f5fbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_78089661-4fb1-4600-8aa9-36c463408d5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_78089661-4fb1-4600-8aa9-36c463408d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPrepayments_f9caaa5d-47df-4b80-b56f-f5ab37f49bdf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_NoncurrentPrepayments_f9caaa5d-47df-4b80-b56f-f5ab37f49bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentResearchTaxCredit_24ccf43c-6edc-4611-83b6-26ccd839224e" xlink:href="inpha-20251231.xsd#inpha_NonCurrentResearchTaxCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_NonCurrentResearchTaxCredit_24ccf43c-6edc-4611-83b6-26ccd839224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentPrepaidExpenses_c19a3cab-af53-4950-ad01-d2c2c9830cd4" xlink:href="inpha-20251231.xsd#inpha_NonCurrentPrepaidExpenses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_NonCurrentPrepaidExpenses_c19a3cab-af53-4950-ad01-d2c2c9830cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivables_6b140e6b-1594-4730-a2f0-947862f3f148" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_NoncurrentReceivables_6b140e6b-1594-4730-a2f0-947862f3f148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_bcaa8023-4227-44f3-9421-fb24c027f0b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_bcaa8023-4227-44f3-9421-fb24c027f0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeFromResearchTaxCredit2019_52423520-f952-4249-ac99-6b33023de6fe" xlink:href="inpha-20251231.xsd#inpha_IncomeFromResearchTaxCredit2019"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_IncomeFromResearchTaxCredit2019_52423520-f952-4249-ac99-6b33023de6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeFromResearchTaxCredit2020_2fbb3094-5f22-47ef-811e-6ecbdf12543c" xlink:href="inpha-20251231.xsd#inpha_IncomeFromResearchTaxCredit2020"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_IncomeFromResearchTaxCredit2020_2fbb3094-5f22-47ef-811e-6ecbdf12543c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeFromResearchTaxCredit2023_019d3e01-bbf8-7c5b-9f14-bfaf0ea7623c" xlink:href="inpha-20251231.xsd#inpha_IncomeFromResearchTaxCredit2023"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_IncomeFromResearchTaxCredit2023_019d3e01-bbf8-7c5b-9f14-bfaf0ea7623c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfPreFinancedCIRCollected_c603107d-de8f-4aa6-8d84-e3f18f810cbf" xlink:href="inpha-20251231.xsd#inpha_PercentageOfPreFinancedCIRCollected"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_PercentageOfPreFinancedCIRCollected_c603107d-de8f-4aa6-8d84-e3f18f810cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WithholdingRateCIR_3c7e4f2d-9f73-4038-a580-95676e4fed07" xlink:href="inpha-20251231.xsd#inpha_WithholdingRateCIR"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_WithholdingRateCIR_3c7e4f2d-9f73-4038-a580-95676e4fed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CIRRetentionMaturity_7946984d-5dbf-4878-9709-1fab933c255e" xlink:href="inpha-20251231.xsd#inpha_CIRRetentionMaturity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_CIRRetentionMaturity_7946984d-5dbf-4878-9709-1fab933c255e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WithholdingTaxCIRReclassifiedUnderNonCurrentFinancialAssets_5cc9d8de-9236-44d3-bc62-f8d2825ca3c3" xlink:href="inpha-20251231.xsd#inpha_WithholdingTaxCIRReclassifiedUnderNonCurrentFinancialAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_WithholdingTaxCIRReclassifiedUnderNonCurrentFinancialAssets_5cc9d8de-9236-44d3-bc62-f8d2825ca3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_2e419f96-fe52-4f9e-8b44-45af14194e76" xlink:href="inpha-20251231.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_2e419f96-fe52-4f9e-8b44-45af14194e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturity_229c19b1-4cf1-4f47-aa42-8cfe0779aa7e" xlink:href="inpha-20251231.xsd#inpha_BorrowingMaturity"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_inpha_BorrowingMaturity_229c19b1-4cf1-4f47-aa42-8cfe0779aa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_e858704e-b060-449f-aec4-4c6b6035d8c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_89c8b384-e018-4d7b-be06-596150e33122" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_e858704e-b060-449f-aec4-4c6b6035d8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IntangibleassetsDisclosureofDetailedInformationaboutIntangibleAssetsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IntangibleassetsDisclosureofDetailedInformationaboutIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IntangibleassetsDisclosureofDetailedInformationaboutIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_a918d062-f054-4b27-843d-13a9a77c6896" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2e46d92b-6f4b-4b07-aa06-7b2105cd50d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_a918d062-f054-4b27-843d-13a9a77c6896" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2e46d92b-6f4b-4b07-aa06-7b2105cd50d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_e5896724-0f42-4891-a900-dcd99290aa97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2e46d92b-6f4b-4b07-aa06-7b2105cd50d2" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_e5896724-0f42-4891-a900-dcd99290aa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_077da412-a4fe-4280-bd5e-6213f7d0b1e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_e5896724-0f42-4891-a900-dcd99290aa97" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_077da412-a4fe-4280-bd5e-6213f7d0b1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LicencesMember_ee72ed34-f9a6-4ea1-8b85-700efc79fed0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_077da412-a4fe-4280-bd5e-6213f7d0b1e4" xlink:to="loc_ifrs-full_LicencesMember_ee72ed34-f9a6-4ea1-8b85-700efc79fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_b0b7b051-67af-4a4e-a751-7290ad937e1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_077da412-a4fe-4280-bd5e-6213f7d0b1e4" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_b0b7b051-67af-4a4e-a751-7290ad937e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopmentMember_63a2e51c-2b38-4e7a-91fb-153648acd121" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_077da412-a4fe-4280-bd5e-6213f7d0b1e4" xlink:to="loc_ifrs-full_IntangibleAssetsUnderDevelopmentMember_63a2e51c-2b38-4e7a-91fb-153648acd121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_175ab68e-e93f-424d-8d4a-fed7951ab7d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2e46d92b-6f4b-4b07-aa06-7b2105cd50d2" xlink:to="loc_ifrs-full_TypesOfContractsAxis_175ab68e-e93f-424d-8d4a-fed7951ab7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_5f036d62-202d-498c-b3c2-1f6d218fc011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_175ab68e-e93f-424d-8d4a-fed7951ab7d2" xlink:to="loc_ifrs-full_TypesOfContractsDomain_5f036d62-202d-498c-b3c2-1f6d218fc011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabAgreementMember_5a548393-be37-444e-8166-69a4a9159ee0" xlink:href="inpha-20251231.xsd#inpha_MonalizumabAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_5f036d62-202d-498c-b3c2-1f6d218fc011" xlink:to="loc_inpha_MonalizumabAgreementMember_5a548393-be37-444e-8166-69a4a9159ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IPH5201Member_ee47b851-6f98-413e-b4c8-3c65cf4e6bea" xlink:href="inpha-20251231.xsd#inpha_IPH5201Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_5f036d62-202d-498c-b3c2-1f6d218fc011" xlink:to="loc_inpha_IPH5201Member_ee47b851-6f98-413e-b4c8-3c65cf4e6bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_7a24c6cc-4d33-4a67-bc8d-8770a867faad" xlink:href="inpha-20251231.xsd#inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_5f036d62-202d-498c-b3c2-1f6d218fc011" xlink:to="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_7a24c6cc-4d33-4a67-bc8d-8770a867faad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7fd3a0a8-fd5c-4d7f-b9d7-b8c7ae2ef0f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_2e46d92b-6f4b-4b07-aa06-7b2105cd50d2" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7fd3a0a8-fd5c-4d7f-b9d7-b8c7ae2ef0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7fd3a0a8-fd5c-4d7f-b9d7-b8c7ae2ef0f7" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_903feef7-066e-476a-9b14-6663ce544b2f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_903feef7-066e-476a-9b14-6663ce544b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_fc6b1e99-70e4-4879-9ab5-cde744ade03a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_fc6b1e99-70e4-4879-9ab5-cde744ade03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_5cdd1b1f-e545-4e08-a86e-ae48e64dd9b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_5cdd1b1f-e545-4e08-a86e-ae48e64dd9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_5677a2d2-b78e-4cfc-8ca2-7625e62a3078" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_5677a2d2-b78e-4cfc-8ca2-7625e62a3078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_95e1d53a-fd5c-44a9-844f-1a38f849e9c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_95e1d53a-fd5c-44a9-844f-1a38f849e9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7ed4e94b-6521-4415-a8c8-828a723135cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_7ed4e94b-6521-4415-a8c8-828a723135cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_019d4362-fc6f-7a6e-bffc-1d4558751e32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_019d4362-fc6f-7a6e-bffc-1d4558751e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_5d58c718-83b4-446a-8a91-811ae91a23cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_5d58c718-83b4-446a-8a91-811ae91a23cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_28589bb4-7653-4b75-8a99-a4b5332c0154" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_e1037f7b-b315-4e3f-ab92-5ce9cae5b57e" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_28589bb4-7653-4b75-8a99-a4b5332c0154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IntangibleassetsAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IntangibleassetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IntangibleassetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_c4092e88-c1d9-4984-9c9d-e8c533d04f88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_d55a4cc8-28cb-4466-9886-bb9b6b809115" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_c4092e88-c1d9-4984-9c9d-e8c533d04f88" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_d55a4cc8-28cb-4466-9886-bb9b6b809115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_d025faa8-77cd-498c-9fa1-876baf189312" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_d55a4cc8-28cb-4466-9886-bb9b6b809115" xlink:to="loc_ifrs-full_TypesOfContractsAxis_d025faa8-77cd-498c-9fa1-876baf189312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_d025faa8-77cd-498c-9fa1-876baf189312" xlink:to="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember_3a383856-0ef1-498e-974c-a8f22f9cf089" xlink:href="inpha-20251231.xsd#inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember_3a383856-0ef1-498e-974c-a8f22f9cf089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2014NovoNordiskASMonalizumabAgreementMember_019d2557-0d2e-7209-989d-67de966b33b0" xlink:href="inpha-20251231.xsd#inpha_A2014NovoNordiskASMonalizumabAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_A2014NovoNordiskASMonalizumabAgreementMember_019d2557-0d2e-7209-989d-67de966b33b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember_13252d8a-d5c4-4421-ae7c-6681338b31f3" xlink:href="inpha-20251231.xsd#inpha_IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember_13252d8a-d5c4-4421-ae7c-6681338b31f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_fc5440f7-f40a-44a1-a025-379e20ba6907" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_fc5440f7-f40a-44a1-a025-379e20ba6907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_09e0b11e-52dc-431d-b34f-d2373f15acf7" xlink:href="inpha-20251231.xsd#inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_PH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember_09e0b11e-52dc-431d-b34f-d2373f15acf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019d255b-b9ef-754c-8c08-d6661bd8647a" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2deb296d-70e7-4c64-9fef-6f8201844d76" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019d255b-b9ef-754c-8c08-d6661bd8647a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_d55a4cc8-28cb-4466-9886-bb9b6b809115" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_c5fde2ab-f694-4579-a565-1bbeccdd7127" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_c5fde2ab-f694-4579-a565-1bbeccdd7127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_05b4982d-17f9-4c94-818f-e5bb1646bc38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_05b4982d-17f9-4c94-818f-e5bb1646bc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_e03fb32b-0317-428b-ba0d-f21868de38c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_e03fb32b-0317-428b-ba0d-f21868de38c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_f39b345b-2f71-4204-9afd-190cc10ddcc1" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_f39b345b-2f71-4204-9afd-190cc10ddcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LicensingAgreementMaximumMilestonePayment_73cb30cd-168c-4bc3-bde2-611eef62646f" xlink:href="inpha-20251231.xsd#inpha_LicensingAgreementMaximumMilestonePayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_inpha_LicensingAgreementMaximumMilestonePayment_73cb30cd-168c-4bc3-bde2-611eef62646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PaymentsForMilestone_cf3ede23-b2f3-4392-85c1-54ffb0b666f4" xlink:href="inpha-20251231.xsd#inpha_PaymentsForMilestone"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_inpha_PaymentsForMilestone_cf3ede23-b2f3-4392-85c1-54ffb0b666f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_65011fa3-0114-40bf-8303-da2aed042ac9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_65011fa3-0114-40bf-8303-da2aed042ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_99acc5a3-54d4-4e75-a6a3-10551f0a0775" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_ifrs-full_FinancialLiabilities_99acc5a3-54d4-4e75-a6a3-10551f0a0775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MilestonePaymentsPercentage_019d3bb0-9dc5-7cc3-b085-019e3bf24ace" xlink:href="inpha-20251231.xsd#inpha_MilestonePaymentsPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_inpha_MilestonePaymentsPercentage_019d3bb0-9dc5-7cc3-b085-019e3bf24ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MilestonePaymentsMaximumAmount_019d3bb0-9dc5-77aa-944e-e5dd4c5e1723" xlink:href="inpha-20251231.xsd#inpha_MilestonePaymentsMaximumAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_574d89ca-73ca-4ee8-a565-c8c7b35fde29" xlink:to="loc_inpha_MilestonePaymentsMaximumAmount_019d3bb0-9dc5-77aa-944e-e5dd4c5e1723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/PropertyandequipmentDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#PropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/PropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_9f5e058d-48fa-44f8-a4b1-730329a51b9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_d7b7c98d-e5dd-49f9-aede-c2b6026e9ff7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_9f5e058d-48fa-44f8-a4b1-730329a51b9d" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_d7b7c98d-e5dd-49f9-aede-c2b6026e9ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5c4278f1-fa82-47de-a9c5-9f563b4852c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_d7b7c98d-e5dd-49f9-aede-c2b6026e9ff7" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5c4278f1-fa82-47de-a9c5-9f563b4852c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc53199e-3350-4449-991f-b8c6e410f0d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5c4278f1-fa82-47de-a9c5-9f563b4852c9" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc53199e-3350-4449-991f-b8c6e410f0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_7a7dd9e8-732d-4143-9564-ba564b3cfb89" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc53199e-3350-4449-991f-b8c6e410f0d4" xlink:to="loc_ifrs-full_LandAndBuildingsMember_7a7dd9e8-732d-4143-9564-ba564b3cfb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LaboratoryEquipmentAndOtherMember_1387506b-b64f-448f-96a1-00abe0078549" xlink:href="inpha-20251231.xsd#inpha_LaboratoryEquipmentAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc53199e-3350-4449-991f-b8c6e410f0d4" xlink:to="loc_inpha_LaboratoryEquipmentAndOtherMember_1387506b-b64f-448f-96a1-00abe0078549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgressMember_146dca4a-e463-4799-9264-9b94fa5fcb87" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_fc53199e-3350-4449-991f-b8c6e410f0d4" xlink:to="loc_ifrs-full_ConstructionInProgressMember_146dca4a-e463-4799-9264-9b94fa5fcb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_38600acf-6cbc-4f03-a1f4-4312d581b3b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_d7b7c98d-e5dd-49f9-aede-c2b6026e9ff7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_38600acf-6cbc-4f03-a1f4-4312d581b3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_30a186b0-a0cb-4098-a618-965c6f1240bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_38600acf-6cbc-4f03-a1f4-4312d581b3b9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_30a186b0-a0cb-4098-a618-965c6f1240bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssetsMember_6ca0d1b2-407c-434b-9d87-cbb47cc82430" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_30a186b0-a0cb-4098-a618-965c6f1240bd" xlink:to="loc_ifrs-full_RightofuseAssetsMember_6ca0d1b2-407c-434b-9d87-cbb47cc82430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_33f2d545-a1bb-4e65-8c17-9659972ff3c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_d7b7c98d-e5dd-49f9-aede-c2b6026e9ff7" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_33f2d545-a1bb-4e65-8c17-9659972ff3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_33f2d545-a1bb-4e65-8c17-9659972ff3c9" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_43367ede-8ca5-461f-8b71-508ba5f3e62c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_43367ede-8ca5-461f-8b71-508ba5f3e62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_53472982-154e-4668-920a-24f2628cfea9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_53472982-154e-4668-920a-24f2628cfea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_ec84ff73-bdf6-48c8-bec3-9fed36a64020" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_ec84ff73-bdf6-48c8-bec3-9fed36a64020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_1bf71c68-2534-4f56-9fdb-fbcf56928f7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_1bf71c68-2534-4f56-9fdb-fbcf56928f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets_ff6e2898-e924-4d3a-9ad4-003aaa37ca21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets_ff6e2898-e924-4d3a-9ad4-003aaa37ca21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_365c347b-b8e5-4b41-8da3-8020f798ef7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_365c347b-b8e5-4b41-8da3-8020f798ef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_da3a7f37-a107-4f9d-b788-84b91bf8bdbc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_4ddfed6e-3ce2-4a28-8b8f-066e779b1186" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_da3a7f37-a107-4f9d-b788-84b91bf8bdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradepayablesandothersDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#TradepayablesandothersDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradepayablesandothersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_a693734d-3310-4684-ba07-8f745f205e66" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersTable_0202e6de-fa83-418b-b199-395c74ab073f" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_a693734d-3310-4684-ba07-8f745f205e66" xlink:to="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersTable_0202e6de-fa83-418b-b199-395c74ab073f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7a3c77e4-7e76-4526-b91e-bccc58496788" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersTable_0202e6de-fa83-418b-b199-395c74ab073f" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7a3c77e4-7e76-4526-b91e-bccc58496788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_c7f566e5-1f2d-4748-ba53-ed843315f928" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7a3c77e4-7e76-4526-b91e-bccc58496788" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_c7f566e5-1f2d-4748-ba53-ed843315f928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_b233fcff-fcdb-4d4f-914d-b14d4befcdf6" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_c7f566e5-1f2d-4748-ba53-ed843315f928" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_b233fcff-fcdb-4d4f-914d-b14d4befcdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:href="inpha-20251231.xsd#inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersTable_0202e6de-fa83-418b-b199-395c74ab073f" xlink:to="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_bc697ec7-7e2b-4f05-9d93-726024fe2a5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_bc697ec7-7e2b-4f05-9d93-726024fe2a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_dc5fd345-9d9b-4d27-a4c5-7f84b68af582" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_dc5fd345-9d9b-4d27-a4c5-7f84b68af582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentPayables_4a69a206-36e0-44db-aff3-0c60b7058cb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_ifrs-full_OtherCurrentPayables_4a69a206-36e0-44db-aff3-0c60b7058cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures_40e29ae2-756d-41b6-8af2-b302eb3c3cb4" xlink:href="inpha-20251231.xsd#inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures_40e29ae2-756d-41b6-8af2-b302eb3c3cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CurrentPayablesRelatedToCapitalExpenditures_a67ce451-bebe-4d1c-9655-4b5fd94d8bed" xlink:href="inpha-20251231.xsd#inpha_CurrentPayablesRelatedToCapitalExpenditures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_inpha_CurrentPayablesRelatedToCapitalExpenditures_a67ce451-bebe-4d1c-9655-4b5fd94d8bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_d50f9d84-3884-46f8-b496-0420f03aaba2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_d50f9d84-3884-46f8-b496-0420f03aaba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_a22dd04d-4fc1-490b-98e4-bfac9b6e5e32" xlink:href="inpha-20251231.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfDetailedInformationAboutTradePayablesAndOthersLineItems_aa5c98c5-9871-404d-a82a-82da0d03ec9c" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_a22dd04d-4fc1-490b-98e4-bfac9b6e5e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofFinancialLiabilitiesPerMaturityDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialliabilitiesDisclosureofFinancialLiabilitiesPerMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofFinancialLiabilitiesPerMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_55093afc-33b6-49b2-875e-bf1a0d047031" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_55093afc-33b6-49b2-875e-bf1a0d047031" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ee17013a-c4d8-47bf-937d-f0b082007ab9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ee17013a-c4d8-47bf-937d-f0b082007ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_ee17013a-c4d8-47bf-937d-f0b082007ab9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:href="inpha-20251231.xsd#inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_97a7c743-a200-4d2b-bf38-6926e5f889ea" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_97a7c743-a200-4d2b-bf38-6926e5f889ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_68126511-1092-4d14-9b25-0cbb41522345" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_68126511-1092-4d14-9b25-0cbb41522345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsRealEstatePropertyMember_019d256b-003f-78fd-9f93-8dfc24bdf953" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsRealEstatePropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_LeaseFinancingObligationsRealEstatePropertyMember_019d256b-003f-78fd-9f93-8dfc24bdf953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementAccruedInterestMember_7b19e6ef-2c8d-42fd-9d5a-6585439c6ffa" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementAccruedInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_PGELoanAgreementAccruedInterestMember_7b19e6ef-2c8d-42fd-9d5a-6585439c6ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DownPaymentMember_621e29d8-963e-4d9a-8480-21c1d64b750f" xlink:href="inpha-20251231.xsd#inpha_DownPaymentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_DownPaymentMember_621e29d8-963e-4d9a-8480-21c1d64b750f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanEquipmentMember_eb09f50d-c100-49e6-87e2-da372d4742fa" xlink:href="inpha-20251231.xsd#inpha_LoanEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_LoanEquipmentMember_eb09f50d-c100-49e6-87e2-da372d4742fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_84050a50-00b0-4d16-a3c5-c64353d9cf16" xlink:href="inpha-20251231.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PropertyPlantAndEquipmentExcludingRightOfUseAssetsMember_019d2572-74b3-7e83-9c71-fa1d880210a8" xlink:to="loc_inpha_LoanBuildingMember_84050a50-00b0-4d16-a3c5-c64353d9cf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f3e779fd-6d1d-4798-884e-7596cc920f5f" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsBuildingLeVirageMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f3e779fd-6d1d-4798-884e-7596cc920f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_5c6aef2a-b099-4b92-8a7b-027d8236d537" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsInnateIncPremisesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_5c6aef2a-b099-4b92-8a7b-027d8236d537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsEquipmentMember_382ba4d6-38cd-48e1-8b5e-955a76328210" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LeaseFinancingObligationsEquipmentMember_382ba4d6-38cd-48e1-8b5e-955a76328210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsVehiclesMember_ace450d2-bc98-4276-ad06-5f7920b052b6" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsVehiclesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LeaseFinancingObligationsVehiclesMember_ace450d2-bc98-4276-ad06-5f7920b052b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsPrintersMember_301a737e-2fe1-4b3e-bfa5-dfd0f8995cd7" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsPrintersMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LeaseFinancingObligationsPrintersMember_301a737e-2fe1-4b3e-bfa5-dfd0f8995cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_176042aa-2acd-4c4e-a0ac-72defd39d176" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_176042aa-2acd-4c4e-a0ac-72defd39d176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementWithSocitGnraleMember_80a4ff83-8b1e-4cf3-8712-3ad7d79c965d" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementWithSocitGnraleMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4ef57fd4-f08b-486a-8e29-f848ffb1fa3d" xlink:to="loc_inpha_LoanAgreementWithSocitGnraleMember_80a4ff83-8b1e-4cf3-8712-3ad7d79c965d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_4cc6bb68-cd49-4839-9184-df89016c0c27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_4cc6bb68-cd49-4839-9184-df89016c0c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_7125247d-7c48-42a3-9bce-eb9d2b7b22cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_4cc6bb68-cd49-4839-9184-df89016c0c27" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_7125247d-7c48-42a3-9bce-eb9d2b7b22cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_9e231c9a-9a41-462b-9c0e-0a87036858e9" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_7125247d-7c48-42a3-9bce-eb9d2b7b22cd" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_9e231c9a-9a41-462b-9c0e-0a87036858e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_4cff2176-256f-4932-8109-b23f5a1121d3" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_7125247d-7c48-42a3-9bce-eb9d2b7b22cd" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_4cff2176-256f-4932-8109-b23f5a1121d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_271125f4-69a3-44a3-80f2-2ee2ff0fbc09" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_7125247d-7c48-42a3-9bce-eb9d2b7b22cd" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_271125f4-69a3-44a3-80f2-2ee2ff0fbc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis_8fe3fb2a-1f1e-44be-a440-9372c4ab0757" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsAxis_8fe3fb2a-1f1e-44be-a440-9372c4ab0757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_560325e8-ac96-4697-ac27-98432244776d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_8fe3fb2a-1f1e-44be-a440-9372c4ab0757" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_560325e8-ac96-4697-ac27-98432244776d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GuaranteesMember_7b15663d-2655-4147-af82-0945de5f540a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_560325e8-ac96-4697-ac27-98432244776d" xlink:to="loc_ifrs-full_GuaranteesMember_7b15663d-2655-4147-af82-0945de5f540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_4b95e195-3d52-4c11-82ad-eb789707763e" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_c121b845-437b-4469-add0-02c31edad897" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_FinancialLiabilities_c121b845-437b-4469-add0-02c31edad897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesDownPayment_f37e310e-f278-40d5-ba38-c11e10c6db5e" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesDownPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_FinancialLiabilitiesDownPayment_f37e310e-f278-40d5-ba38-c11e10c6db5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_72f30dfb-1483-4266-846f-d0c4eaecbaef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_72f30dfb-1483-4266-846f-d0c4eaecbaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProceedsFromLeaseLiabilitiesAndOtherNonCashEffectsClassifiedAsFinancingActivities_a713bbdd-5491-49bb-9ea5-667f0b0b85d1" xlink:href="inpha-20251231.xsd#inpha_ProceedsFromLeaseLiabilitiesAndOtherNonCashEffectsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_ProceedsFromLeaseLiabilitiesAndOtherNonCashEffectsClassifiedAsFinancingActivities_a713bbdd-5491-49bb-9ea5-667f0b0b85d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RepaymentsOfBorrowingsAndLeaseLiabilitiesNetOfExchangeRateVariationClassifiedAsFinancingActivities_28a7d0bc-3881-4b74-a7f9-27cd13b754a3" xlink:href="inpha-20251231.xsd#inpha_RepaymentsOfBorrowingsAndLeaseLiabilitiesNetOfExchangeRateVariationClassifiedAsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_RepaymentsOfBorrowingsAndLeaseLiabilitiesNetOfExchangeRateVariationClassifiedAsFinancingActivities_28a7d0bc-3881-4b74-a7f9-27cd13b754a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseInDownPayment_7d84e4c7-097e-4145-b212-2e49258d772f" xlink:href="inpha-20251231.xsd#inpha_DecreaseInDownPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_DecreaseInDownPayment_7d84e4c7-097e-4145-b212-2e49258d772f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_8bd8ef8f-603e-45fa-9c5f-60fdc6bb7afa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_FinancialLiabilities_8bd8ef8f-603e-45fa-9c5f-60fdc6bb7afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesDownPayment_3e000e62-7491-4689-8df0-73e19ba690a6" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesDownPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_FinancialLiabilitiesDownPayment_3e000e62-7491-4689-8df0-73e19ba690a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_b4cf445e-c390-4e32-901e-ec9911d4df0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_NotionalAmount_b4cf445e-c390-4e32-901e-ec9911d4df0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_01588793-2a65-4ccb-8985-e238067403b7" xlink:href="inpha-20251231.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_01588793-2a65-4ccb-8985-e238067403b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturity_a1567b29-a590-45ba-a085-7477776cc2a0" xlink:href="inpha-20251231.xsd#inpha_BorrowingMaturity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_BorrowingMaturity_a1567b29-a590-45ba-a085-7477776cc2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturityExtensionPeriodOption_01300250-19be-4ac8-ae6c-fa9d9a8143c2" xlink:href="inpha-20251231.xsd#inpha_BorrowingMaturityExtensionPeriodOption"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_BorrowingMaturityExtensionPeriodOption_01300250-19be-4ac8-ae6c-fa9d9a8143c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingPercentageOfStateGuaranteedLoan_46d6df2a-3273-4d5e-9eb5-ed415db462ed" xlink:href="inpha-20251231.xsd#inpha_BorrowingPercentageOfStateGuaranteedLoan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_BorrowingPercentageOfStateGuaranteedLoan_46d6df2a-3273-4d5e-9eb5-ed415db462ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingGracePeriod_eb2ab92b-6488-462e-abc6-4a77b3ac9cd6" xlink:href="inpha-20251231.xsd#inpha_BorrowingGracePeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_BorrowingGracePeriod_eb2ab92b-6488-462e-abc6-4a77b3ac9cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_61916a76-93d3-4724-9544-59b0ed711009" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_BorrowingsInterestRate_61916a76-93d3-4724-9544-59b0ed711009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfLoans_eedad754-7e16-4205-88f5-5b0c48d8b5f8" xlink:href="inpha-20251231.xsd#inpha_NumberOfLoans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_NumberOfLoans_eedad754-7e16-4205-88f5-5b0c48d8b5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_5d918b01-47e0-4676-982b-c035ddcb72d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_5d918b01-47e0-4676-982b-c035ddcb72d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementMaximumBorrowingCapacity_9aa59420-6d90-449c-a812-9511d5fc5886" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementMaximumBorrowingCapacity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_10135927-9c0a-4e9c-b5a0-f0263a87e6a3" xlink:to="loc_inpha_LoanAgreementMaximumBorrowingCapacity_9aa59420-6d90-449c-a812-9511d5fc5886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialliabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_7447760e-dee0-4f01-bcbe-7d94ea3e970a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_a17e4347-f98f-4ce1-bcca-c477665973eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_7447760e-dee0-4f01-bcbe-7d94ea3e970a" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_a17e4347-f98f-4ce1-bcca-c477665973eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8d7619b6-e225-4402-9b15-801e82561b1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_a17e4347-f98f-4ce1-bcca-c477665973eb" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8d7619b6-e225-4402-9b15-801e82561b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_37bc24e8-eb21-44bb-bd40-08eddd3f56e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8d7619b6-e225-4402-9b15-801e82561b1c" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_37bc24e8-eb21-44bb-bd40-08eddd3f56e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementWithSocitGnraleMember_72ee3bdb-32df-409b-b656-2791240dfff8" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementWithSocitGnraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_37bc24e8-eb21-44bb-bd40-08eddd3f56e6" xlink:to="loc_inpha_LoanAgreementWithSocitGnraleMember_72ee3bdb-32df-409b-b656-2791240dfff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_38d6e405-dc13-47c1-8977-df74bd108807" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_a17e4347-f98f-4ce1-bcca-c477665973eb" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_38d6e405-dc13-47c1-8977-df74bd108807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_36aa2d19-36ff-46bf-93b1-107647bb8d87" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_38d6e405-dc13-47c1-8977-df74bd108807" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_36aa2d19-36ff-46bf-93b1-107647bb8d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_047902ea-34e1-4aa9-95a5-13054deb02e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_36aa2d19-36ff-46bf-93b1-107647bb8d87" xlink:to="loc_ifrs-full_FixedInterestRateMember_047902ea-34e1-4aa9-95a5-13054deb02e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_a17e4347-f98f-4ce1-bcca-c477665973eb" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementCollateral_aa1a6c7b-8feb-4534-9f9a-cbf78ff2c1e0" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementCollateral"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_LoanAgreementCollateral_aa1a6c7b-8feb-4534-9f9a-cbf78ff2c1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f4853e15-e385-4ad8-b41f-9b57cc4d547d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_f4853e15-e385-4ad8-b41f-9b57cc4d547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingsMaturityPeriod_827b8834-d7ee-4450-9034-d4342eae1354" xlink:href="inpha-20251231.xsd#inpha_BorrowingsMaturityPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_BorrowingsMaturityPeriod_827b8834-d7ee-4450-9034-d4342eae1354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_cc0f8e21-a82d-4473-b16c-279c9a4e3c70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_ifrs-full_FinancialLiabilities_cc0f8e21-a82d-4473-b16c-279c9a4e3c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_f9e09ea4-2ebe-4d1f-89a4-305c398a34e1" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_f9e09ea4-2ebe-4d1f-89a4-305c398a34e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_764bc80c-ce1d-4bcf-adf2-3e1d80f44f6f" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_764bc80c-ce1d-4bcf-adf2-3e1d80f44f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_595a9dd3-cdde-44d0-91f6-d1707c26f2a0" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_595a9dd3-cdde-44d0-91f6-d1707c26f2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_499b39b5-894f-4727-83d7-c838c5a2821a" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_499b39b5-894f-4727-83d7-c838c5a2821a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_cd4ccf3e-7c4a-4aad-b665-914efe69d1b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_ifrs-full_BorrowingsInterestRate_cd4ccf3e-7c4a-4aad-b665-914efe69d1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WriteOffOfARightOfUseAsset_b1a87ca4-8732-4aa0-828e-26f29749a442" xlink:href="inpha-20251231.xsd#inpha_WriteOffOfARightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_WriteOffOfARightOfUseAsset_b1a87ca4-8732-4aa0-828e-26f29749a442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WriteOffOfALeaseLiability_6f076495-cc06-4226-a1b9-37caab78a1c8" xlink:href="inpha-20251231.xsd#inpha_WriteOffOfALeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_458e07c6-d053-4f8a-958e-3f4bfcb649f9" xlink:to="loc_inpha_WriteOffOfALeaseLiability_6f076495-cc06-4226-a1b9-37caab78a1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofSchedulefortheContractualFlowsofFinancialLiabilitiesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialliabilitiesDisclosureofSchedulefortheContractualFlowsofFinancialLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofSchedulefortheContractualFlowsofFinancialLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_674dddf4-2b61-4e9d-9357-0a2332885d2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_b027edb7-4445-4efd-97ca-178858f0dd93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_674dddf4-2b61-4e9d-9357-0a2332885d2e" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_b027edb7-4445-4efd-97ca-178858f0dd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3facfecd-fb93-472c-a815-d72e092700c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_b027edb7-4445-4efd-97ca-178858f0dd93" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3facfecd-fb93-472c-a815-d72e092700c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_3facfecd-fb93-472c-a815-d72e092700c2" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_e9c35699-6873-4bf1-924f-b0a1b4a8b29f" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_e9c35699-6873-4bf1-924f-b0a1b4a8b29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_907d722e-fcae-4351-9d2a-efb3fd6860a2" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_907d722e-fcae-4351-9d2a-efb3fd6860a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementAccruedInterestMember_334116d5-119b-4206-b2b6-38bae8690a77" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementAccruedInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_PGELoanAgreementAccruedInterestMember_334116d5-119b-4206-b2b6-38bae8690a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f7126e87-89bd-4ded-a1f4-9cf6fb35c86f" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsBuildingLeVirageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f7126e87-89bd-4ded-a1f4-9cf6fb35c86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_17d0f92d-f9bb-452d-83d7-330b0b95176e" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsInnateIncPremisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_17d0f92d-f9bb-452d-83d7-330b0b95176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsEquipmentMember_d514fd30-db4c-4073-97c4-1d4b6b1312c4" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsEquipmentMember_d514fd30-db4c-4073-97c4-1d4b6b1312c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsVehiclesMember_b6e6087c-6493-495a-9ba7-ec32740bdb59" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsVehiclesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsVehiclesMember_b6e6087c-6493-495a-9ba7-ec32740bdb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsPrintersMember_7be076e3-f68c-47c5-b970-c14c7cccd559" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsPrintersMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsPrintersMember_7be076e3-f68c-47c5-b970-c14c7cccd559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsITSecurityMember_019d2577-eef2-7f4e-9699-55a5f8e7a0ce" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsITSecurityMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LeaseFinancingObligationsITSecurityMember_019d2577-eef2-7f4e-9699-55a5f8e7a0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanEquipmentMember_02447031-d804-4ac6-81d0-26f51605a789" xlink:href="inpha-20251231.xsd#inpha_LoanEquipmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LoanEquipmentMember_02447031-d804-4ac6-81d0-26f51605a789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_557fe2b8-380e-4eff-a4ca-d7a385a149c7" xlink:href="inpha-20251231.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_7a0015cd-72a0-4020-9185-cf366530f57f" xlink:to="loc_inpha_LoanBuildingMember_557fe2b8-380e-4eff-a4ca-d7a385a149c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9f155e6d-cfad-4528-bd3f-e19bb1f113d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_b027edb7-4445-4efd-97ca-178858f0dd93" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9f155e6d-cfad-4528-bd3f-e19bb1f113d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities_c363c9f0-da0f-4cb3-814a-f0bcead2b25c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9f155e6d-cfad-4528-bd3f-e19bb1f113d4" xlink:to="loc_ifrs-full_CurrentFinancialLiabilities_c363c9f0-da0f-4cb3-814a-f0bcead2b25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities_dd10155f-8254-4244-869d-62165d871b57" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_9f155e6d-cfad-4528-bd3f-e19bb1f113d4" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilities_dd10155f-8254-4244-869d-62165d871b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofMaturityAnalysisforNonDerivativeFinancialLiabilitiesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialliabilitiesDisclosureofMaturityAnalysisforNonDerivativeFinancialLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofMaturityAnalysisforNonDerivativeFinancialLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_d5b9e17e-33fa-4b79-ba25-310a034b18fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_617e33ab-b12b-4dc5-9936-a6f7457f5dc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract_d5b9e17e-33fa-4b79-ba25-310a034b18fd" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_617e33ab-b12b-4dc5-9936-a6f7457f5dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f32bd5eb-c205-4374-852b-a5d5eafdb5fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_617e33ab-b12b-4dc5-9936-a6f7457f5dc1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f32bd5eb-c205-4374-852b-a5d5eafdb5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_f32bd5eb-c205-4374-852b-a5d5eafdb5fb" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_00ff89a4-106e-4e97-8569-bb5935e55c6e" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_00ff89a4-106e-4e97-8569-bb5935e55c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_8c20571c-f4d4-4b6e-afeb-4a532b4c94c0" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_8c20571c-f4d4-4b6e-afeb-4a532b4c94c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementAccruedInterestMember_019d257a-b86d-7fca-8690-48a0c39974c8" xlink:href="inpha-20251231.xsd#inpha_PGELoanAgreementAccruedInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_PGELoanAgreementAccruedInterestMember_019d257a-b86d-7fca-8690-48a0c39974c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f921d377-f9e2-46f1-ac84-cedaf640b8a5" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsBuildingLeVirageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_f921d377-f9e2-46f1-ac84-cedaf640b8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_04cc38de-d0bc-4233-8b14-6ff44bd8834c" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsInnateIncPremisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_04cc38de-d0bc-4233-8b14-6ff44bd8834c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsVehiclesMember_a5b3a9ce-c6d4-4900-8554-816472be3916" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsVehiclesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LeaseFinancingObligationsVehiclesMember_a5b3a9ce-c6d4-4900-8554-816472be3916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsPrintersMember_d4892ecc-93ac-4e05-9452-3a19075f7eca" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsPrintersMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LeaseFinancingObligationsPrintersMember_d4892ecc-93ac-4e05-9452-3a19075f7eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsITSecurityMember_019d257a-3934-7c17-96ad-e1e6c267cf2c" xlink:href="inpha-20251231.xsd#inpha_LeaseFinancingObligationsITSecurityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LeaseFinancingObligationsITSecurityMember_019d257a-3934-7c17-96ad-e1e6c267cf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanEquipmentMember_90e1018a-bf83-4b17-bc22-cec32a9fa868" xlink:href="inpha-20251231.xsd#inpha_LoanEquipmentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LoanEquipmentMember_90e1018a-bf83-4b17-bc22-cec32a9fa868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_2c280c11-d881-4d55-941c-8063a3fc25b2" xlink:href="inpha-20251231.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_31c6c8a0-e9a7-4d7d-bdd0-25d33dec708d" xlink:to="loc_inpha_LoanBuildingMember_2c280c11-d881-4d55-941c-8063a3fc25b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_f3386969-aeb8-48b9-ba32-78a4e48d2bd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_617e33ab-b12b-4dc5-9936-a6f7457f5dc1" xlink:to="loc_ifrs-full_MaturityAxis_f3386969-aeb8-48b9-ba32-78a4e48d2bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_f3386969-aeb8-48b9-ba32-78a4e48d2bd5" xlink:to="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_20c03c77-17b7-4d51-9d69-500b34fe7c0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_20c03c77-17b7-4d51-9d69-500b34fe7c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_09d1b1f7-4867-4f89-bda2-bc0abe9e4db5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_09d1b1f7-4867-4f89-bda2-bc0abe9e4db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0b3ba139-b191-42d2-937d-b1ab990d008c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_0b3ba139-b191-42d2-937d-b1ab990d008c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_f2c833ef-7a99-4a9c-a3ae-cf2d4864f726" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_f2c833ef-7a99-4a9c-a3ae-cf2d4864f726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1f3f573c-8d87-4542-9f60-53b263ce6495" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1f3f573c-8d87-4542-9f60-53b263ce6495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_d564a38d-6dcc-475e-ae50-df037ac846ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_53c76066-fad4-4218-9234-1204747eeec6" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_d564a38d-6dcc-475e-ae50-df037ac846ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_6761c2dc-a47c-4ea9-a306-bd481eb6c480" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_617e33ab-b12b-4dc5-9936-a6f7457f5dc1" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_6761c2dc-a47c-4ea9-a306-bd481eb6c480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_93e45f12-89f5-4dcb-a909-605b2a7ebb17" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_6761c2dc-a47c-4ea9-a306-bd481eb6c480" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_93e45f12-89f5-4dcb-a909-605b2a7ebb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofdefinedbenefitplansDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#EmployeebenefitsDisclosureofdefinedbenefitplansDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofdefinedbenefitplansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_159526ce-41ac-4df3-8396-27cd44a3ee0d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_df871ed2-9fdd-4154-93ae-26163c9876c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_159526ce-41ac-4df3-8396-27cd44a3ee0d" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_df871ed2-9fdd-4154-93ae-26163c9876c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_421c0539-8790-4b43-95eb-b251240044d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_df871ed2-9fdd-4154-93ae-26163c9876c2" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_421c0539-8790-4b43-95eb-b251240044d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_f77d02ca-d3d5-4110-a55e-2ca4c3b9436f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_421c0539-8790-4b43-95eb-b251240044d1" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_f77d02ca-d3d5-4110-a55e-2ca4c3b9436f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RetirementDefinedBenefitMember_a6aabdf5-dbaa-4a74-ad29-ef2901a72ae5" xlink:href="inpha-20251231.xsd#inpha_RetirementDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_f77d02ca-d3d5-4110-a55e-2ca4c3b9436f" xlink:to="loc_inpha_RetirementDefinedBenefitMember_a6aabdf5-dbaa-4a74-ad29-ef2901a72ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SeniorityAwardsMember_5db197a4-45e8-49d8-819e-b00b2b56cb3a" xlink:href="inpha-20251231.xsd#inpha_SeniorityAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_f77d02ca-d3d5-4110-a55e-2ca4c3b9436f" xlink:to="loc_inpha_SeniorityAwardsMember_5db197a4-45e8-49d8-819e-b00b2b56cb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_b6f18889-e887-4a32-b71b-adfbfc12fab5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_df871ed2-9fdd-4154-93ae-26163c9876c2" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_b6f18889-e887-4a32-b71b-adfbfc12fab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_b8c7a5c7-47de-453f-b33e-334aeee4cfa5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_b6f18889-e887-4a32-b71b-adfbfc12fab5" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_b8c7a5c7-47de-453f-b33e-334aeee4cfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#EmployeebenefitsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_a4758789-608d-4152-acf3-7f2557e3d801" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7e2308f7-743b-4476-90b4-29c199c80a67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_a4758789-608d-4152-acf3-7f2557e3d801" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7e2308f7-743b-4476-90b4-29c199c80a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_2b3acd30-f4bf-4b03-ab50-5f730dc32c9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7e2308f7-743b-4476-90b4-29c199c80a67" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_2b3acd30-f4bf-4b03-ab50-5f730dc32c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_5ab3b5c5-479f-4a9b-b547-24fc01d03ea2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_2b3acd30-f4bf-4b03-ab50-5f730dc32c9f" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_5ab3b5c5-479f-4a9b-b547-24fc01d03ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SeniorityAwardsMember_dc7e751d-b9ac-440b-acd2-0d8594931546" xlink:href="inpha-20251231.xsd#inpha_SeniorityAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_5ab3b5c5-479f-4a9b-b547-24fc01d03ea2" xlink:to="loc_inpha_SeniorityAwardsMember_dc7e751d-b9ac-440b-acd2-0d8594931546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LengthOfServiceAwardsMember_1367f132-3a16-4063-8c3c-c131cde1e6cb" xlink:href="inpha-20251231.xsd#inpha_LengthOfServiceAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_5ab3b5c5-479f-4a9b-b547-24fc01d03ea2" xlink:to="loc_inpha_LengthOfServiceAwardsMember_1367f132-3a16-4063-8c3c-c131cde1e6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_4f4f7ef9-0075-489b-9d27-fc9e1712d083" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7e2308f7-743b-4476-90b4-29c199c80a67" xlink:to="loc_ifrs-full_CounterpartiesAxis_4f4f7ef9-0075-489b-9d27-fc9e1712d083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_4f4f7ef9-0075-489b-9d27-fc9e1712d083" xlink:to="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExecutivesMember_b092a975-4296-4f73-8c99-2e1093de76b0" xlink:href="inpha-20251231.xsd#inpha_ExecutivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:to="loc_inpha_ExecutivesMember_b092a975-4296-4f73-8c99-2e1093de76b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonExecutivesMember_9899db06-79f2-435a-bcc2-9c25c6953591" xlink:href="inpha-20251231.xsd#inpha_NonExecutivesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:to="loc_inpha_NonExecutivesMember_9899db06-79f2-435a-bcc2-9c25c6953591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExecutivesBornAfter1968Member_019d258a-a60d-7fb6-a6bc-8508f00be7a0" xlink:href="inpha-20251231.xsd#inpha_ExecutivesBornAfter1968Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:to="loc_inpha_ExecutivesBornAfter1968Member_019d258a-a60d-7fb6-a6bc-8508f00be7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonExecutivesBornAfter1968Member_019d258a-d30c-741d-9bcc-2fb54b16b7f4" xlink:href="inpha-20251231.xsd#inpha_NonExecutivesBornAfter1968Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_b0deece8-91c8-4f94-a61c-31235a5d8256" xlink:to="loc_inpha_NonExecutivesBornAfter1968Member_019d258a-d30c-741d-9bcc-2fb54b16b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_7e2308f7-743b-4476-90b4-29c199c80a67" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo_986fa772-11bc-4bda-8321-ab354a334da0" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdTwo_986fa772-11bc-4bda-8321-ab354a334da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree_236a8170-5756-4df2-9a71-47c7101f362d" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdThree_236a8170-5756-4df2-9a71-47c7101f362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne_626082e8-23b3-410a-a9af-77fd977590c4" xlink:href="inpha-20251231.xsd#inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_OtherLongTermBenefitsYearsOfServiceThresholdOne_626082e8-23b3-410a-a9af-77fd977590c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_093ac386-8013-4766-b5b7-3a677a072092" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_093ac386-8013-4766-b5b7-3a677a072092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInEmployeeBenefitObligationPer25BasisPointChangesInDiscountRate_c2440b9f-ca0b-4243-9328-d62259d6cd49" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInEmployeeBenefitObligationPer25BasisPointChangesInDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_IncreaseDecreaseInEmployeeBenefitObligationPer25BasisPointChangesInDiscountRate_c2440b9f-ca0b-4243-9328-d62259d6cd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_0635b1ff-dfbd-445e-936d-6c48e7a4e499" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_0635b1ff-dfbd-445e-936d-6c48e7a4e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_98d7766c-d833-44b2-befb-481061db7270" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_98d7766c-d833-44b2-befb-481061db7270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfRateOfContributions_16a00f3a-9b87-423a-97d5-813b385dc95e" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfRateOfContributions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_ActuarialAssumptionOfRateOfContributions_16a00f3a-9b87-423a-97d5-813b385dc95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfEmployeeContributions_e4be2966-f339-442c-bbbd-b7c4ab4c1d7f" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfEmployeeContributions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_ActuarialAssumptionOfEmployeeContributions_e4be2966-f339-442c-bbbd-b7c4ab4c1d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_31abd1df-c49b-4507-8fa7-187aa58ae792" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfRetirementAge2019"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_31abd1df-c49b-4507-8fa7-187aa58ae792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualMobilityRate_933e3d42-dcb7-405b-8885-18b54cc683fd" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualMobilityRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualMobilityRate_933e3d42-dcb7-405b-8885-18b54cc683fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_93fe96b3-6f39-49f6-827e-d79ad356f6d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_c331570a-b782-4d20-b186-ab8a36ef0e71" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_93fe96b3-6f39-49f6-827e-d79ad356f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofActuarialAssumptionsforDefinedBenefitPlansDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#EmployeebenefitsDisclosureofActuarialAssumptionsforDefinedBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofActuarialAssumptionsforDefinedBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_80cd926d-ade3-4948-a824-939f2a421af8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_80cd926d-ade3-4948-a824-939f2a421af8" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_9e43c67d-5179-458e-922f-f103fb0a6b6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_9e43c67d-5179-458e-922f-f103fb0a6b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_b5eb6d86-15a9-4874-be90-a66c7ca376ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_9e43c67d-5179-458e-922f-f103fb0a6b6c" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_b5eb6d86-15a9-4874-be90-a66c7ca376ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RetirementDefinedBenefitMember_25da2127-76c9-4317-9296-1fa9a66de589" xlink:href="inpha-20251231.xsd#inpha_RetirementDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_b5eb6d86-15a9-4874-be90-a66c7ca376ec" xlink:to="loc_inpha_RetirementDefinedBenefitMember_25da2127-76c9-4317-9296-1fa9a66de589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_2c22d590-6a18-4b02-9143-406f49189569" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:to="loc_ifrs-full_CounterpartiesAxis_2c22d590-6a18-4b02-9143-406f49189569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_fddc843a-eac2-49a5-85bd-7304b0d37e2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_2c22d590-6a18-4b02-9143-406f49189569" xlink:to="loc_ifrs-full_CounterpartiesDomain_fddc843a-eac2-49a5-85bd-7304b0d37e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExecutivesMember_b9ce8919-7a6e-4582-aab6-1d6c3019633b" xlink:href="inpha-20251231.xsd#inpha_ExecutivesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_fddc843a-eac2-49a5-85bd-7304b0d37e2e" xlink:to="loc_inpha_ExecutivesMember_b9ce8919-7a6e-4582-aab6-1d6c3019633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonExecutivesMember_915a5ffe-9310-41ee-bbce-05f757adfccf" xlink:href="inpha-20251231.xsd#inpha_NonExecutivesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_fddc843a-eac2-49a5-85bd-7304b0d37e2e" xlink:to="loc_inpha_NonExecutivesMember_915a5ffe-9310-41ee-bbce-05f757adfccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PeriodOfBirthAxis_f88bd42d-fce9-42db-a4de-70358b13c919" xlink:href="inpha-20251231.xsd#inpha_PeriodOfBirthAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:to="loc_inpha_PeriodOfBirthAxis_f88bd42d-fce9-42db-a4de-70358b13c919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PeriodOfBirthDomain_f77559d3-547c-40c2-abdd-08d9850ab435" xlink:href="inpha-20251231.xsd#inpha_PeriodOfBirthDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PeriodOfBirthAxis_f88bd42d-fce9-42db-a4de-70358b13c919" xlink:to="loc_inpha_PeriodOfBirthDomain_f77559d3-547c-40c2-abdd-08d9850ab435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_EmployeesBornBefore1January1968Member_022626c7-9a2a-47be-93b8-5646a73ac1e6" xlink:href="inpha-20251231.xsd#inpha_EmployeesBornBefore1January1968Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PeriodOfBirthDomain_f77559d3-547c-40c2-abdd-08d9850ab435" xlink:to="loc_inpha_EmployeesBornBefore1January1968Member_022626c7-9a2a-47be-93b8-5646a73ac1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_EmployeesBornAfter1January1968Member_48ed9f93-bc05-47b3-8ea2-828e97a9c608" xlink:href="inpha-20251231.xsd#inpha_EmployeesBornAfter1January1968Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_PeriodOfBirthDomain_f77559d3-547c-40c2-abdd-08d9850ab435" xlink:to="loc_inpha_EmployeesBornAfter1January1968Member_48ed9f93-bc05-47b3-8ea2-828e97a9c608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_2210eab2-3aac-4753-8d17-2a9317d102c7" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_7c1abca7-ae86-404f-87ce-a4a31fc20308" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_7c1abca7-ae86-404f-87ce-a4a31fc20308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_26062750-560a-4e3d-801c-1dc8d968c2ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_26062750-560a-4e3d-801c-1dc8d968c2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualMobilityRate_a534cf93-26e0-45a2-9b22-2947ff84dc7d" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualMobilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualMobilityRate_a534cf93-26e0-45a2-9b22-2947ff84dc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfRateOfContributions_dec65a08-a189-4e36-81fb-82d7a5306f72" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfRateOfContributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfRateOfContributions_dec65a08-a189-4e36-81fb-82d7a5306f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfEmployeeContributions_d0d594a2-d80b-4d33-86a9-2576cdea30c8" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfEmployeeContributions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfEmployeeContributions_d0d594a2-d80b-4d33-86a9-2576cdea30c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_fb203436-2ec5-47b2-ba90-203c209f2f17" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfRetirementAge2019"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_ifrs-full_ActuarialAssumptionOfRetirementAge2019_fb203436-2ec5-47b2-ba90-203c209f2f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge1624Years_4578ec85-ee63-43ed-9e13-d1ecb6788464" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge1624Years"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge1624Years_4578ec85-ee63-43ed-9e13-d1ecb6788464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge2529Years_7a1ebb68-588e-44e9-9a77-0f168dc73052" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge2529Years"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge2529Years_7a1ebb68-588e-44e9-9a77-0f168dc73052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3034Years_585f2902-4ffe-48b0-a2c5-3b450a47a172" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3034Years"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3034Years_585f2902-4ffe-48b0-a2c5-3b450a47a172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3539Years_6f828bf9-0974-4ec2-9aa1-0acaf610438c" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3539Years"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge3539Years_6f828bf9-0974-4ec2-9aa1-0acaf610438c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4044Years_ac85cf69-bd48-4d79-a1b4-401b0af7a1df" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4044Years"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4044Years_ac85cf69-bd48-4d79-a1b4-401b0af7a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4549Years_43448f2b-2108-4c29-84ef-b0143c3c890b" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4549Years"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAge4549Years_43448f2b-2108-4c29-84ef-b0143c3c890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAgeOver50Years_cc55bdc2-5c19-46b0-bf17-d9c9cbfc8b58" xlink:href="inpha-20251231.xsd#inpha_ActuarialAssumptionOfAnnualTurnoverRateByAgeOver50Years"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f0361a7f-9f84-4838-9e08-71ada924e6ad" xlink:to="loc_inpha_ActuarialAssumptionOfAnnualTurnoverRateByAgeOver50Years_cc55bdc2-5c19-46b0-bf17-d9c9cbfc8b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofNetDefinedBenefitLiabilityAssetDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#EmployeebenefitsDisclosureofNetDefinedBenefitLiabilityAssetDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofNetDefinedBenefitLiabilityAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_7c96c5ad-a080-4c54-8b09-10db47663c24" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_a643a331-b371-4e9d-b440-fca29f6a9a59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_7c96c5ad-a080-4c54-8b09-10db47663c24" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_a643a331-b371-4e9d-b440-fca29f6a9a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_97a4bd73-e62c-408c-ac4e-579e599ac16b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_a643a331-b371-4e9d-b440-fca29f6a9a59" xlink:to="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_97a4bd73-e62c-408c-ac4e-579e599ac16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_3c749d91-627c-4f99-8e4d-3f315d1d042c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis_97a4bd73-e62c-408c-ac4e-579e599ac16b" xlink:to="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_3c749d91-627c-4f99-8e4d-3f315d1d042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_6603dc7b-c7f1-4e78-b318-f3b4479c3ccc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OpeningBalanceBeforeAdjustmentCumulativeEffectAtDateOfInitialApplicationMember_3c749d91-627c-4f99-8e4d-3f315d1d042c" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsCumulativeEffectAtDateOfInitialApplicationMember_6603dc7b-c7f1-4e78-b318-f3b4479c3ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_a643a331-b371-4e9d-b440-fca29f6a9a59" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_844a1caf-879c-4888-83bc-8b156ca113a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_844a1caf-879c-4888-83bc-8b156ca113a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentServiceAndActualizationCosts_019d3e10-d81b-7285-82ff-356ab377ffd9" xlink:href="inpha-20251231.xsd#inpha_IncreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentServiceAndActualizationCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_inpha_IncreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentServiceAndActualizationCosts_019d3e10-d81b-7285-82ff-356ab377ffd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges_019d2585-2dd1-7786-a181-86e0076142f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges_019d2585-2dd1-7786-a181-86e0076142f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_ebc7d961-02e0-4250-8799-efdd945f6037" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_ebc7d961-02e0-4250-8799-efdd945f6037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_b0fe413a-aafa-4140-abde-4db632ea0196" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_b0fe413a-aafa-4140-abde-4db632ea0196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2024347c-059e-47ba-9b9d-d444dc342a46" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_989fb8a6-d989-44b6-a76e-9c25b01e85be" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2024347c-059e-47ba-9b9d-d444dc342a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_09ebc709-9ff8-4963-907d-800a8e5f8a85" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_c33c5c5b-84f9-4c69-aef0-37abd757ea8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_09ebc709-9ff8-4963-907d-800a8e5f8a85" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_c33c5c5b-84f9-4c69-aef0-37abd757ea8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019d29a6-d101-7916-a473-49ee45814c27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_c33c5c5b-84f9-4c69-aef0-37abd757ea8b" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019d29a6-d101-7916-a473-49ee45814c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019d29a6-d101-7ec8-b13e-0352310e1408" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019d29a6-d101-7916-a473-49ee45814c27" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019d29a6-d101-7ec8-b13e-0352310e1408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019d29a6-d101-7d6a-90ea-100a1152674c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019d29a6-d101-7ec8-b13e-0352310e1408" xlink:to="loc_ifrs-full_OrdinarySharesMember_019d29a6-d101-7d6a-90ea-100a1152674c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2016FreePreferredSharesMember_019d29a6-d101-72c9-8ab9-5d37b4bea863" xlink:href="inpha-20251231.xsd#inpha_A2016FreePreferredSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019d29a6-d101-7ec8-b13e-0352310e1408" xlink:to="loc_inpha_A2016FreePreferredSharesMember_019d29a6-d101-72c9-8ab9-5d37b4bea863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2017FreePreferredSharesMember_019d29a6-d101-7ede-a957-d0c28f0d89c6" xlink:href="inpha-20251231.xsd#inpha_A2017FreePreferredSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019d29a6-d101-7ec8-b13e-0352310e1408" xlink:to="loc_inpha_A2017FreePreferredSharesMember_019d29a6-d101-7ede-a957-d0c28f0d89c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019d29a7-bd09-75c0-b7f1-72729fcbbba4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_c33c5c5b-84f9-4c69-aef0-37abd757ea8b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019d29a7-bd09-75c0-b7f1-72729fcbbba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019d29a7-bd09-75c0-b7f1-72729fcbbba4" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20191Member_019d29a7-bd09-777c-b578-b0a2a58900e1" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20191Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfManagement20191Member_019d29a7-bd09-777c-b578-b0a2a58900e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20221Member_019d29a8-0966-7630-9aca-fb8811940b23" xlink:href="inpha-20251231.xsd#inpha_AGABonus20221Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGABonus20221Member_019d29a8-0966-7630-9aca-fb8811940b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20201AGAPerfManagement2020Member_019d29a9-56f9-737b-9f1f-60742b16924d" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20201AGAPerfManagement2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfEmployees20201AGAPerfManagement2020Member_019d29a9-56f9-737b-9f1f-60742b16924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20201Member_019d29a9-efed-7888-a10e-93bb20b77ace" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20201Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfManagement20201Member_019d29a9-efed-7888-a10e-93bb20b77ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2020AGAPManagement2020Member_019d29a9-efed-7bf8-8393-f1e55b63c2f5" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2020AGAPManagement2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPEmployee2020AGAPManagement2020Member_019d29a9-efed-7bf8-8393-f1e55b63c2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20201Member_019d29a9-efed-7f68-a870-4c2823edc337" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20201Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfEmployees20201Member_019d29a9-efed-7f68-a870-4c2823edc337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees2019AGAPerfManagement2019Member_019d29aa-b79e-7e3b-81c6-2635bada4c92" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees2019AGAPerfManagement2019Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfEmployees2019AGAPerfManagement2019Member_019d29aa-b79e-7e3b-81c6-2635bada4c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2021AGAPManagement2021Member_019d29ac-8fda-7134-ad5b-c56291a7d3a9" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2021AGAPManagement2021Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPEmployee2021AGAPManagement2021Member_019d29ac-8fda-7134-ad5b-c56291a7d3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2023AGAPManagement2023Member_019d29ae-e762-708f-8441-90c6cf917a8c" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2023AGAPManagement2023Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPEmployee2023AGAPManagement2023Member_019d29ae-e762-708f-8441-90c6cf917a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2022AGAPManagement2022Member_019d29af-12c9-79ac-bd5b-e791f6995dfc" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2022AGAPManagement2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPEmployee2022AGAPManagement2022Member_019d29af-12c9-79ac-bd5b-e791f6995dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20231ManagementMember_019d29b0-92f6-7a1c-a1dc-ee03bfa19916" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20231ManagementMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGANewMembers20231ManagementMember_019d29b0-92f6-7a1c-a1dc-ee03bfa19916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241ManagementMember_019d29b5-ce3c-7e8a-8e36-106beee7701b" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20241ManagementMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGANewMembers20241ManagementMember_019d29b5-ce3c-7e8a-8e36-106beee7701b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_019d29b6-b86e-7776-adee-41764469ffd3" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPerfManagement20241Member_019d29b6-b86e-7776-adee-41764469ffd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherFreeSharesMember_019d29b7-1323-7107-bc06-4de332626305" xlink:href="inpha-20251231.xsd#inpha_OtherFreeSharesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_OtherFreeSharesMember_019d29b7-1323-7107-bc06-4de332626305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2024AGAPManagement2024Member_019d29b7-6e5d-7b71-b0b6-5b277fa73ad8" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2024AGAPManagement2024Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAPEmployee2024AGAPManagement2024Member_019d29b7-6e5d-7b71-b0b6-5b277fa73ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployee2025Member_019d29b8-0fc0-785f-a69c-c5941ae3034e" xlink:href="inpha-20251231.xsd#inpha_AGAEmployee2025Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_AGAEmployee2025Member_019d29b8-0fc0-785f-a69c-c5941ae3034e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAARMember_019d29b8-43b7-725f-bcd9-1c4cc2fb7388" xlink:href="inpha-20251231.xsd#inpha_BSAARMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019d29a7-bd09-7e60-8ee3-7a6174e388a8" xlink:to="loc_inpha_BSAARMember_019d29b8-43b7-725f-bcd9-1c4cc2fb7388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_c33c5c5b-84f9-4c69-aef0-37abd757ea8b" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019d29a6-d101-7466-815c-05dc45c5cfba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_IssuedCapital_019d29a6-d101-7466-815c-05dc45c5cfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_019d29a6-d101-70a6-b1d2-f8c1105968d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_019d29a6-d101-70a6-b1d2-f8c1105968d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019d29a6-d101-7b58-b9fc-1d65c9fe13ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_ParValuePerShare_019d29a6-d101-7b58-b9fc-1d65c9fe13ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_019d29a7-19d4-77af-84cd-05a99c8b4a38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_019d29a7-19d4-77af-84cd-05a99c8b4a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherEquityInstrumentsPerformanceConditionsThreshold_019d29a7-bd09-7f59-ab5f-8cdc8b17d4d5" xlink:href="inpha-20251231.xsd#inpha_OtherEquityInstrumentsPerformanceConditionsThreshold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_OtherEquityInstrumentsPerformanceConditionsThreshold_019d29a7-bd09-7f59-ab5f-8cdc8b17d4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019d29a7-bd09-7255-88f5-1218c9f50cd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019d29a7-bd09-7255-88f5-1218c9f50cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019d29a8-0966-781b-94bd-06ca5f9d7bd5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019d29a8-0966-781b-94bd-06ca5f9d7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfVestingKickers_019d29a9-56f9-70bd-8326-c2f52160995a" xlink:href="inpha-20251231.xsd#inpha_NumberOfVestingKickers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfVestingKickers_019d29a9-56f9-70bd-8326-c2f52160995a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InternalConditionsPerformanceRevenueFromCollaborationAndLicensingAgreementsMinimumAccrualBetweenAttributionAndDefinitiveAcquisitionDate_019d29a9-56f9-7c32-b6dc-f43f48a1af79" xlink:href="inpha-20251231.xsd#inpha_InternalConditionsPerformanceRevenueFromCollaborationAndLicensingAgreementsMinimumAccrualBetweenAttributionAndDefinitiveAcquisitionDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_InternalConditionsPerformanceRevenueFromCollaborationAndLicensingAgreementsMinimumAccrualBetweenAttributionAndDefinitiveAcquisitionDate_019d29a9-56f9-7c32-b6dc-f43f48a1af79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FreePerformancesSharesPlansPerformancePercentage_019d29a9-efed-7b87-9a42-c7cc1a57dadd" xlink:href="inpha-20251231.xsd#inpha_FreePerformancesSharesPlansPerformancePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_FreePerformancesSharesPlansPerformancePercentage_019d29a9-efed-7b87-9a42-c7cc1a57dadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfFilingAndApprovalOfABiologicLicenseApplication_019d29ae-e762-7c9d-90ca-377891fafcd1" xlink:href="inpha-20251231.xsd#inpha_NumberOfFilingAndApprovalOfABiologicLicenseApplication"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfFilingAndApprovalOfABiologicLicenseApplication_019d29ae-e762-7c9d-90ca-377891fafcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfAnnualVariableCompensation_019d29af-893f-7704-bb72-45f183a22d3d" xlink:href="inpha-20251231.xsd#inpha_PercentageOfAnnualVariableCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_PercentageOfAnnualVariableCompensation_019d29af-893f-7704-bb72-45f183a22d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfPremiumIncreased_019d29af-893f-7312-a0a7-6c3d8231a4e2" xlink:href="inpha-20251231.xsd#inpha_PercentageOfPremiumIncreased"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_PercentageOfPremiumIncreased_019d29af-893f-7312-a0a7-6c3d8231a4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfOverPerformance_019d29af-893f-715d-8411-7628d9c671d4" xlink:href="inpha-20251231.xsd#inpha_PercentageOfOverPerformance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_PercentageOfOverPerformance_019d29af-893f-715d-8411-7628d9c671d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfEnvironmentalOrSocialActionsImplemented_019d29b5-6673-751b-9652-7a50b4879a0d" xlink:href="inpha-20251231.xsd#inpha_NumberOfEnvironmentalOrSocialActionsImplemented"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfEnvironmentalOrSocialActionsImplemented_019d29b5-6673-751b-9652-7a50b4879a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfInternalConditionsPerformanceFreePerformanceShares_019d29b6-b86e-72a3-bfa5-8490d13d711e" xlink:href="inpha-20251231.xsd#inpha_NumberOfInternalConditionsPerformanceFreePerformanceShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfInternalConditionsPerformanceFreePerformanceShares_019d29b6-b86e-72a3-bfa5-8490d13d711e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentOfEmployeesUsingTransportMobility_019d29b7-a213-7c4d-8694-3e55e1122b41" xlink:href="inpha-20251231.xsd#inpha_PercentOfEmployeesUsingTransportMobility"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_PercentOfEmployeesUsingTransportMobility_019d29b7-a213-7c4d-8694-3e55e1122b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareBasedPaymentTransactionsWithEmployeesAwardsExpectedTerm_019d29b8-43b7-7ad9-b3f0-93465a396b81" xlink:href="inpha-20251231.xsd#inpha_ShareBasedPaymentTransactionsWithEmployeesAwardsExpectedTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_ShareBasedPaymentTransactionsWithEmployeesAwardsExpectedTerm_019d29b8-43b7-7ad9-b3f0-93465a396b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy_019d2a59-0f01-7037-bea1-10a5d60fdece" xlink:href="inpha-20251231.xsd#inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfPatientsPlannedToBeEnrolledInMedicalStudy_019d2a59-0f01-7037-bea1-10a5d60fdece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfWhollyOwnedSubsidiaries_019d2a8b-fa11-7a3f-8100-a72645ae3e6c" xlink:href="inpha-20251231.xsd#inpha_NumberOfWhollyOwnedSubsidiaries"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_019d29a6-d101-76c4-8666-95e3c01e114b" xlink:to="loc_inpha_NumberOfWhollyOwnedSubsidiaries_019d2a8b-fa11-7a3f-8100-a72645ae3e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinShareCapitalDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofChangesinShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_c1989b23-3f39-458b-833a-b96043ffa40f" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_c1989b23-3f39-458b-833a-b96043ffa40f" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_2832a4f6-588f-43aa-8c6b-c602bf38e9de" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_2832a4f6-588f-43aa-8c6b-c602bf38e9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_a5de01cf-e771-49fd-a93b-d29422f2655e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_2832a4f6-588f-43aa-8c6b-c602bf38e9de" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_a5de01cf-e771-49fd-a93b-d29422f2655e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_c2688f93-9ea4-4e3c-a855-d0dad7cdf415" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a5de01cf-e771-49fd-a93b-d29422f2655e" xlink:to="loc_ifrs-full_IssuedCapitalMember_c2688f93-9ea4-4e3c-a855-d0dad7cdf415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_51993a0d-de2f-4e97-8764-bba313efc57e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_a5de01cf-e771-49fd-a93b-d29422f2655e" xlink:to="loc_ifrs-full_SharePremiumMember_51993a0d-de2f-4e97-8764-bba313efc57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_719f32b5-8115-4eb2-8dc8-6b2239941ff5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_719f32b5-8115-4eb2-8dc8-6b2239941ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1016c92a-2727-4b1c-9b5c-abce7288938c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_719f32b5-8115-4eb2-8dc8-6b2239941ff5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1016c92a-2727-4b1c-9b5c-abce7288938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_f41a1a70-7392-4542-aed5-8f869a6b0bf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1016c92a-2727-4b1c-9b5c-abce7288938c" xlink:to="loc_ifrs-full_OrdinarySharesMember_f41a1a70-7392-4542-aed5-8f869a6b0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PreferenceSharesMember_c8cdf303-8782-44b8-a5fb-fe391543ad2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PreferenceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1016c92a-2727-4b1c-9b5c-abce7288938c" xlink:to="loc_ifrs-full_PreferenceSharesMember_c8cdf303-8782-44b8-a5fb-fe391543ad2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesAxis_b0b52b80-956e-4972-9273-7efd9048e5e1" xlink:href="inpha-20251231.xsd#inpha_TypeOfExerciseAndSubscriptionOfSharesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:to="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesAxis_b0b52b80-956e-4972-9273-7efd9048e5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:href="inpha-20251231.xsd#inpha_TypeOfExerciseAndSubscriptionOfSharesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesAxis_b0b52b80-956e-4972-9273-7efd9048e5e1" xlink:to="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseOfShareWarrantsMember_b529affe-5a26-4691-9230-063d732ed960" xlink:href="inpha-20251231.xsd#inpha_ExerciseOfShareWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:to="loc_inpha_ExerciseOfShareWarrantsMember_b529affe-5a26-4691-9230-063d732ed960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_6e5d0d87-a3b1-4d57-9cf9-f3031f8b455e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:to="loc_ifrs-full_OrdinarySharesMember_6e5d0d87-a3b1-4d57-9cf9-f3031f8b455e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DefinitiveAcquisitionOfFreeSharesMember_e5f08e30-a82e-4518-859f-2bc629a9d201" xlink:href="inpha-20251231.xsd#inpha_DefinitiveAcquisitionOfFreeSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:to="loc_inpha_DefinitiveAcquisitionOfFreeSharesMember_e5f08e30-a82e-4518-859f-2bc629a9d201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SubscriptionOfShareWarrantsMember_00544962-5de0-4596-a0e2-b239d42f877e" xlink:href="inpha-20251231.xsd#inpha_SubscriptionOfShareWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfExerciseAndSubscriptionOfSharesDomain_837b3dd6-862f-4915-9023-2fdac5402dbb" xlink:to="loc_inpha_SubscriptionOfShareWarrantsMember_00544962-5de0-4596-a0e2-b239d42f877e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_f3cf4d2d-97bd-4750-9bc6-8843161c7e59" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_81c45b1e-cf15-4026-a15f-1c790fc42c44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_Equity_81c45b1e-cf15-4026-a15f-1c790fc42c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_3479c186-2f5b-48cc-b17c-ed1977f0c85a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_3479c186-2f5b-48cc-b17c-ed1977f0c85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_0c947662-407b-4010-bf79-e8a146808703" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_ParValuePerShare_0c947662-407b-4010-bf79-e8a146808703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_2e813e4c-3cee-4fff-857a-68cbaaf98cdb" xlink:href="inpha-20251231.xsd#inpha_ExerciseAndSubscriptionOfEquityInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_2e813e4c-3cee-4fff-857a-68cbaaf98cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_a7d11176-6583-4ed4-b0c8-bc0d8e0cb494" xlink:href="inpha-20251231.xsd#inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_a7d11176-6583-4ed4-b0c8-bc0d8e0cb494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseThroughConversionOfEquityInstrumentsEquity_03b75ebd-bb6c-4eae-a081-6d13cfa8e404" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseThroughConversionOfEquityInstrumentsEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_inpha_IncreaseDecreaseThroughConversionOfEquityInstrumentsEquity_03b75ebd-bb6c-4eae-a081-6d13cfa8e404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInNumberOfSharesIssuedFromConversionOfEquityInstruments_4e5b429e-d0c4-4737-ae6c-d1a167b15418" xlink:href="inpha-20251231.xsd#inpha_IncreaseDecreaseInNumberOfSharesIssuedFromConversionOfEquityInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_inpha_IncreaseDecreaseInNumberOfSharesIssuedFromConversionOfEquityInstruments_4e5b429e-d0c4-4737-ae6c-d1a167b15418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_c7cd2b61-8ce6-4c7e-8d3e-533402d4250a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_c7cd2b61-8ce6-4c7e-8d3e-533402d4250a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_ac2668bd-3281-4071-b09b-d6181f0f41fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_ac2668bd-3281-4071-b09b-d6181f0f41fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_7e90eb39-4abe-49ed-9faa-0ecafefe93ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_Equity_7e90eb39-4abe-49ed-9faa-0ecafefe93ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_8fcf48c4-11a1-47a8-97a0-1a916e78d2da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f210fd9d-81d5-4174-906b-312c7a439992" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_8fcf48c4-11a1-47a8-97a0-1a916e78d2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofNumberandWeightedAverageExercisePricesofOtherEquityInstrumentsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofNumberandWeightedAverageExercisePricesofOtherEquityInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofNumberandWeightedAverageExercisePricesofOtherEquityInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_51ec542f-2664-467b-8460-15ed7966c319" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0f133cea-8a2e-4fba-b144-67cd85c9208c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_51ec542f-2664-467b-8460-15ed7966c319" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0f133cea-8a2e-4fba-b144-67cd85c9208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bf4a646-dae2-4bba-b16e-1fd57708d93f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0f133cea-8a2e-4fba-b144-67cd85c9208c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bf4a646-dae2-4bba-b16e-1fd57708d93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_fe413c45-a35f-48b4-8c0c-bb425097978c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_4bf4a646-dae2-4bba-b16e-1fd57708d93f" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_fe413c45-a35f-48b4-8c0c-bb425097978c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_fe413c45-a35f-48b4-8c0c-bb425097978c" xlink:to="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2011Member_201fc517-e3d7-4a30-ac8b-1c51f7884721" xlink:href="inpha-20251231.xsd#inpha_BSAAR2011Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSAAR2011Member_201fc517-e3d7-4a30-ac8b-1c51f7884721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2012Member_016141ba-d9aa-4eaa-82b9-567ecccf5be2" xlink:href="inpha-20251231.xsd#inpha_BSAAR2012Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSAAR2012Member_016141ba-d9aa-4eaa-82b9-567ecccf5be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2015Member_5f0e1fbf-a2d7-4011-99f0-1284993498fd" xlink:href="inpha-20251231.xsd#inpha_BSAAR2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSAAR2015Member_5f0e1fbf-a2d7-4011-99f0-1284993498fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20161Member_665d0e06-1e97-4ca5-a78c-9d4663239be0" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20161Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPManagement20161Member_665d0e06-1e97-4ca5-a78c-9d4663239be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20161Member_0319733c-b4ac-4e6a-af43-d86c3951a856" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployees20161Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPEmployees20161Member_0319733c-b4ac-4e6a-af43-d86c3951a856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20161Member_734b8ece-c5d0-4367-b35d-c59668aaeffb" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20161Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAManagement20161Member_734b8ece-c5d0-4367-b35d-c59668aaeffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20162Member_afe8053b-0f9d-456d-a1d5-2b58f69711a5" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20162Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPManagement20162Member_afe8053b-0f9d-456d-a1d5-2b58f69711a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20162Member_f6b7e1da-01cd-4002-bbf1-22e8621ca4a3" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20162Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAManagement20162Member_f6b7e1da-01cd-4002-bbf1-22e8621ca4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20171Member_80a6998c-9a2a-44b0-9960-c95c4790e96b" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployees20171Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPEmployees20171Member_80a6998c-9a2a-44b0-9960-c95c4790e96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20171Member_836e1409-2a39-4e3b-b143-f3b8210fe394" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20171Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPManagement20171Member_836e1409-2a39-4e3b-b143-f3b8210fe394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees2017Member_83518a94-c7c6-451f-83d4-33c8d8629373" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees2017Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAEmployees2017Member_83518a94-c7c6-451f-83d4-33c8d8629373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20181Member_343bf60f-f6ea-4e9c-9df8-c7a03fb3bb53" xlink:href="inpha-20251231.xsd#inpha_AGABonus20181Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGABonus20181Member_343bf60f-f6ea-4e9c-9df8-c7a03fb3bb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPPerfEmployees20181Member_7a5d4538-5619-4671-b586-54c08100ac8c" xlink:href="inpha-20251231.xsd#inpha_AGAPPerfEmployees20181Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPPerfEmployees20181Member_7a5d4538-5619-4671-b586-54c08100ac8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPPerfManagement20181Member_843cafc0-169e-4abc-82c2-bef90a54d978" xlink:href="inpha-20251231.xsd#inpha_AGAPPerfManagement20181Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPPerfManagement20181Member_843cafc0-169e-4abc-82c2-bef90a54d978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees2018Member_1e7b14e7-f043-4da0-a798-f5e0fc996fb1" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees2018Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAEmployees2018Member_1e7b14e7-f043-4da0-a798-f5e0fc996fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20171Member_bafc28c0-c850-403d-95ff-0d9d8ab966cd" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20171Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGANewMembers20171Member_bafc28c0-c850-403d-95ff-0d9d8ab966cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20191Member_cc79f203-720c-45cc-b348-9f2ebb0f5810" xlink:href="inpha-20251231.xsd#inpha_AGABonus20191Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGABonus20191Member_cc79f203-720c-45cc-b348-9f2ebb0f5810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAP2019Employees2019Member_d3bf487f-24d4-4420-83c0-033645747483" xlink:href="inpha-20251231.xsd#inpha_AGAP2019Employees2019Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAP2019Employees2019Member_d3bf487f-24d4-4420-83c0-033645747483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAP2019Management2019Member_ea454814-29d3-4ea4-8b72-8674ca5bee6a" xlink:href="inpha-20251231.xsd#inpha_AGAP2019Management2019Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAP2019Management2019Member_ea454814-29d3-4ea4-8b72-8674ca5bee6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus202012Member_a810a5d8-326a-461b-b251-877f3f395fd5" xlink:href="inpha-20251231.xsd#inpha_AGABonus202012Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGABonus202012Member_a810a5d8-326a-461b-b251-877f3f395fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20201Member_5ad7d769-c61f-4e2f-9c67-85b698a52a57" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20201Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfEmployees20201Member_5ad7d769-c61f-4e2f-9c67-85b698a52a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20201Member_08e37671-5002-40eb-935d-1531939e53eb" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20201Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20201Member_08e37671-5002-40eb-935d-1531939e53eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20211Member_dd0148ee-2f51-43bd-bc10-30989d71e118" xlink:href="inpha-20251231.xsd#inpha_AGABonus20211Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGABonus20211Member_dd0148ee-2f51-43bd-bc10-30989d71e118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20211Member_f9ff7d7a-9069-4bc8-871a-4c2a479ccd8d" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20211Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfEmployees20211Member_f9ff7d7a-9069-4bc8-871a-4c2a479ccd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20211Member_83adc788-eb90-43f3-8262-6f9c29573f90" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20211Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20211Member_83adc788-eb90-43f3-8262-6f9c29573f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2022Member_3bb760df-6ff4-4a99-831e-bbe23318b631" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2022Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2022Member_3bb760df-6ff4-4a99-831e-bbe23318b631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20221Member_f958e17f-a76c-4df4-ba0a-6c863e313b71" xlink:href="inpha-20251231.xsd#inpha_AGABonus20221Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGABonus20221Member_f958e17f-a76c-4df4-ba0a-6c863e313b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20221Member_b32bf891-6ea0-4c37-aa90-99202e1d1735" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20221Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfEmployees20221Member_b32bf891-6ea0-4c37-aa90-99202e1d1735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20221Member_df1e8f8e-9ec1-403d-a23b-30aa5cb2150e" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20221Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20221Member_df1e8f8e-9ec1-403d-a23b-30aa5cb2150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2023Member_42fd3098-57a4-49a4-bd66-588fc23d89b0" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2023Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2023Member_42fd3098-57a4-49a4-bd66-588fc23d89b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20231ManagementMember_4cd65e92-672a-4e6b-aa47-421d39bcbc71" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20231ManagementMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGANewMembers20231ManagementMember_4cd65e92-672a-4e6b-aa47-421d39bcbc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20231Member_895ce1f0-c2fa-4de9-96c0-b9a506c6681b" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20231Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfEmployees20231Member_895ce1f0-c2fa-4de9-96c0-b9a506c6681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20231Member_34456586-736d-4a24-8bbc-0bad3f195eec" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20231Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20231Member_34456586-736d-4a24-8bbc-0bad3f195eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241ManagementMember_019ba29c-a41a-7a67-a201-534250cf3be4" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20241ManagementMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGANewMembers20241ManagementMember_019ba29c-a41a-7a67-a201-534250cf3be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2024Member_019ba29c-ce6a-7099-bab7-14fa95bf4fab" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2024Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2024Member_019ba29c-ce6a-7099-bab7-14fa95bf4fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_019ba29c-ed1d-7214-821a-bee6863a5550" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20241Member_019ba29c-ed1d-7214-821a-bee6863a5550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20241Member_019ba29d-0d7c-7c2e-b75e-57f9120567e9" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20241Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAEmployees20241Member_019ba29d-0d7c-7c2e-b75e-57f9120567e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20241Member_019ba29d-2a80-7f6c-95b3-f578c6afb7bb" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20241Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfEmployees20241Member_019ba29d-2a80-7f6c-95b3-f578c6afb7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20242Member_019ba29d-4519-7877-8989-1d45d51ac4a1" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20242Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAPerfManagement20242Member_019ba29d-4519-7877-8989-1d45d51ac4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20241Member_019ba29d-6020-709e-9235-67d16771fe3e" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20241Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAManagement20241Member_019ba29d-6020-709e-9235-67d16771fe3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees202501Member_019ba2ac-aa29-7598-9a54-901f43d5df16" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees202501Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_AGAEmployees202501Member_019ba2ac-aa29-7598-9a54-901f43d5df16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StockOptions20201Member_3f1226c1-a4c8-4ba6-bc03-1597e6a52d62" xlink:href="inpha-20251231.xsd#inpha_StockOptions20201Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_StockOptions20201Member_3f1226c1-a4c8-4ba6-bc03-1597e6a52d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StockOptions2024Member_019ba29d-8722-7371-a5aa-cb4048b1056b" xlink:href="inpha-20251231.xsd#inpha_StockOptions2024Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_StockOptions2024Member_019ba29d-8722-7371-a5aa-cb4048b1056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20112Member_c314f514-77e4-4080-bdf0-1a413204f181" xlink:href="inpha-20251231.xsd#inpha_BSA20112Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20112Member_c314f514-77e4-4080-bdf0-1a413204f181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2013Member_fa2e5e8b-9b7b-4333-bf45-e6a0ad6918c8" xlink:href="inpha-20251231.xsd#inpha_BSA2013Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA2013Member_fa2e5e8b-9b7b-4333-bf45-e6a0ad6918c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2014Member_bcd688bb-a4f3-4cba-896c-0f4d4b543d20" xlink:href="inpha-20251231.xsd#inpha_BSA2014Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA2014Member_bcd688bb-a4f3-4cba-896c-0f4d4b543d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20151Member_81a3b630-9d4a-4d62-b242-581e7af16c20" xlink:href="inpha-20251231.xsd#inpha_BSA20151Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20151Member_81a3b630-9d4a-4d62-b242-581e7af16c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20152Member_76ad7c01-c2aa-4f98-9b7a-3cb489751119" xlink:href="inpha-20251231.xsd#inpha_BSA20152Member"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20152Member_76ad7c01-c2aa-4f98-9b7a-3cb489751119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2017Member_55084a35-1816-44c5-b926-d4934f5fac18" xlink:href="inpha-20251231.xsd#inpha_BSA2017Member"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA2017Member_55084a35-1816-44c5-b926-d4934f5fac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20221Member_15d4195a-98e8-47ee-af95-db3d847b1f7b" xlink:href="inpha-20251231.xsd#inpha_BSA20221Member"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20221Member_15d4195a-98e8-47ee-af95-db3d847b1f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20231Member_903010cc-a740-4436-824e-c753f2538759" xlink:href="inpha-20251231.xsd#inpha_BSA20231Member"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20231Member_903010cc-a740-4436-824e-c753f2538759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20251Member_019ba2ad-6394-70b1-a607-f0025e34637b" xlink:href="inpha-20251231.xsd#inpha_BSA20251Member"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_fe95593b-e1d5-4b44-9ea9-f77cf6937e85" xlink:to="loc_inpha_BSA20251Member_019ba2ad-6394-70b1-a607-f0025e34637b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0f133cea-8a2e-4fba-b144-67cd85c9208c" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1f956b7b-062b-433e-aa6f-058bc60095b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1f956b7b-062b-433e-aa6f-058bc60095b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_718c3733-85d1-455c-9cde-42c7066d92c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_718c3733-85d1-455c-9cde-42c7066d92c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_d5293944-43a5-4254-91fe-ac310134df3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_d5293944-43a5-4254-91fe-ac310134df3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_ed2e1487-2f6a-456c-b5fa-ecaefdd9d56d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_ed2e1487-2f6a-456c-b5fa-ecaefdd9d56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_15cb2a74-485d-4334-b91a-54f6723e9772" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_15cb2a74-485d-4334-b91a-54f6723e9772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_4b27c7c7-64dd-4eb9-bce0-31b7257b1805" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_69d07abf-982c-4d41-9ff6-42049bb4fd53" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_4b27c7c7-64dd-4eb9-bce0-31b7257b1805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofTermsandConditionsofOtherEquityInstrumentsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofTermsandConditionsofOtherEquityInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofTermsandConditionsofOtherEquityInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_7dd73de2-cbf9-4a16-8931-0de99f3cbc0a" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_694b48f3-8387-42e8-b19e-3b612e0d9b9e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_7dd73de2-cbf9-4a16-8931-0de99f3cbc0a" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_694b48f3-8387-42e8-b19e-3b612e0d9b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_106fc09c-ff03-4cac-8e3b-51c72f082fc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_694b48f3-8387-42e8-b19e-3b612e0d9b9e" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_106fc09c-ff03-4cac-8e3b-51c72f082fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_106fc09c-ff03-4cac-8e3b-51c72f082fc1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20161Member_245d60d2-a9d8-4d39-8258-e297c9eeed50" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20161Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPManagement20161Member_245d60d2-a9d8-4d39-8258-e297c9eeed50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20161Member_6b84f5f0-57f5-4e01-99d3-5e69f9cf4e0c" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployees20161Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPEmployees20161Member_6b84f5f0-57f5-4e01-99d3-5e69f9cf4e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20161Member_4c56207a-5f5b-4f74-b04a-4d6156f75a4b" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20161Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAManagement20161Member_4c56207a-5f5b-4f74-b04a-4d6156f75a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20161Member_f516ac9f-c1c4-45ea-bb55-a69ef55c7f3a" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20161Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAEmployees20161Member_f516ac9f-c1c4-45ea-bb55-a69ef55c7f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20162Member_4c230182-b69d-4b2e-9cac-5fd8a1774ad7" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20162Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPManagement20162Member_4c230182-b69d-4b2e-9cac-5fd8a1774ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20162Member_d8c9692f-b199-4b9b-80de-77cf68f7fb46" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20162Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAManagement20162Member_d8c9692f-b199-4b9b-80de-77cf68f7fb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20162Member_e97be350-e84f-4956-81d4-b68eef1b4e50" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20162Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAEmployees20162Member_e97be350-e84f-4956-81d4-b68eef1b4e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus2017Member_3b0a29b1-9eb4-4be7-94f7-6e838534223e" xlink:href="inpha-20251231.xsd#inpha_AGABonus2017Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus2017Member_3b0a29b1-9eb4-4be7-94f7-6e838534223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees2017Member_02270df8-5988-481c-8bc3-40f858d07a87" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees2017Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAEmployees2017Member_02270df8-5988-481c-8bc3-40f858d07a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees2017Member_628828dc-683a-4d29-8000-3116def9d042" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployees2017Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPEmployees2017Member_628828dc-683a-4d29-8000-3116def9d042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement2017Member_2fcb168c-5020-4c28-8b6f-823c9117713d" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement2017Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPManagement2017Member_2fcb168c-5020-4c28-8b6f-823c9117713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus2018Member_4cc5b8da-bc17-4b66-8091-33cce0806c44" xlink:href="inpha-20251231.xsd#inpha_AGABonus2018Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus2018Member_4cc5b8da-bc17-4b66-8091-33cce0806c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees2018Member_7f8c4cce-bbfa-4b39-99b0-9c6d36d23926" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees2018Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees2018Member_7f8c4cce-bbfa-4b39-99b0-9c6d36d23926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement2018Member_213d6689-917d-4800-ae25-07ddf016a97b" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement2018Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement2018Member_213d6689-917d-4800-ae25-07ddf016a97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20171Member_3f5733cf-3482-46a1-9762-ad7b854f208b" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20171Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGANewMembers20171Member_3f5733cf-3482-46a1-9762-ad7b854f208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20181Member_4e58035d-cd9b-460e-b529-2aa020b3c04b" xlink:href="inpha-20251231.xsd#inpha_AGABonus20181Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus20181Member_4e58035d-cd9b-460e-b529-2aa020b3c04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20191Member_a8962c27-eb42-4ea2-acae-1011cec9d0c1" xlink:href="inpha-20251231.xsd#inpha_AGABonus20191Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus20191Member_a8962c27-eb42-4ea2-acae-1011cec9d0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees2019Member_93af173a-42d5-459c-878f-a0b2d6766f17" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees2019Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees2019Member_93af173a-42d5-459c-878f-a0b2d6766f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement2019Member_fab8c270-c850-49c2-a9c5-2135e7c2121c" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement2019Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement2019Member_fab8c270-c850-49c2-a9c5-2135e7c2121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus2020Member_1ff02e3d-779c-4cde-8280-c2041bd30b03" xlink:href="inpha-20251231.xsd#inpha_AGABonus2020Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus2020Member_1ff02e3d-779c-4cde-8280-c2041bd30b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20201Member_a9e6d1b9-6fa4-49e2-a321-a2518e064c87" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20201Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees20201Member_a9e6d1b9-6fa4-49e2-a321-a2518e064c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20201Member_5e0069d0-c25c-47fd-894d-f257d3ba5be8" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20201Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20201Member_5e0069d0-c25c-47fd-894d-f257d3ba5be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20211Member_b655327a-543a-4ddc-a5f9-04ff6a6be829" xlink:href="inpha-20251231.xsd#inpha_AGABonus20211Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus20211Member_b655327a-543a-4ddc-a5f9-04ff6a6be829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20211Member_7ab91b8b-ef9c-4bbd-8b10-fcb48e10fed0" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20211Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees20211Member_7ab91b8b-ef9c-4bbd-8b10-fcb48e10fed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20211Member_3d418336-bd43-455e-8be5-f31e73bc36b2" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20211Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20211Member_3d418336-bd43-455e-8be5-f31e73bc36b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2022Member_b36579a2-7119-4471-b448-46bbcd0072ac" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2022Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2022Member_b36579a2-7119-4471-b448-46bbcd0072ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20221Member_f6479f72-cebf-44f2-a665-74f9c5710b89" xlink:href="inpha-20251231.xsd#inpha_AGABonus20221Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus20221Member_f6479f72-cebf-44f2-a665-74f9c5710b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20221Member_f433e8e2-e5d6-41bf-8805-c80b7f762ea3" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20221Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees20221Member_f433e8e2-e5d6-41bf-8805-c80b7f762ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20221Member_6fc14701-5990-4250-9892-4223bd408bd6" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20221Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20221Member_6fc14701-5990-4250-9892-4223bd408bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2023Member_8f71bdfd-f474-4928-a5ed-043710961d85" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2023Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2023Member_8f71bdfd-f474-4928-a5ed-043710961d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20231Member_13b6c8d8-e8ef-46d5-bfcb-a22e8e064442" xlink:href="inpha-20251231.xsd#inpha_AGABonus20231Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGABonus20231Member_13b6c8d8-e8ef-46d5-bfcb-a22e8e064442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20231Member_98d024cb-d664-40ac-9545-eb061a1a1d73" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20231Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees20231Member_98d024cb-d664-40ac-9545-eb061a1a1d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20231Member_57f0637a-a742-4814-a207-42f554e087a1" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20231Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20231Member_57f0637a-a742-4814-a207-42f554e087a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241ManagementMember_c18c361b-f12c-44c9-a5f6-982871409b1d" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20241ManagementMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGANewMembers20241ManagementMember_c18c361b-f12c-44c9-a5f6-982871409b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2024Member_e76384fa-2b7c-468d-8ccf-0c104852448f" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2024Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2024Member_e76384fa-2b7c-468d-8ccf-0c104852448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_937e2ef7-7de0-4512-84ac-c95cebd1b49d" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20241Member_937e2ef7-7de0-4512-84ac-c95cebd1b49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20241Member_217554bd-020c-4dd7-91b0-73772394c94b" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20241Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAEmployees20241Member_217554bd-020c-4dd7-91b0-73772394c94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20241Member_9f54d4e2-f112-45df-a03b-7b58928ca353" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20241Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfEmployees20241Member_9f54d4e2-f112-45df-a03b-7b58928ca353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20242Member_8275280b-83b9-4c4a-b53b-c18e13a363f6" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20242Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAPerfManagement20242Member_8275280b-83b9-4c4a-b53b-c18e13a363f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20241Member_7829a465-8e4e-4e3f-b1a5-301afcd4e0a7" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20241Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAManagement20241Member_7829a465-8e4e-4e3f-b1a5-301afcd4e0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees202501Member_019ba2bf-cb4c-723a-94e8-95ffe75144f7" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees202501Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_98844422-ef81-450e-bd75-2379bed88e83" xlink:to="loc_inpha_AGAEmployees202501Member_019ba2bf-cb4c-723a-94e8-95ffe75144f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_694b48f3-8387-42e8-b19e-3b612e0d9b9e" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_VestingPeriodOtherEquityInstrumentsGranted_673f37fb-7de1-4148-af8f-8d5d1957cc65" xlink:href="inpha-20251231.xsd#inpha_VestingPeriodOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_VestingPeriodOtherEquityInstrumentsGranted_673f37fb-7de1-4148-af8f-8d5d1957cc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NontransferabilityPeriodOtherEquityInstrumentsGranted_209fbc10-a582-4170-9b40-7c99d395e8dd" xlink:href="inpha-20251231.xsd#inpha_NontransferabilityPeriodOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_NontransferabilityPeriodOtherEquityInstrumentsGranted_209fbc10-a582-4170-9b40-7c99d395e8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_38e6cfbb-4a4a-4748-be41-864caf83ec3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_38e6cfbb-4a4a-4748-be41-864caf83ec3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted_b2581a21-5889-4c82-a3d8-0bd7191856ac" xlink:href="inpha-20251231.xsd#inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted_b2581a21-5889-4c82-a3d8-0bd7191856ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted_d9a23052-1ccc-495a-aef6-b40db84a84d2" xlink:href="inpha-20251231.xsd#inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted_d9a23052-1ccc-495a-aef6-b40db84a84d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedDividendOtherEquityInstrumentsGranted_a97d7721-daea-4448-ab90-ac3f1b6eb714" xlink:href="inpha-20251231.xsd#inpha_ExpectedDividendOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_ExpectedDividendOtherEquityInstrumentsGranted_a97d7721-daea-4448-ab90-ac3f1b6eb714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedTurnoverOtherInstrumentsGranted_6fbf7b0e-9a61-460b-a95a-d29bd60aa3b9" xlink:href="inpha-20251231.xsd#inpha_ExpectedTurnoverOtherInstrumentsGranted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_ExpectedTurnoverOtherInstrumentsGranted_6fbf7b0e-9a61-460b-a95a-d29bd60aa3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedVolatilityOtherEquityInstrumentsGranted_c6bb968e-6ef5-4156-9f3a-559a129ed825" xlink:href="inpha-20251231.xsd#inpha_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_ExpectedVolatilityOtherEquityInstrumentsGranted_c6bb968e-6ef5-4156-9f3a-559a129ed825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted_4863734b-93ef-4738-a7d3-0b2a5ae3f8a4" xlink:href="inpha-20251231.xsd#inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_ae85cdbe-0428-4c1a-9caa-9546cb2f02db" xlink:to="loc_inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted_4863734b-93ef-4738-a7d3-0b2a5ae3f8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinNumberofOtherEquityInstrumentsOutstandingDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofChangesinNumberofOtherEquityInstrumentsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinNumberofOtherEquityInstrumentsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_571e47a7-67fa-4f40-89f4-0814268dac89" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_56acab0f-fd3e-442a-9a4f-1646221b2b31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_571e47a7-67fa-4f40-89f4-0814268dac89" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_56acab0f-fd3e-442a-9a4f-1646221b2b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_ab16ba51-aed2-4234-b38b-cce266d1dac9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_56acab0f-fd3e-442a-9a4f-1646221b2b31" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_ab16ba51-aed2-4234-b38b-cce266d1dac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_9bc673d4-8098-4b12-bae7-c5c3a9b689db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_ab16ba51-aed2-4234-b38b-cce266d1dac9" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_9bc673d4-8098-4b12-bae7-c5c3a9b689db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAMember_20d7d3f8-2516-4268-aef3-c1cc28d185d1" xlink:href="inpha-20251231.xsd#inpha_AGAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_9bc673d4-8098-4b12-bae7-c5c3a9b689db" xlink:to="loc_inpha_AGAMember_20d7d3f8-2516-4268-aef3-c1cc28d185d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAMember_3211e921-387d-45a5-86f2-3ff6bfafc6b5" xlink:href="inpha-20251231.xsd#inpha_BSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_9bc673d4-8098-4b12-bae7-c5c3a9b689db" xlink:to="loc_inpha_BSAMember_3211e921-387d-45a5-86f2-3ff6bfafc6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAARMember_99f792e4-2b68-4a9a-b7ac-1b1687ae875b" xlink:href="inpha-20251231.xsd#inpha_BSAARMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_9bc673d4-8098-4b12-bae7-c5c3a9b689db" xlink:to="loc_inpha_BSAARMember_99f792e4-2b68-4a9a-b7ac-1b1687ae875b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_56acab0f-fd3e-442a-9a4f-1646221b2b31" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_36be8c3f-9851-4a4d-a394-fe7fada9e8f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_36be8c3f-9851-4a4d-a394-fe7fada9e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_d10f9b88-202a-457f-b331-3ead188a13ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_d10f9b88-202a-457f-b331-3ead188a13ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_35556b0f-bc77-4287-b83f-131f331e6a01" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_35556b0f-bc77-4287-b83f-131f331e6a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_852aea1b-f60f-4f22-b900-8d3eb3302415" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_852aea1b-f60f-4f22-b900-8d3eb3302415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e30c567d-d2a7-4c69-b7d6-7c0308f93afe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_e30c567d-d2a7-4c69-b7d6-7c0308f93afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_cc3597d0-cb4d-4bbe-9501-5b439bef8207" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_620b313f-2fa8-4409-8821-22ff2a893174" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_cc3597d0-cb4d-4bbe-9501-5b439bef8207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofClosingBalanceofShareBasedPaymentArrangementsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofClosingBalanceofShareBasedPaymentArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofClosingBalanceofShareBasedPaymentArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_d638b846-5e31-46bf-90cd-a64def748d06" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_33e981fe-f203-46b6-a23d-b7efad732457" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_d638b846-5e31-46bf-90cd-a64def748d06" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_33e981fe-f203-46b6-a23d-b7efad732457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c99cb1e9-c3ca-477e-a032-c4a7b9b36cb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_33e981fe-f203-46b6-a23d-b7efad732457" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c99cb1e9-c3ca-477e-a032-c4a7b9b36cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5934afc2-3eea-4ff0-9249-dc13d98e5b83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_c99cb1e9-c3ca-477e-a032-c4a7b9b36cb4" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5934afc2-3eea-4ff0-9249-dc13d98e5b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:href="inpha-20251231.xsd#inpha_AGAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5934afc2-3eea-4ff0-9249-dc13d98e5b83" xlink:to="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20161Member_c5aec3b1-4793-4ccd-922d-1077abde26a1" xlink:href="inpha-20251231.xsd#inpha_AGAPManagement20161Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPManagement20161Member_c5aec3b1-4793-4ccd-922d-1077abde26a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20161Member_338b7fb2-0dc2-408d-b093-f8ecb4c4f155" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployees20161Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPEmployees20161Member_338b7fb2-0dc2-408d-b093-f8ecb4c4f155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAP20162Member_7d5f02ba-f0d9-4755-82c5-6df1800ba41b" xlink:href="inpha-20251231.xsd#inpha_AGAP20162Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAP20162Member_7d5f02ba-f0d9-4755-82c5-6df1800ba41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20171Member_b4fbfc56-c6cf-4ab7-8d56-e324eba5a281" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20171Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGANewMembers20171Member_b4fbfc56-c6cf-4ab7-8d56-e324eba5a281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20191Member_0dbf02df-f1b7-4aa6-92d7-ab17fa15dcbf" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20191Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20191Member_0dbf02df-f1b7-4aa6-92d7-ab17fa15dcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20191Member_ef19888d-e020-4906-8f95-40f17dab6992" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20191Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20191Member_ef19888d-e020-4906-8f95-40f17dab6992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20201Member_3f212a05-a8e6-44a8-a068-ea582a75ed55" xlink:href="inpha-20251231.xsd#inpha_AGABonus20201Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGABonus20201Member_3f212a05-a8e6-44a8-a068-ea582a75ed55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20201Member_d0325f17-5838-463c-83f6-61f1166dca19" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20201Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20201Member_d0325f17-5838-463c-83f6-61f1166dca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20201Member_acffe09d-e923-4274-9074-2913b6b1a5dd" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20201Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20201Member_acffe09d-e923-4274-9074-2913b6b1a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20211Member_444fbff4-aed8-4366-95a0-e3700c45c282" xlink:href="inpha-20251231.xsd#inpha_AGABonus20211Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGABonus20211Member_444fbff4-aed8-4366-95a0-e3700c45c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20211Member_47a3f8c2-c2cd-4c90-b199-1fcf2066fe77" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20211Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20211Member_47a3f8c2-c2cd-4c90-b199-1fcf2066fe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20211Member_4f9be3f4-4656-495a-b7ad-d11265be6634" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20211Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20211Member_4f9be3f4-4656-495a-b7ad-d11265be6634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20221Member_538a61b5-0c32-40c6-b176-6ed9f57e849d" xlink:href="inpha-20251231.xsd#inpha_AGABonus20221Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGABonus20221Member_538a61b5-0c32-40c6-b176-6ed9f57e849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20221Member_4c00a3f7-c981-4ce1-8268-08858688e672" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20221Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20221Member_4c00a3f7-c981-4ce1-8268-08858688e672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20221Member_cf62e50f-8732-426b-9f22-a764941520f1" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20221Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20221Member_cf62e50f-8732-426b-9f22-a764941520f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20231ManagementMember_94d8d28c-7953-4158-9122-895de60dfad3" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20231ManagementMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGANewMembers20231ManagementMember_94d8d28c-7953-4158-9122-895de60dfad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20231Member_ef1118be-4fd4-4d2c-b948-b76c8669f57e" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20231Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20231Member_ef1118be-4fd4-4d2c-b948-b76c8669f57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20231Member_1e492a67-665d-41ff-8321-94fbcbd76a09" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20231Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20231Member_1e492a67-665d-41ff-8321-94fbcbd76a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241ManagementMember_d4412290-f08d-4cc8-924c-2b667a1f5edb" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20241ManagementMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGANewMembers20241ManagementMember_d4412290-f08d-4cc8-924c-2b667a1f5edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2024Member_d066f252-56d2-4281-ab5b-a20b8bce8121" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2024Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2024Member_d066f252-56d2-4281-ab5b-a20b8bce8121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_edc5ef3d-5800-4dd8-930f-ef1a14375992" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20241Member_edc5ef3d-5800-4dd8-930f-ef1a14375992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20241Member_d6f3569d-d624-48b5-9e0d-f97853279879" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20241Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAEmployees20241Member_d6f3569d-d624-48b5-9e0d-f97853279879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20241Member_02b3770e-dd98-4d73-810d-cb3ec3d008da" xlink:href="inpha-20251231.xsd#inpha_AGAPerfEmployees20241Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfEmployees20241Member_02b3770e-dd98-4d73-810d-cb3ec3d008da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20242Member_94f1eb30-0529-40b2-a986-4c4f9ee09556" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20242Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAPerfManagement20242Member_94f1eb30-0529-40b2-a986-4c4f9ee09556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20241Member_c2c33d9c-2309-4293-9f87-55d87256def6" xlink:href="inpha-20251231.xsd#inpha_AGAManagement20241Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAManagement20241Member_c2c33d9c-2309-4293-9f87-55d87256def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20251Member_019ba2c4-f19a-7c93-9d89-7d7764f1759b" xlink:href="inpha-20251231.xsd#inpha_AGAEmployees20251Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AGAMember_6c11ee3e-43aa-4619-8965-99814af4757f" xlink:to="loc_inpha_AGAEmployees20251Member_019ba2c4-f19a-7c93-9d89-7d7764f1759b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:href="inpha-20251231.xsd#inpha_BSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5934afc2-3eea-4ff0-9249-dc13d98e5b83" xlink:to="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2013Member_b1def4d1-9b5d-472b-bbb8-2b3e5a0d0cf8" xlink:href="inpha-20251231.xsd#inpha_BSA2013Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA2013Member_b1def4d1-9b5d-472b-bbb8-2b3e5a0d0cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2014Member_8e42a04f-6840-4e85-b511-67d646d50c69" xlink:href="inpha-20251231.xsd#inpha_BSA2014Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA2014Member_8e42a04f-6840-4e85-b511-67d646d50c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20151Member_c4a4626b-17b1-4cf0-a1b7-85be75ef64be" xlink:href="inpha-20251231.xsd#inpha_BSA20151Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA20151Member_c4a4626b-17b1-4cf0-a1b7-85be75ef64be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20152Member_379e8a09-b0e1-4f84-85e2-03c0bebe3bc6" xlink:href="inpha-20251231.xsd#inpha_BSA20152Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA20152Member_379e8a09-b0e1-4f84-85e2-03c0bebe3bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2017Member_1fa269d4-b540-465f-9631-b9d0901f394e" xlink:href="inpha-20251231.xsd#inpha_BSA2017Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA2017Member_1fa269d4-b540-465f-9631-b9d0901f394e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20221Member_6570ef22-4f3e-48f4-a1a7-471f2fb2d001" xlink:href="inpha-20251231.xsd#inpha_BSA20221Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA20221Member_6570ef22-4f3e-48f4-a1a7-471f2fb2d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20231Member_c0e5cec7-db07-47d0-9472-02ab5a3887b2" xlink:href="inpha-20251231.xsd#inpha_BSA20231Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA20231Member_c0e5cec7-db07-47d0-9472-02ab5a3887b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20251Member_019ba2c7-6877-7b0e-a335-8b38aecbeac6" xlink:href="inpha-20251231.xsd#inpha_BSA20251Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAMember_95710736-bac4-48cc-96fb-d313ed62049a" xlink:to="loc_inpha_BSA20251Member_019ba2c7-6877-7b0e-a335-8b38aecbeac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAARMember_aa02976e-b6c2-4f09-b20a-99345a126ff0" xlink:href="inpha-20251231.xsd#inpha_BSAARMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_5934afc2-3eea-4ff0-9249-dc13d98e5b83" xlink:to="loc_inpha_BSAARMember_aa02976e-b6c2-4f09-b20a-99345a126ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2011Member_f79d4dd3-ce16-4367-a737-181c7bb508a1" xlink:href="inpha-20251231.xsd#inpha_BSAAR2011Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAARMember_aa02976e-b6c2-4f09-b20a-99345a126ff0" xlink:to="loc_inpha_BSAAR2011Member_f79d4dd3-ce16-4367-a737-181c7bb508a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2012Member_d5c238be-db27-4739-8a06-961370d40c24" xlink:href="inpha-20251231.xsd#inpha_BSAAR2012Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAARMember_aa02976e-b6c2-4f09-b20a-99345a126ff0" xlink:to="loc_inpha_BSAAR2012Member_d5c238be-db27-4739-8a06-961370d40c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2015Member_56f8db34-2581-41e3-978a-f3c2171bfc8a" xlink:href="inpha-20251231.xsd#inpha_BSAAR2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_BSAARMember_aa02976e-b6c2-4f09-b20a-99345a126ff0" xlink:to="loc_inpha_BSAAR2015Member_56f8db34-2581-41e3-978a-f3c2171bfc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_33e981fe-f203-46b6-a23d-b7efad732457" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_cf609526-a671-479e-aedd-acfadead1e7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_cf609526-a671-479e-aedd-acfadead1e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4dac7237-7647-4026-bbc7-c3b62a991534" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_4dac7237-7647-4026-bbc7-c3b62a991534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_VestingPeriodOtherEquityInstrumentsGranted_5de7bdac-f262-4567-9be9-e506285aceae" xlink:href="inpha-20251231.xsd#inpha_VestingPeriodOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_VestingPeriodOtherEquityInstrumentsGranted_5de7bdac-f262-4567-9be9-e506285aceae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_8a098670-c117-4a7c-9bcc-ff5bc9e79452" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_8a098670-c117-4a7c-9bcc-ff5bc9e79452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted_9b23d306-aab0-443d-8e30-f7f1237a9a8c" xlink:href="inpha-20251231.xsd#inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_ShareEntitlementPerFreeShareOtherEquityInstrumentsGranted_9b23d306-aab0-443d-8e30-f7f1237a9a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExercisePriceOtherEquityInstrumentsGranted_38543c21-0769-4bba-a1ab-a65ddbabd4ac" xlink:href="inpha-20251231.xsd#inpha_ExercisePriceOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_ExercisePriceOtherEquityInstrumentsGranted_38543c21-0769-4bba-a1ab-a65ddbabd4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted_bd37db84-b5b3-4fe6-9aef-63d4b95d5a79" xlink:href="inpha-20251231.xsd#inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_GrantDateShareFairValueOtherEquityInstrumentsGranted_bd37db84-b5b3-4fe6-9aef-63d4b95d5a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedVolatilityOtherEquityInstrumentsGranted_0b014944-d438-4da2-a8c9-9b03f301b6fe" xlink:href="inpha-20251231.xsd#inpha_ExpectedVolatilityOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_ExpectedVolatilityOtherEquityInstrumentsGranted_0b014944-d438-4da2-a8c9-9b03f301b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AverageLifeOtherEquityInstrumentsGranted_350a4241-e0af-44c8-817e-a0c2c789b10a" xlink:href="inpha-20251231.xsd#inpha_AverageLifeOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_AverageLifeOtherEquityInstrumentsGranted_350a4241-e0af-44c8-817e-a0c2c789b10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RiskFreeInterestRateOtherEquityInstrumentsGranted_9e77f773-1612-4cc4-aa23-a49e000efb3c" xlink:href="inpha-20251231.xsd#inpha_RiskFreeInterestRateOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_RiskFreeInterestRateOtherEquityInstrumentsGranted_9e77f773-1612-4cc4-aa23-a49e000efb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExpectedDividendOtherEquityInstrumentsGranted_0808482b-29a0-4725-93f3-d9047c821e41" xlink:href="inpha-20251231.xsd#inpha_ExpectedDividendOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_ExpectedDividendOtherEquityInstrumentsGranted_0808482b-29a0-4725-93f3-d9047c821e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted_9756bef8-a898-4ce2-81ab-72cc9b15f900" xlink:href="inpha-20251231.xsd#inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8a1ffb6e-7186-421a-91c9-778e25641f87" xlink:to="loc_inpha_FairValuePerShareAtGrantDateOtherEquityInstrumentsGranted_9756bef8-a898-4ce2-81ab-72cc9b15f900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofBreakdownofExpensesperFinancialYearDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#SharecapitalandsharebasedpaymentsDisclosureofBreakdownofExpensesperFinancialYearDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofBreakdownofExpensesperFinancialYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0c559d84-67f4-486f-95b4-fb0bec480a0a" xlink:href="inpha-20251231.xsd#inpha_ShareCapitalAndShareBasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1e7e9e28-fbd5-4386-a6fe-e1f2667d5d4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasedPaymentsAbstract_0c559d84-67f4-486f-95b4-fb0bec480a0a" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1e7e9e28-fbd5-4386-a6fe-e1f2667d5d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9d236ff7-5e59-4211-93c2-c6782621c50b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1e7e9e28-fbd5-4386-a6fe-e1f2667d5d4c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9d236ff7-5e59-4211-93c2-c6782621c50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_9d236ff7-5e59-4211-93c2-c6782621c50b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2020AGAPManagement2020Member_019d29d3-ab8e-7b98-9a7b-f55f86929373" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2020AGAPManagement2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPEmployee2020AGAPManagement2020Member_019d29d3-ab8e-7b98-9a7b-f55f86929373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2021AGAPManagement2021Member_019d29d3-ab8e-7e8c-b76f-a9ad3b9e21d2" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2021AGAPManagement2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPEmployee2021AGAPManagement2021Member_019d29d3-ab8e-7e8c-b76f-a9ad3b9e21d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2022AGAPManagement2022Member_019d29d3-ab8e-7a3b-89ec-70ed64df9e66" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2022AGAPManagement2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPEmployee2022AGAPManagement2022Member_019d29d3-ab8e-7a3b-89ec-70ed64df9e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20231ManagementMember_019d29d3-ab8e-7471-bd5c-3253079013b6" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20231ManagementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGANewMembers20231ManagementMember_019d29d3-ab8e-7471-bd5c-3253079013b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2023AGAPManagement2023Member_019d29d3-ab8e-7d51-87dc-3769ab7a52ac" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2023AGAPManagement2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPEmployee2023AGAPManagement2023Member_019d29d3-ab8e-7d51-87dc-3769ab7a52ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2023Member_019d29d3-ab8e-7852-84cc-e491b6e2b5d8" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2023Member_019d29d3-ab8e-7852-84cc-e491b6e2b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_019d29d3-ab8e-7242-aec5-2395f6b9c794" xlink:href="inpha-20251231.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPerfManagement20241Member_019d29d3-ab8e-7242-aec5-2395f6b9c794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployee2024AGAPManagement2024Member_019d29d3-ab8e-73e1-a946-fed866df078c" xlink:href="inpha-20251231.xsd#inpha_AGAPEmployee2024AGAPManagement2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPEmployee2024AGAPManagement2024Member_019d29d3-ab8e-73e1-a946-fed866df078c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2024Member_019d29d3-ab8e-7f00-8c71-4123d012310f" xlink:href="inpha-20251231.xsd#inpha_AGAPlanEpargneEntreprise2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2024Member_019d29d3-ab8e-7f00-8c71-4123d012310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241ManagementMember_019d29d3-ab8e-7eec-97d6-82142feed8e2" xlink:href="inpha-20251231.xsd#inpha_AGANewMembers20241ManagementMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGANewMembers20241ManagementMember_019d29d3-ab8e-7eec-97d6-82142feed8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StockOptions2024Member_019d29d3-ab8e-75a0-90ae-df7f874939e4" xlink:href="inpha-20251231.xsd#inpha_StockOptions2024Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_StockOptions2024Member_019d29d3-ab8e-75a0-90ae-df7f874939e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherFreeSharesMember_019d29d3-ab8e-7129-b7ed-de7799ab1acc" xlink:href="inpha-20251231.xsd#inpha_OtherFreeSharesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_OtherFreeSharesMember_019d29d3-ab8e-7129-b7ed-de7799ab1acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployee2025Member_019d29d3-ab8e-73c3-a338-3d915fdfc6db" xlink:href="inpha-20251231.xsd#inpha_AGAEmployee2025Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_43ab58eb-9a77-45b5-a7c6-11a992e9675e" xlink:to="loc_inpha_AGAEmployee2025Member_019d29d3-ab8e-73c3-a338-3d915fdfc6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_200fdab0-7254-42f6-8a32-7e89a9a6d108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1e7e9e28-fbd5-4386-a6fe-e1f2667d5d4c" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_200fdab0-7254-42f6-8a32-7e89a9a6d108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_026889da-f3bd-4acb-9afc-617f4a266916" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_200fdab0-7254-42f6-8a32-7e89a9a6d108" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_026889da-f3bd-4acb-9afc-617f4a266916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_ca6511d5-f98b-424d-86fc-c52b1d5ffaad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_ca6511d5-f98b-424d-86fc-c52b1d5ffaad" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_5d66d955-7a8f-4eb5-8e19-0342bef81d6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_5d66d955-7a8f-4eb5-8e19-0342bef81d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_5d66d955-7a8f-4eb5-8e19-0342bef81d6c" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsMember_9fca1c71-d1ff-4b41-967d-4151c33fcdb2" xlink:href="inpha-20251231.xsd#inpha_NonCurrentFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:to="loc_inpha_NonCurrentFinancialAssetsMember_9fca1c71-d1ff-4b41-967d-4151c33fcdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TradeReceivablesAndOthersMember_33a1e208-853f-4718-b882-f5c4e0f09430" xlink:href="inpha-20251231.xsd#inpha_TradeReceivablesAndOthersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:to="loc_inpha_TradeReceivablesAndOthersMember_33a1e208-853f-4718-b882-f5c4e0f09430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentMember_c6a24771-30f9-49ad-a688-4d2cd4f23aa3" xlink:href="inpha-20251231.xsd#inpha_ShortTermInvestmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:to="loc_inpha_ShortTermInvestmentMember_c6a24771-30f9-49ad-a688-4d2cd4f23aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashAndCashEquivalentMember_fb8e8765-4fce-4120-8d53-e5ab5c555030" xlink:href="inpha-20251231.xsd#inpha_CashAndCashEquivalentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_f8251164-e4e4-41f3-9180-30d8fd7de30b" xlink:to="loc_inpha_CashAndCashEquivalentMember_fb8e8765-4fce-4120-8d53-e5ab5c555030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_52522fd4-d06d-46e4-8ee4-3ff6c1cdfd78" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_52522fd4-d06d-46e4-8ee4-3ff6c1cdfd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5d9904ba-72e9-474a-bbd9-8f45dba0893f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_52522fd4-d06d-46e4-8ee4-3ff6c1cdfd78" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5d9904ba-72e9-474a-bbd9-8f45dba0893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_9bc6e827-aa08-4ab1-aa6e-fc3e1eee9b65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5d9904ba-72e9-474a-bbd9-8f45dba0893f" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_9bc6e827-aa08-4ab1-aa6e-fc3e1eee9b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LoansAndReceivablesCategoryMember_30296e3c-0350-4bb9-a141-05ac2a615f27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LoansAndReceivablesCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_5d9904ba-72e9-474a-bbd9-8f45dba0893f" xlink:to="loc_ifrs-full_LoansAndReceivablesCategoryMember_30296e3c-0350-4bb9-a141-05ac2a615f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_90028be5-2363-4d6e-a7f7-723346850cb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_90028be5-2363-4d6e-a7f7-723346850cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_fa265a29-2339-48b6-b048-dd6fc55cc960" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_90028be5-2363-4d6e-a7f7-723346850cb8" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_fa265a29-2339-48b6-b048-dd6fc55cc960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesNonCurrentPortionMember_d78bd350-6ec9-401c-892a-2316a2a4b5fb" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesNonCurrentPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_fa265a29-2339-48b6-b048-dd6fc55cc960" xlink:to="loc_inpha_FinancialLiabilitiesNonCurrentPortionMember_d78bd350-6ec9-401c-892a-2316a2a4b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesCurrentPortionMember_d625ac5e-9609-4352-ac82-b8c21cdb4460" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesCurrentPortionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_fa265a29-2339-48b6-b048-dd6fc55cc960" xlink:to="loc_inpha_FinancialLiabilitiesCurrentPortionMember_d625ac5e-9609-4352-ac82-b8c21cdb4460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TradePayablesAndOthersMember_7bcc2cd5-33d1-4a22-a3a1-31aa88f2f8f1" xlink:href="inpha-20251231.xsd#inpha_TradePayablesAndOthersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_fa265a29-2339-48b6-b048-dd6fc55cc960" xlink:to="loc_inpha_TradePayablesAndOthersMember_7bcc2cd5-33d1-4a22-a3a1-31aa88f2f8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_2868faac-496e-40a5-a6cf-4a1e6bc20624" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_2868faac-496e-40a5-a6cf-4a1e6bc20624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_3795f967-3635-4bb7-946c-877a2fc88c31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_2868faac-496e-40a5-a6cf-4a1e6bc20624" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_3795f967-3635-4bb7-946c-877a2fc88c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_d7c815b0-6e96-4b52-b5af-bf4960c921b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_3795f967-3635-4bb7-946c-877a2fc88c31" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_d7c815b0-6e96-4b52-b5af-bf4960c921b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_a94fa8aa-1031-416c-8773-9f9e5a7089c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_3795f967-3635-4bb7-946c-877a2fc88c31" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_a94fa8aa-1031-416c-8773-9f9e5a7089c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e28d3fd5-f383-4aa9-9f0c-e336edc4021e" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_ec9243ad-3b77-4bae-a937-231b4936b027" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:to="loc_ifrs-full_FinancialAssets_ec9243ad-3b77-4bae-a937-231b4936b027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_023c83d8-7ede-4838-af63-4f9bbc6cc8a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_023c83d8-7ede-4838-af63-4f9bbc6cc8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesTradePayablesAndOthers_1bd66211-30a2-48af-8b8e-bc58c68d8a1a" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesTradePayablesAndOthers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:to="loc_inpha_FinancialLiabilitiesTradePayablesAndOthers_1bd66211-30a2-48af-8b8e-bc58c68d8a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue_85ead8de-bce2-455f-8fbe-633fde9b3aa3" xlink:href="inpha-20251231.xsd#inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_cde0a208-b013-41a9-8ba2-f8bea55b0bfe" xlink:to="loc_inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue_85ead8de-bce2-455f-8fbe-633fde9b3aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_28e38a34-39ab-4976-9a6c-48a9a10ccf85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d9fb8b39-02b2-49b1-b35e-5b1239fd96d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_28e38a34-39ab-4976-9a6c-48a9a10ccf85" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d9fb8b39-02b2-49b1-b35e-5b1239fd96d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_019d29f6-e0d0-777b-bd10-8219946255f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d9fb8b39-02b2-49b1-b35e-5b1239fd96d8" xlink:to="loc_ifrs-full_TypesOfContractsAxis_019d29f6-e0d0-777b-bd10-8219946255f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_019d29f6-e0d0-777b-bd10-8219946255f8" xlink:to="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_019d29f6-e0d0-7202-847a-7e27ee8c1a53" xlink:href="inpha-20251231.xsd#inpha_A2015AstraZenecaMonalizumabAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_019d29f6-e0d0-7202-847a-7e27ee8c1a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_019d29fc-5947-739f-afcc-b472387066ce" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_019d29fc-5947-739f-afcc-b472387066ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019d29fe-16b1-7b05-8897-3c0a00a0e066" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_019d29fe-16b1-7b05-8897-3c0a00a0e066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_019d29fe-819e-702d-b226-5ff7be0fd79a" xlink:href="inpha-20251231.xsd#inpha_AgreementsWithGenzymeForNKCellEngagesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_019d29fe-819e-702d-b226-5ff7be0fd79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_019d29fe-ae4d-7291-8936-b26feafcdaab" xlink:href="inpha-20251231.xsd#inpha_AgreementsWithSanofiForNKCellEngagesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_019d29fe-ae4d-7291-8936-b26feafcdaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_019d29ff-7656-7548-9858-bf79d8d42c3d" xlink:href="inpha-20251231.xsd#inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_019d29f6-e0d0-75e3-bdfd-55b3cd2811f5" xlink:to="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_019d29ff-7656-7548-9858-bf79d8d42c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019d29f6-fbfb-702d-a2a5-c2825724f22e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d9fb8b39-02b2-49b1-b35e-5b1239fd96d8" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019d29f6-fbfb-702d-a2a5-c2825724f22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019d29f6-fbfb-7677-8f4f-2ce2ce2af986" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019d29f6-fbfb-702d-a2a5-c2825724f22e" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019d29f6-fbfb-7677-8f4f-2ce2ce2af986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesMember_019d29f6-fbfb-7d60-8108-5d6cd6046e0c" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019d29f6-fbfb-7677-8f4f-2ce2ce2af986" xlink:to="loc_inpha_CollaborationLiabilitiesMember_019d29f6-fbfb-7d60-8108-5d6cd6046e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_d9fb8b39-02b2-49b1-b35e-5b1239fd96d8" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019d29f6-b887-7199-ba66-a78757c68f8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019d29f6-b887-7199-ba66-a78757c68f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersInitialPayment_019d29f6-e0d0-7298-81bb-1513f3730b63" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersInitialPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersInitialPayment_019d29f6-e0d0-7298-81bb-1513f3730b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersExerciseOfOption_019d29f6-e0d0-7b53-a816-90a22647f43c" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersExerciseOfOption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersExerciseOfOption_019d29f6-e0d0-7b53-a816-90a22647f43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersFavorableCumulativeAdjustment_019d29f6-fbfb-70d7-8101-b565f2cef44c" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersFavorableCumulativeAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersFavorableCumulativeAdjustment_019d29f6-fbfb-70d7-8101-b565f2cef44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_019d29f6-fbfb-7a62-82c9-42f6db759e98" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_019d29f6-fbfb-7a62-82c9-42f6db759e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_019d29f6-fbfb-745c-be8e-54f0116c6edb" xlink:href="inpha-20251231.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_019d29f6-fbfb-745c-be8e-54f0116c6edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherRevenueReinvoicingExternalExpensesUnderAgreement_019d29fc-5947-7a86-bd0d-7f39dee71e75" xlink:href="inpha-20251231.xsd#inpha_OtherRevenueReinvoicingExternalExpensesUnderAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_OtherRevenueReinvoicingExternalExpensesUnderAgreement_019d29fc-5947-7a86-bd0d-7f39dee71e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_019d29fe-819e-70f2-9f83-cb37e419774a" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_019d29fe-819e-70f2-9f83-cb37e419774a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses_019d29fe-819e-7881-ae4d-5539bfcee315" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses_019d29fe-819e-7881-ae4d-5539bfcee315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch_019d29fe-ae4d-762f-8c24-8d3fcffc73dd" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch_019d29fe-ae4d-762f-8c24-8d3fcffc73dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions_019d29fe-ae4d-7517-884c-258c3ed2ad40" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions_019d29fe-ae4d-7517-884c-258c3ed2ad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfExclusiveOptionsGranted_019d29fe-ae4d-7a48-b1e5-df4f49b4f47d" xlink:href="inpha-20251231.xsd#inpha_NumberOfExclusiveOptionsGranted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_NumberOfExclusiveOptionsGranted_019d29fe-ae4d-7a48-b1e5-df4f49b4f47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfOptionsExcercisedForLicenses_019d29fe-ae4d-73a1-baf6-771ab179e4d9" xlink:href="inpha-20251231.xsd#inpha_NumberOfOptionsExcercisedForLicenses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_NumberOfOptionsExcercisedForLicenses_019d29fe-ae4d-73a1-baf6-771ab179e4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised_019d29fe-ae4d-77ed-aabf-c35ed9eeff15" xlink:href="inpha-20251231.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised_019d29fe-ae4d-77ed-aabf-c35ed9eeff15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TerminationNoticePeriod_019d29ff-9096-7372-a31a-376c45353626" xlink:href="inpha-20251231.xsd#inpha_TerminationNoticePeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019d29f6-b887-7eda-b2ab-581f7c31834a" xlink:to="loc_inpha_TerminationNoticePeriod_019d29ff-9096-7372-a31a-376c45353626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofRevenuefromCollaborationandLicensingAgreementsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresDisclosureofRevenuefromCollaborationandLicensingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofRevenuefromCollaborationandLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_a1ebdcee-6ddb-48cb-82f7-6066cd8af05e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_06680421-b322-42e3-ba9b-de2da2f7d90f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_a1ebdcee-6ddb-48cb-82f7-6066cd8af05e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_06680421-b322-42e3-ba9b-de2da2f7d90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_e8cc1175-3f96-46e7-a9a5-80c2b549bd26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_06680421-b322-42e3-ba9b-de2da2f7d90f" xlink:to="loc_ifrs-full_TypesOfContractsAxis_e8cc1175-3f96-46e7-a9a5-80c2b549bd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_e8cc1175-3f96-46e7-a9a5-80c2b549bd26" xlink:to="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationAndLicensingAgreementsMember_ee73f3ea-f831-4b44-ad83-0b0fa555b412" xlink:href="inpha-20251231.xsd#inpha_CollaborationAndLicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_CollaborationAndLicensingAgreementsMember_ee73f3ea-f831-4b44-ad83-0b0fa555b412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabAgreementMember_9ff8e19d-d506-413e-afdb-9f8c3ba795cc" xlink:href="inpha-20251231.xsd#inpha_MonalizumabAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_MonalizumabAgreementMember_9ff8e19d-d506-413e-afdb-9f8c3ba795cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_cb484612-778d-4904-ab4f-ff65d1829d77" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH5201WithAstraZenecaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_AgreementRelatedToIPH5201WithAstraZenecaMember_cb484612-778d-4904-ab4f-ff65d1829d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PreclinicalMoleculesAgreementWithAstraZenecaMember_782596ef-16e6-4078-a702-6bb2a0336abf" xlink:href="inpha-20251231.xsd#inpha_PreclinicalMoleculesAgreementWithAstraZenecaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_PreclinicalMoleculesAgreementWithAstraZenecaMember_782596ef-16e6-4078-a702-6bb2a0336abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_9c59b95b-db16-4eac-940d-968fd2b4c17d" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_9c59b95b-db16-4eac-940d-968fd2b4c17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToANKETIPH62WithSanofiMember_a0b657ed-923b-4b1a-a14b-17778de9662c" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToANKETIPH62WithSanofiMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_AgreementRelatedToANKETIPH62WithSanofiMember_a0b657ed-923b-4b1a-a14b-17778de9662c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToANKETIPH67WithSanofiMember_43255ad0-6805-4012-88d4-7d3ba83e42e5" xlink:href="inpha-20251231.xsd#inpha_AgreementRelatedToANKETIPH67WithSanofiMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_AgreementRelatedToANKETIPH67WithSanofiMember_43255ad0-6805-4012-88d4-7d3ba83e42e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithTakedaMember_19c79cb4-9c48-4f49-8f44-ef9ad12f080d" xlink:href="inpha-20251231.xsd#inpha_AgreementWithTakedaMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_AgreementWithTakedaMember_19c79cb4-9c48-4f49-8f44-ef9ad12f080d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_a9e69519-02cd-47f7-bcf2-74ae9c49142d" xlink:href="inpha-20251231.xsd#inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_a9e69519-02cd-47f7-bcf2-74ae9c49142d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherAgreementMember_96799545-6dfb-4bdf-bac9-0684ddabdae5" xlink:href="inpha-20251231.xsd#inpha_OtherAgreementMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_532b34f8-8c1f-4e6b-8cd9-9a3a93bc39ba" xlink:to="loc_inpha_OtherAgreementMember_96799545-6dfb-4bdf-bac9-0684ddabdae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6bd140c4-c221-4b25-a54f-595a2d588f04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_06680421-b322-42e3-ba9b-de2da2f7d90f" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6bd140c4-c221-4b25-a54f-595a2d588f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_2292f74f-e7d4-4b15-948b-eb241bc1d2f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6bd140c4-c221-4b25-a54f-595a2d588f04" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_2292f74f-e7d4-4b15-948b-eb241bc1d2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofChangesinDeferredRevenueandCollaborationLiabilitiesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresDisclosureofChangesinDeferredRevenueandCollaborationLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofChangesinDeferredRevenueandCollaborationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_6fedda18-7fca-4264-80c6-139ce63aeaca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_32adb1f5-340e-44f9-aa17-a697d23e6206" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_6fedda18-7fca-4264-80c6-139ce63aeaca" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_32adb1f5-340e-44f9-aa17-a697d23e6206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_44b20fac-291a-4ad5-8cf1-f933ee5ba530" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_32adb1f5-340e-44f9-aa17-a697d23e6206" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_44b20fac-291a-4ad5-8cf1-f933ee5ba530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_8219c4a1-689e-45b3-bca3-6dbff47cced9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_44b20fac-291a-4ad5-8cf1-f933ee5ba530" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_8219c4a1-689e-45b3-bca3-6dbff47cced9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueMember_cdb1cb13-5dd8-4aec-aa04-4b42bdc15664" xlink:href="inpha-20251231.xsd#inpha_DeferredRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_8219c4a1-689e-45b3-bca3-6dbff47cced9" xlink:to="loc_inpha_DeferredRevenueMember_cdb1cb13-5dd8-4aec-aa04-4b42bdc15664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesMember_d21fa972-2998-4b85-931e-60749f53ae8b" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_8219c4a1-689e-45b3-bca3-6dbff47cced9" xlink:to="loc_inpha_CollaborationLiabilitiesMember_d21fa972-2998-4b85-931e-60749f53ae8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_a186e456-0ca6-4421-a041-b29f03a0c108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_32adb1f5-340e-44f9-aa17-a697d23e6206" xlink:to="loc_ifrs-full_TypesOfContractsAxis_a186e456-0ca6-4421-a041-b29f03a0c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_f80f3a34-f23c-4983-a210-703e83843459" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_a186e456-0ca6-4421-a041-b29f03a0c108" xlink:to="loc_ifrs-full_TypesOfContractsDomain_f80f3a34-f23c-4983-a210-703e83843459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_223802ee-6c32-43bf-bc80-c75c53c88cd0" xlink:href="inpha-20251231.xsd#inpha_A2015AstraZenecaMonalizumabAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_f80f3a34-f23c-4983-a210-703e83843459" xlink:to="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_223802ee-6c32-43bf-bc80-c75c53c88cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_18607ab4-226f-4fde-bfd8-a40f39fbd64b" xlink:href="inpha-20251231.xsd#inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_f80f3a34-f23c-4983-a210-703e83843459" xlink:to="loc_inpha_AgreementWithTakedaOnResearchOfAntibodyDrugConjugatesADCMember_18607ab4-226f-4fde-bfd8-a40f39fbd64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_05ac703f-c767-4b0b-93e1-366a8e3ce5c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_32adb1f5-340e-44f9-aa17-a697d23e6206" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_05ac703f-c767-4b0b-93e1-366a8e3ce5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:href="inpha-20251231.xsd#inpha_DeferredRevenueRollForwardAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_05ac703f-c767-4b0b-93e1-366a8e3ce5c5" xlink:to="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_88f18342-2c5b-47e2-97ba-d792ef1fc1bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:to="loc_ifrs-full_ContractLiabilities_88f18342-2c5b-47e2-97ba-d792ef1fc1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_e4ea2e68-f66e-4a84-8f71-b22ba9eac1f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:to="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_e4ea2e68-f66e-4a84-8f71-b22ba9eac1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferFromToCollaborationLiabilities_43b9cd26-9f9f-4755-8627-e9f7fb5363c9" xlink:href="inpha-20251231.xsd#inpha_TransferFromToCollaborationLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:to="loc_inpha_TransferFromToCollaborationLiabilities_43b9cd26-9f9f-4755-8627-e9f7fb5363c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_beb455fe-06f2-4125-ba82-7e830fa94d03" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueRollForwardAbstract_1fdb12c9-f3fe-46a3-98da-b4b11ed69081" xlink:to="loc_ifrs-full_ContractLiabilities_beb455fe-06f2-4125-ba82-7e830fa94d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesRollForwardAbstract_092fcf08-8a7e-4322-aa6f-c66699720700" xlink:href="inpha-20251231.xsd#inpha_CollaborationLiabilitiesRollForwardAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_05ac703f-c767-4b0b-93e1-366a8e3ce5c5" xlink:to="loc_inpha_CollaborationLiabilitiesRollForwardAbstract_092fcf08-8a7e-4322-aa6f-c66699720700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationLiabilitiesRollForwardAbstract_092fcf08-8a7e-4322-aa6f-c66699720700" xlink:to="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_019d29dc-8b91-71d0-83dd-6a4305a01f39" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:to="loc_ifrs-full_CurrentContractLiabilities_019d29dc-8b91-71d0-83dd-6a4305a01f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_019d29e0-7db7-780c-9537-e24fe6da74c2" xlink:href="inpha-20251231.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_019d29e0-7db7-780c-9537-e24fe6da74c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsCurrentContractLiabilities_019d29e0-f305-7f6a-8f79-583580e368a4" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughRepaymentsCurrentContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:to="loc_inpha_DecreaseThroughRepaymentsCurrentContractLiabilities_019d29e0-f305-7f6a-8f79-583580e368a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossCurrentContractLiabilities_019d29e1-5729-7636-8839-a80970368cd8" xlink:href="inpha-20251231.xsd#inpha_ForeignExchangeGainLossCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:to="loc_inpha_ForeignExchangeGainLossCurrentContractLiabilities_019d29e1-5729-7636-8839-a80970368cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_019d29df-d024-7eac-ade5-5d6be260a8ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_019d29dd-56b7-77c1-9aac-04a2ee864665" xlink:to="loc_ifrs-full_CurrentContractLiabilities_019d29df-d024-7eac-ade5-5d6be260a8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationLiabilitiesRollForwardAbstract_092fcf08-8a7e-4322-aa6f-c66699720700" xlink:to="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_019d29de-6da5-73c3-8d1f-cd8fe6dd010d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_019d29de-6da5-73c3-8d1f-cd8fe6dd010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_019d29e2-7682-7176-a520-9f7650164788" xlink:href="inpha-20251231.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_019d29e2-7682-7176-a520-9f7650164788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities_019d29e1-f9ca-7f6d-9813-2eb630aa309e" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:to="loc_inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities_019d29e1-f9ca-7f6d-9813-2eb630aa309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossNonCurrentContractLiabilities_019d29e1-9bbf-7220-8a98-bed9de4abd84" xlink:href="inpha-20251231.xsd#inpha_ForeignExchangeGainLossNonCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:to="loc_inpha_ForeignExchangeGainLossNonCurrentContractLiabilities_019d29e1-9bbf-7220-8a98-bed9de4abd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_019d29df-5f59-75e6-86c2-2419fbc7a4bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_019d29de-b6dd-77d3-97c1-c6f0b9eb33ae" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_019d29df-5f59-75e6-86c2-2419fbc7a4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationLiabilitiesRollForwardAbstract_092fcf08-8a7e-4322-aa6f-c66699720700" xlink:to="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_b05033e5-33d1-4e3a-be23-d04b344d5c26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:to="loc_ifrs-full_ContractLiabilities_b05033e5-33d1-4e3a-be23-d04b344d5c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_2d46a7de-6f48-4495-8047-7ccc3fba8753" xlink:href="inpha-20251231.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_2d46a7de-6f48-4495-8047-7ccc3fba8753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsContractLiabilities_bb760058-4ef2-4762-b13b-f6c356ec559a" xlink:href="inpha-20251231.xsd#inpha_DecreaseThroughRepaymentsContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:to="loc_inpha_DecreaseThroughRepaymentsContractLiabilities_bb760058-4ef2-4762-b13b-f6c356ec559a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossContractLiabilities_019d29e3-b717-7f08-bc59-22d6323605f2" xlink:href="inpha-20251231.xsd#inpha_ForeignExchangeGainLossContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:to="loc_inpha_ForeignExchangeGainLossContractLiabilities_019d29e3-b717-7f08-bc59-22d6323605f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_d02ef9cc-fc37-4a43-9775-986d2928ed38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_019d29de-eb34-7353-a9b6-99b85faf2c59" xlink:to="loc_ifrs-full_ContractLiabilities_d02ef9cc-fc37-4a43-9775-986d2928ed38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofVarianceofDeferredRevenueDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresDisclosureofVarianceofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofVarianceofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_9dfe9e18-6222-4acf-b2f5-fafb05e95ea2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3a18d94a-9b4b-4c5b-8bed-5acaaab1654f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_9dfe9e18-6222-4acf-b2f5-fafb05e95ea2" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3a18d94a-9b4b-4c5b-8bed-5acaaab1654f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_de3857d6-e0bb-4101-8ee2-a67bb8c41276" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3a18d94a-9b4b-4c5b-8bed-5acaaab1654f" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_de3857d6-e0bb-4101-8ee2-a67bb8c41276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_021d54b9-5440-4e12-b03d-4efb86867e15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_de3857d6-e0bb-4101-8ee2-a67bb8c41276" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_021d54b9-5440-4e12-b03d-4efb86867e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueMember_d837548c-a55c-4e2f-97ff-61070a07413f" xlink:href="inpha-20251231.xsd#inpha_DeferredRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_021d54b9-5440-4e12-b03d-4efb86867e15" xlink:to="loc_inpha_DeferredRevenueMember_d837548c-a55c-4e2f-97ff-61070a07413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_ed36e8d4-2837-4551-aead-1d7d52df848c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3a18d94a-9b4b-4c5b-8bed-5acaaab1654f" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_ed36e8d4-2837-4551-aead-1d7d52df848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_ed36e8d4-2837-4551-aead-1d7d52df848c" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabMember_5b238005-151b-460b-9ae6-1ed01a6bdfb5" xlink:href="inpha-20251231.xsd#inpha_MonalizumabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:to="loc_inpha_MonalizumabMember_5b238005-151b-460b-9ae6-1ed01a6bdfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiServicesMember_4d37d997-a2be-4051-90a2-35db25b72e97" xlink:href="inpha-20251231.xsd#inpha_SanofiServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:to="loc_inpha_SanofiServicesMember_4d37d997-a2be-4051-90a2-35db25b72e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiOptionsMember_61cc0d26-d0c2-4a8d-b9d7-4d5fa621a33a" xlink:href="inpha-20251231.xsd#inpha_SanofiOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:to="loc_inpha_SanofiOptionsMember_61cc0d26-d0c2-4a8d-b9d7-4d5fa621a33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherProductAndServicesMember_17007728-65a5-4ffe-b691-e8c490b87cf4" xlink:href="inpha-20251231.xsd#inpha_OtherProductAndServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_45b79c68-4b2a-41d6-b1d5-dd2507cadef0" xlink:to="loc_inpha_OtherProductAndServicesMember_17007728-65a5-4ffe-b691-e8c490b87cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_3a18d94a-9b4b-4c5b-8bed-5acaaab1654f" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_7aed79a4-d577-4463-9360-7bb8640bb251" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_ifrs-full_ContractLiabilities_7aed79a4-d577-4463-9360-7bb8640bb251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_e20968c2-16d7-425d-9dc6-6af8a2557d04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_e20968c2-16d7-425d-9dc6-6af8a2557d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughUpfrontPaymentContractLiabilities_85b1af95-94c5-4f49-983d-a66bab3185de" xlink:href="inpha-20251231.xsd#inpha_IncreaseThroughUpfrontPaymentContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_inpha_IncreaseThroughUpfrontPaymentContractLiabilities_85b1af95-94c5-4f49-983d-a66bab3185de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferFromToCollaborationLiabilities_34f535b7-e7b4-4cc4-a321-bb902863c464" xlink:href="inpha-20251231.xsd#inpha_TransferFromToCollaborationLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_inpha_TransferFromToCollaborationLiabilities_34f535b7-e7b4-4cc4-a321-bb902863c464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_8518b794-ae21-43b5-8cb2-c158f170200a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_ifrs-full_ContractLiabilities_8518b794-ae21-43b5-8cb2-c158f170200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_027e61d2-9ec9-46d3-acfc-3d5c7a84b4dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_027e61d2-9ec9-46d3-acfc-3d5c7a84b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_26e8979e-af57-4e6e-88f1-3046699246d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_89f6b202-eb83-4ace-9a25-ed123fb9d354" xlink:to="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_26e8979e-af57-4e6e-88f1-3046699246d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofGovernmentFinancingforResearchExpendituresDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RevenueandgovernmentfinancingforresearchexpendituresDisclosureofGovernmentFinancingforResearchExpendituresDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofGovernmentFinancingforResearchExpendituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e2810f64-7985-4359-9a8f-345eb32cc976" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeFromResearchTaxCredit_0281cdac-26c7-43a9-9e31-e216b8aa3029" xlink:href="inpha-20251231.xsd#inpha_IncomeFromResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e2810f64-7985-4359-9a8f-345eb32cc976" xlink:to="loc_inpha_IncomeFromResearchTaxCredit_0281cdac-26c7-43a9-9e31-e216b8aa3029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_1c33a2de-fdf6-4ea1-a2e4-260fe01a721a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e2810f64-7985-4359-9a8f-345eb32cc976" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_1c33a2de-fdf6-4ea1-a2e4-260fe01a721a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GovernmentFinancingForResearchExpenditures_315e39da-7a37-428f-80a7-b4d7bb02a7ee" xlink:href="inpha-20251231.xsd#inpha_GovernmentFinancingForResearchExpenditures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e2810f64-7985-4359-9a8f-345eb32cc976" xlink:to="loc_inpha_GovernmentFinancingForResearchExpenditures_315e39da-7a37-428f-80a7-b4d7bb02a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofExpensesbyNatureDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#OperatingexpensesDisclosureofExpensesbyNatureDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofExpensesbyNatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e4f8fd0d-04ca-41c3-92aa-44e4f7f80020" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_f53196ea-c198-4259-8935-0ee26c69708f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e4f8fd0d-04ca-41c3-92aa-44e4f7f80020" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_f53196ea-c198-4259-8935-0ee26c69708f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_00a95771-f414-407e-bf84-655f8f93fcd0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_f53196ea-c198-4259-8935-0ee26c69708f" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_00a95771-f414-407e-bf84-655f8f93fcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4f86f5cc-a5eb-4960-b131-fd47a3f76134" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_00a95771-f414-407e-bf84-655f8f93fcd0" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4f86f5cc-a5eb-4960-b131-fd47a3f76134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchAndDevelopmentMember_41ceace8-6709-4326-b68e-2e05327452b1" xlink:href="inpha-20251231.xsd#inpha_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4f86f5cc-a5eb-4960-b131-fd47a3f76134" xlink:to="loc_inpha_ResearchAndDevelopmentMember_41ceace8-6709-4326-b68e-2e05327452b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GeneralAndAdministrativeMember_6e5d02d4-a734-48df-bbdc-8e59e33868b0" xlink:href="inpha-20251231.xsd#inpha_GeneralAndAdministrativeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4f86f5cc-a5eb-4960-b131-fd47a3f76134" xlink:to="loc_inpha_GeneralAndAdministrativeMember_6e5d02d4-a734-48df-bbdc-8e59e33868b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ImpairmentLossMember_425c0f47-beeb-4777-98a7-c414720e3c69" xlink:href="inpha-20251231.xsd#inpha_ImpairmentLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4f86f5cc-a5eb-4960-b131-fd47a3f76134" xlink:to="loc_inpha_ImpairmentLossMember_425c0f47-beeb-4777-98a7-c414720e3c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_f53196ea-c198-4259-8935-0ee26c69708f" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SubcontractingCosts_ff97f1e0-4bfe-4b4c-9518-4835184cf372" xlink:href="inpha-20251231.xsd#inpha_SubcontractingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_SubcontractingCosts_ff97f1e0-4bfe-4b4c-9518-4835184cf372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterialsAndConsumablesUsed_03bb4bb2-3d20-4c7a-8f3d-3153c3d98160" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_RawMaterialsAndConsumablesUsed_03bb4bb2-3d20-4c7a-8f3d-3153c3d98160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_9d91a1e5-ed8c-4c2b-a23a-459acd03ded6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_9d91a1e5-ed8c-4c2b-a23a-459acd03ded6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2417cbe8-a077-4954-9913-dfa5c97743f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2417cbe8-a077-4954-9913-dfa5c97743f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_019d3f3d-9c29-7a47-99d5-88f191a58d05" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_019d3f3d-9c29-7a47-99d5-88f191a58d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_2b8e9303-fb3c-48ff-97da-f2b926eea35f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_2b8e9303-fb3c-48ff-97da-f2b926eea35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonScientificAdvisoryAndConsulting_4035118e-3dac-4ff6-af05-b5fcc67ac772" xlink:href="inpha-20251231.xsd#inpha_NonScientificAdvisoryAndConsulting"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_NonScientificAdvisoryAndConsulting_4035118e-3dac-4ff6-af05-b5fcc67ac772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeasingAndMaintenance_aa9aa553-a72b-4914-ae50-ed335ccf5495" xlink:href="inpha-20251231.xsd#inpha_LeasingAndMaintenance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_LeasingAndMaintenance_aa9aa553-a72b-4914-ae50-ed335ccf5495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TravelExpense_a4e7bb18-b524-470e-8343-fa1cd33d2024" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_TravelExpense_a4e7bb18-b524-470e-8343-fa1cd33d2024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_e882ea6f-1302-489c-90b2-9623215c6978" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_e882ea6f-1302-489c-90b2-9623215c6978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ScientificAdvisoryAndConsulting_29869645-a09b-48d7-bd60-f4ebcfadd3bf" xlink:href="inpha-20251231.xsd#inpha_ScientificAdvisoryAndConsulting"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_ScientificAdvisoryAndConsulting_29869645-a09b-48d7-bd60-f4ebcfadd3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherPurchasesAndExternalExpenses_eadfaa33-5fe1-4e20-84a0-c434cc6a5738" xlink:href="inpha-20251231.xsd#inpha_OtherPurchasesAndExternalExpenses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_OtherPurchasesAndExternalExpenses_eadfaa33-5fe1-4e20-84a0-c434cc6a5738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_0a0e3866-0f60-4c5e-9e16-d7aa50cff138" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_0a0e3866-0f60-4c5e-9e16-d7aa50cff138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IntellectualPropertyExpenses_25c47b48-e5a2-462c-ac9d-06ee87e65168" xlink:href="inpha-20251231.xsd#inpha_IntellectualPropertyExpenses"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_inpha_IntellectualPropertyExpenses_25c47b48-e5a2-462c-ac9d-06ee87e65168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_194329e8-be37-4f8a-ab49-d03c0acca218" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_194329e8-be37-4f8a-ab49-d03c0acca218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_f6c81958-2ffc-40a5-99e6-cbfc8a146d99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_f6c81958-2ffc-40a5-99e6-cbfc8a146d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_a36faaec-d8ab-4571-aa16-ce77d6d8474f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_ed35c8ae-05fe-4cda-a74a-b03c61f9fc7f" xlink:to="loc_ifrs-full_OperatingExpense_a36faaec-d8ab-4571-aa16-ce77d6d8474f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofAuditandNonAuditFeesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#OperatingexpensesDisclosureofAuditandNonAuditFeesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofAuditandNonAuditFeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_d1b80ad6-afd7-4a19-8786-8615fd9dda7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AuditorRemunerationTable_29119a80-8290-4167-bc3c-be67a47c7d70" xlink:href="inpha-20251231.xsd#inpha_AuditorRemunerationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_d1b80ad6-afd7-4a19-8786-8615fd9dda7f" xlink:to="loc_inpha_AuditorRemunerationTable_29119a80-8290-4167-bc3c-be67a47c7d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8dc7f46e-b2b5-43ec-9328-4ab710fa6129" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorRemunerationTable_29119a80-8290-4167-bc3c-be67a47c7d70" xlink:to="loc_srt_CounterpartyNameAxis_8dc7f46e-b2b5-43ec-9328-4ab710fa6129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e6447df-46dc-4de5-991c-561aa3bb1f32" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8dc7f46e-b2b5-43ec-9328-4ab710fa6129" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e6447df-46dc-4de5-991c-561aa3bb1f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeloitteAssociesMember_00d13169-1fcc-4e48-9475-d2db9f2f67fe" xlink:href="inpha-20251231.xsd#inpha_DeloitteAssociesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e6447df-46dc-4de5-991c-561aa3bb1f32" xlink:to="loc_inpha_DeloitteAssociesMember_00d13169-1fcc-4e48-9475-d2db9f2f67fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PriceWaterhouseCooperPWCMember_57321bea-1819-4a25-813f-e2ccc51c1c46" xlink:href="inpha-20251231.xsd#inpha_PriceWaterhouseCooperPWCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e6447df-46dc-4de5-991c-561aa3bb1f32" xlink:to="loc_inpha_PriceWaterhouseCooperPWCMember_57321bea-1819-4a25-813f-e2ccc51c1c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AuditorsRemunerationLineItems_c326b4f5-d42e-4557-8c97-7c0c0d784e72" xlink:href="inpha-20251231.xsd#inpha_AuditorsRemunerationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorRemunerationTable_29119a80-8290-4167-bc3c-be67a47c7d70" xlink:to="loc_inpha_AuditorsRemunerationLineItems_c326b4f5-d42e-4557-8c97-7c0c0d784e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForAuditServices_743888c7-2aa7-4fc6-aac2-80d2ab403b34" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemunerationForAuditServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorsRemunerationLineItems_c326b4f5-d42e-4557-8c97-7c0c0d784e72" xlink:to="loc_ifrs-full_AuditorsRemunerationForAuditServices_743888c7-2aa7-4fc6-aac2-80d2ab403b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_920cf13d-9165-43e0-a9ea-1f6beb42dfc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorsRemunerationLineItems_c326b4f5-d42e-4557-8c97-7c0c0d784e72" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_920cf13d-9165-43e0-a9ea-1f6beb42dfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AuditorsRemuneration_7ae5fee9-8a6d-4afd-8a6d-4d3fc0f23afb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AuditorsRemuneration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_AuditorsRemunerationLineItems_c326b4f5-d42e-4557-8c97-7c0c0d784e72" xlink:to="loc_ifrs-full_AuditorsRemuneration_7ae5fee9-8a6d-4afd-8a6d-4d3fc0f23afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#OperatingexpensesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_a8be476e-6f6e-45ad-a9ef-7fa9f5adf799" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_a8be476e-6f6e-45ad-a9ef-7fa9f5adf799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfEmployees_154a3d1d-753b-4841-869c-21d3662dfd1b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfEmployees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:to="loc_ifrs-full_NumberOfEmployees_154a3d1d-753b-4841-869c-21d3662dfd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_019d2a03-cd84-72fd-8ff4-f13e5814192c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageNumberOfEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_019d2a03-cd84-72fd-8ff4-f13e5814192c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_019d2a04-5555-745c-b61a-720aa49c7aee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_019d2a04-5555-745c-b61a-720aa49c7aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterialsAndConsumablesUsed_7eeb225b-b85b-4f66-95cd-25ef06f1be75" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_73551f28-6082-49a5-80eb-294e7ab5cf88" xlink:to="loc_ifrs-full_RawMaterialsAndConsumablesUsed_7eeb225b-b85b-4f66-95cd-25ef06f1be75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/NetfinancialincomelossDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#NetfinancialincomelossDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/NetfinancialincomelossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InterestsAndGainsOnFinancialAssets_1f8582ea-aca4-411a-90df-0805b730574b" xlink:href="inpha-20251231.xsd#inpha_InterestsAndGainsOnFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_inpha_InterestsAndGainsOnFinancialAssets_1f8582ea-aca4-411a-90df-0805b730574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnrealizedGainsOnFinancialAssets_662bafc6-0a23-4d15-aefd-4694346a2e7c" xlink:href="inpha-20251231.xsd#inpha_UnrealizedGainsOnFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_inpha_UnrealizedGainsOnFinancialAssets_662bafc6-0a23-4d15-aefd-4694346a2e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetForeignExchangeGain_af5937f4-fbb1-48b5-8bb6-ac0fe984e4b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_NetForeignExchangeGain_af5937f4-fbb1-48b5-8bb6-ac0fe984e4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherFinancialIncome_05b76191-3523-4f80-ae79-a21171b08e5f" xlink:href="inpha-20251231.xsd#inpha_OtherFinancialIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_inpha_OtherFinancialIncome_05b76191-3523-4f80-ae79-a21171b08e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_304170d8-33b7-44fb-8cb2-d209a7c66970" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_FinanceIncome_304170d8-33b7-44fb-8cb2-d209a7c66970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_87c814b3-a534-492a-9e76-ddb08b01cccc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_87c814b3-a534-492a-9e76-ddb08b01cccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnrealizedLossesOnFinancialAssets_99d4bdff-e093-44ca-a3c3-9cb7e56a4adc" xlink:href="inpha-20251231.xsd#inpha_UnrealizedLossesOnFinancialAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_inpha_UnrealizedLossesOnFinancialAssets_99d4bdff-e093-44ca-a3c3-9cb7e56a4adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_7ce34ac4-1afa-41f1-af02-7b781391f828" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_InterestExpense_7ce34ac4-1afa-41f1-af02-7b781391f828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherFinancialExpenses_5d706719-da95-42d2-8260-7c2c4f2d5905" xlink:href="inpha-20251231.xsd#inpha_OtherFinancialExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_inpha_OtherFinancialExpenses_5d706719-da95-42d2-8260-7c2c4f2d5905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_e5994055-1a20-46dc-adad-637cd2cd57e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_FinanceCosts_e5994055-1a20-46dc-adad-637cd2cd57e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_dfccb1b7-e107-497e-89f8-a72a2c909f8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_f7167863-cef4-4fbf-88a0-0757c718e4da" xlink:to="loc_ifrs-full_FinanceIncomeCost_dfccb1b7-e107-497e-89f8-a72a2c909f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomeTaxDisclosureofDeferredAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomeTaxDisclosureofDeferredAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomeTaxDisclosureofDeferredAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_71fbb4c5-5c7d-4efd-8f68-1dd50877eaff" xlink:href="inpha-20251231.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1d2d73ff-9e47-4827-a103-9b81a8c8d800" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_71fbb4c5-5c7d-4efd-8f68-1dd50877eaff" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1d2d73ff-9e47-4827-a103-9b81a8c8d800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_098b737c-c99c-46de-8a7f-b70e1ee701ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1d2d73ff-9e47-4827-a103-9b81a8c8d800" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_098b737c-c99c-46de-8a7f-b70e1ee701ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_098b737c-c99c-46de-8a7f-b70e1ee701ab" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_e79b2fbb-eb52-4c77-ae77-d84e2948bb9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_e79b2fbb-eb52-4c77-ae77-d84e2948bb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionForDefinedBenefitObligationMember_de6e111b-f39e-4bc9-8333-01a27dc6494c" xlink:href="inpha-20251231.xsd#inpha_ProvisionForDefinedBenefitObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_inpha_ProvisionForDefinedBenefitObligationMember_de6e111b-f39e-4bc9-8333-01a27dc6494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_02779dd2-f486-4a92-9381-b2be5f4a4024" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_02779dd2-f486-4a92-9381-b2be5f4a4024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ContractLiabilitiesMember_2f997b62-e254-4918-9977-317d6b305bff" xlink:href="inpha-20251231.xsd#inpha_ContractLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_inpha_ContractLiabilitiesMember_2f997b62-e254-4918-9977-317d6b305bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseContractMember_61f50ce3-fd0c-4f0e-ae72-174778874fe7" xlink:href="inpha-20251231.xsd#inpha_LeaseContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_inpha_LeaseContractMember_61f50ce3-fd0c-4f0e-ae72-174778874fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxAmortizationMember_303e922a-b101-472b-ac2a-1f44c925fd27" xlink:href="inpha-20251231.xsd#inpha_TaxAmortizationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_3f3ad8a5-f394-41bd-bbbd-12a086314a7f" xlink:to="loc_inpha_TaxAmortizationMember_303e922a-b101-472b-ac2a-1f44c925fd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_c56c6fbc-7d74-4d28-9e19-6971c24ae94a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1d2d73ff-9e47-4827-a103-9b81a8c8d800" xlink:to="loc_ifrs-full_GeographicalAreasAxis_c56c6fbc-7d74-4d28-9e19-6971c24ae94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_bc5bbbcf-fdfa-4c06-912f-611e8cc7e82b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_c56c6fbc-7d74-4d28-9e19-6971c24ae94a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_bc5bbbcf-fdfa-4c06-912f-611e8cc7e82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_103afaa8-4466-4af5-92be-266de7aed532" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_bc5bbbcf-fdfa-4c06-912f-611e8cc7e82b" xlink:to="loc_country_FR_103afaa8-4466-4af5-92be-266de7aed532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d9cb1cc2-7298-4250-ae2b-d979c2f605d8" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_bc5bbbcf-fdfa-4c06-912f-611e8cc7e82b" xlink:to="loc_country_US_d9cb1cc2-7298-4250-ae2b-d979c2f605d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_40f574db-702d-4add-b13c-f17a00511b17" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1d2d73ff-9e47-4827-a103-9b81a8c8d800" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_40f574db-702d-4add-b13c-f17a00511b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredTaxAssetsOffsetAmount_d2153fe4-5e41-416b-afc1-43f66cda4720" xlink:href="inpha-20251231.xsd#inpha_DeferredTaxAssetsOffsetAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_40f574db-702d-4add-b13c-f17a00511b17" xlink:to="loc_inpha_DeferredTaxAssetsOffsetAmount_d2153fe4-5e41-416b-afc1-43f66cda4720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredTaxLiabilitiesOffsetAmount_7b815f49-a827-497c-a022-64389f2515c5" xlink:href="inpha-20251231.xsd#inpha_DeferredTaxLiabilitiesOffsetAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_40f574db-702d-4add-b13c-f17a00511b17" xlink:to="loc_inpha_DeferredTaxLiabilitiesOffsetAmount_7b815f49-a827-497c-a022-64389f2515c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_ee358df6-7774-436e-9ab4-15556d4ea672" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_40f574db-702d-4add-b13c-f17a00511b17" xlink:to="loc_ifrs-full_DeferredTaxAssets_ee358df6-7774-436e-9ab4-15556d4ea672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomeTaxAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomeTaxAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_4c8398f3-06d3-4046-b8d1-90721b99a813" xlink:href="inpha-20251231.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnusedTaxLossesWithNoExpirationDate_1f0abaf0-66f1-4233-8c0c-b575a2246d05" xlink:href="inpha-20251231.xsd#inpha_UnusedTaxLossesWithNoExpirationDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_4c8398f3-06d3-4046-b8d1-90721b99a813" xlink:to="loc_inpha_UnusedTaxLossesWithNoExpirationDate_1f0abaf0-66f1-4233-8c0c-b575a2246d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnusedTaxLossesSubjectToExpiration_43791dbe-3364-4db3-ae1c-7fd72d33c610" xlink:href="inpha-20251231.xsd#inpha_UnusedTaxLossesSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_4c8398f3-06d3-4046-b8d1-90721b99a813" xlink:to="loc_inpha_UnusedTaxLossesSubjectToExpiration_43791dbe-3364-4db3-ae1c-7fd72d33c610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnusedTaxLossesSubjectToExpirationPeriod_6d9b2d7f-7222-4b25-83b0-7b6f074753e9" xlink:href="inpha-20251231.xsd#inpha_UnusedTaxLossesSubjectToExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_4c8398f3-06d3-4046-b8d1-90721b99a813" xlink:to="loc_inpha_UnusedTaxLossesSubjectToExpirationPeriod_6d9b2d7f-7222-4b25-83b0-7b6f074753e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomeTaxDisclosureofTaxRateReconciliationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomeTaxDisclosureofTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomeTaxDisclosureofTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:href="inpha-20251231.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccountingProfit_262b10f6-d455-4d4b-8339-b440e620d655" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_AccountingProfit_262b10f6-d455-4d4b-8339-b440e620d655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_071adba3-1c70-4d96-b4e2-9ce5e09ac008" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_ApplicableTaxRate_071adba3-1c70-4d96-b4e2-9ce5e09ac008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_8662149c-8a6e-4e56-8b3e-e1e5a2a49f32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_8662149c-8a6e-4e56-8b3e-e1e5a2a49f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DifferencesInTaxRates_492a9870-8add-4e3a-aab4-1a544727d97d" xlink:href="inpha-20251231.xsd#inpha_DifferencesInTaxRates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_DifferencesInTaxRates_492a9870-8add-4e3a-aab4-1a544727d97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchTaxCredit_44c9e7b5-b720-41eb-84ca-0cafa501ffe8" xlink:href="inpha-20251231.xsd#inpha_ResearchTaxCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_ResearchTaxCredit_44c9e7b5-b720-41eb-84ca-0cafa501ffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfDefinedBenefitObligations_9f9f6bd6-8b3a-4c4b-8112-0869931b4654" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfDefinedBenefitObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfDefinedBenefitObligations_9f9f6bd6-8b3a-4c4b-8112-0869931b4654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfShareBasedCompensation_ae6797c8-b481-48b7-b56e-add08244bdf0" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfShareBasedCompensation_ae6797c8-b481-48b7-b56e-add08244bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfRevenueFromCollaborationsWithCustomers_f0a34eae-183d-410d-8236-da3aa7cacbba" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfRevenueFromCollaborationsWithCustomers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfRevenueFromCollaborationsWithCustomers_f0a34eae-183d-410d-8236-da3aa7cacbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_8a649ec6-9182-454f-9fd0-41bebc2a7dff" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfNonRecognitionOfDeferredTaxAssetsRelatedToTaxLossesAndTemporaryDifferences_8a649ec6-9182-454f-9fd0-41bebc2a7dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfCarryBack_b7934031-7a8b-471e-885b-e01b6c967611" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfCarryBack"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfCarryBack_b7934031-7a8b-471e-885b-e01b6c967611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfIntraGroupMergerOperations_3bb0ac2a-94f5-48a0-8d9d-a9f048747b9b" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfIntraGroupMergerOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfIntraGroupMergerOperations_3bb0ac2a-94f5-48a0-8d9d-a9f048747b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxEffectOfExerciseOfRealEstateLeasingOption_4ca0788b-d040-437d-95d3-c3a32929b934" xlink:href="inpha-20251231.xsd#inpha_TaxEffectOfExerciseOfRealEstateLeasingOption"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_inpha_TaxEffectOfExerciseOfRealEstateLeasingOption_4ca0788b-d040-437d-95d3-c3a32929b934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_7b51ba31-7ee0-4742-be7e-190df14dd319" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_7b51ba31-7ee0-4742-be7e-190df14dd319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_c8a1bcad-600a-4cfe-add6-850a788bc78f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_c8a1bcad-600a-4cfe-add6-850a788bc78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_e4574ca3-a13f-42b9-acd7-4487902d1bfd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageEffectiveTaxRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_e4574ca3-a13f-42b9-acd7-4487902d1bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_74079400-e7d9-4afb-9049-160164d36c54" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_74079400-e7d9-4afb-9049-160164d36c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8af7250e-61d7-4c52-a7b8-743106df9960" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_08dd96dc-95eb-4434-9a2d-6ded16f1651f" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_8af7250e-61d7-4c52-a7b8-743106df9960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CommitmentscontingenciesandlitigationsDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#CommitmentscontingenciesandlitigationsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CommitmentscontingenciesandlitigationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_84f5674c-46d5-47a6-ba3d-b39de2f40f13" xlink:href="inpha-20251231.xsd#inpha_CommitmentsContingenciesAndLitigationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_84f5674c-46d5-47a6-ba3d-b39de2f40f13" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_ee099aaa-132f-4ac2-b044-6efd624943b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:to="loc_ifrs-full_TypesOfContractsAxis_ee099aaa-132f-4ac2-b044-6efd624943b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_7f430b95-f127-4193-8a3d-b20fc11f9fc0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_ee099aaa-132f-4ac2-b044-6efd624943b7" xlink:to="loc_ifrs-full_TypesOfContractsDomain_7f430b95-f127-4193-8a3d-b20fc11f9fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PreclinicalServicesMember_cfdfb1b7-4223-4bc9-83a0-8bc57bf18619" xlink:href="inpha-20251231.xsd#inpha_PreclinicalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_7f430b95-f127-4193-8a3d-b20fc11f9fc0" xlink:to="loc_inpha_PreclinicalServicesMember_cfdfb1b7-4223-4bc9-83a0-8bc57bf18619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ClinicalServicesMember_21e719a0-b284-4ae5-b5ec-a8ba38ec89dc" xlink:href="inpha-20251231.xsd#inpha_ClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_7f430b95-f127-4193-8a3d-b20fc11f9fc0" xlink:to="loc_inpha_ClinicalServicesMember_21e719a0-b284-4ae5-b5ec-a8ba38ec89dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bf94ed0b-b050-458d-86e5-fe02c118cff9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bf94ed0b-b050-458d-86e5-fe02c118cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6126645c-e875-44c7-a399-8466fb4d2347" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_bf94ed0b-b050-458d-86e5-fe02c118cff9" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6126645c-e875-44c7-a399-8466fb4d2347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementWithSocitGnraleMember_e5c903c6-c1e3-44ae-a229-5259f404ad6e" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementWithSocitGnraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6126645c-e875-44c7-a399-8466fb4d2347" xlink:to="loc_inpha_LoanAgreementWithSocitGnraleMember_e5c903c6-c1e3-44ae-a229-5259f404ad6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_019d3bdb-9a83-7d42-99fd-a7f97ea1bb7b" xlink:href="inpha-20251231.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_6126645c-e875-44c7-a399-8466fb4d2347" xlink:to="loc_inpha_LoanBuildingMember_019d3bdb-9a83-7d42-99fd-a7f97ea1bb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_019d2a0d-b485-71a9-b1c6-d3a7e31edae0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_019d2a0d-b485-71a9-b1c6-d3a7e31edae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_019d2a0d-b485-7567-9a6e-9f4870febb9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_019d2a0d-b485-71a9-b1c6-d3a7e31edae0" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_019d2a0d-b485-7567-9a6e-9f4870febb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember_019d2a0d-c63d-7d88-b7cd-e61f369bb669" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_019d2a0d-b485-7567-9a6e-9f4870febb9c" xlink:to="loc_ifrs-full_RestructuringProvisionMember_019d2a0d-c63d-7d88-b7cd-e61f369bb669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_8216ba7e-b697-4940-9332-d04917b801aa" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCancellableOffBalanceSheetPurchasedCommitments_3fd03692-f11d-4441-9913-8ad5c554efc5" xlink:href="inpha-20251231.xsd#inpha_NonCancellableOffBalanceSheetPurchasedCommitments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_NonCancellableOffBalanceSheetPurchasedCommitments_3fd03692-f11d-4441-9913-8ad5c554efc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementCollateral_828e6a61-c7b5-4127-babc-8dac20b62b09" xlink:href="inpha-20251231.xsd#inpha_LoanAgreementCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_LoanAgreementCollateral_828e6a61-c7b5-4127-babc-8dac20b62b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_e8a142a6-cb85-4672-8a44-a187bf839e64" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_e8a142a6-cb85-4672-8a44-a187bf839e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_ce7c3e3e-03cb-47de-b2cd-c767cd3d5fed" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_ce7c3e3e-03cb-47de-b2cd-c767cd3d5fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_193564c1-2896-41d5-b03d-724930bea63e" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_193564c1-2896-41d5-b03d-724930bea63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_68e80bfa-1da7-4f04-883c-f742503f1a71" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_ifrs-full_FinancialLiabilities_68e80bfa-1da7-4f04-883c-f742503f1a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_5522edb8-c446-42ba-a57c-8f2d977f9927" xlink:href="inpha-20251231.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_5522edb8-c446-42ba-a57c-8f2d977f9927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Provisions_f7d8e5cd-5d06-45e4-a934-88e4f06c39e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_ifrs-full_Provisions_f7d8e5cd-5d06-45e4-a934-88e4f06c39e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProvisionsForEmployeeBenefits_9d31f12c-3579-4157-bab4-459a9c6657ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProvisionsForEmployeeBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_dce77fa7-c864-4e51-abdf-2aed68463779" xlink:to="loc_ifrs-full_ProvisionsForEmployeeBenefits_9d31f12c-3579-4157-bab4-459a9c6657ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofKeyManagementPersonnelCompensationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RelatedpartytransactionsDisclosureofKeyManagementPersonnelCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofKeyManagementPersonnelCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_cd91d976-cadc-4e9f-9248-f48a0c47d034" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_cd91d976-cadc-4e9f-9248-f48a0c47d034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_KeyManagementPersonnelCompensationExtraPensionBenefits_019d3e36-0c70-7add-b482-e5ac91f9875b" xlink:href="inpha-20251231.xsd#inpha_KeyManagementPersonnelCompensationExtraPensionBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:to="loc_inpha_KeyManagementPersonnelCompensationExtraPensionBenefits_019d3e36-0c70-7add-b482-e5ac91f9875b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_5bcf496c-daf1-4ff2-ad62-0f0c7162f7f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_5bcf496c-daf1-4ff2-ad62-0f0c7162f7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_KeyManagementPersonnelCompensationAdvisoryFees_b00d5b51-55f2-4e17-960e-fc4da47714cc" xlink:href="inpha-20251231.xsd#inpha_KeyManagementPersonnelCompensationAdvisoryFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:to="loc_inpha_KeyManagementPersonnelCompensationAdvisoryFees_b00d5b51-55f2-4e17-960e-fc4da47714cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_caa42e65-c7f4-4a17-9592-f7aec75b8f5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_f8dfdbc3-4c61-41d8-98ca-e564973607dc" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_caa42e65-c7f4-4a17-9592-f7aec75b8f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RelatedpartytransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_4c73eed9-4020-4926-8c62-7e4aa4fdd074" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_d59f4685-8bcf-4e37-9d30-1658a59ac678" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_4c73eed9-4020-4926-8c62-7e4aa4fdd074" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_d59f4685-8bcf-4e37-9d30-1658a59ac678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4dc0d3b7-70d2-4748-b79f-84d9c247e47b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_d59f4685-8bcf-4e37-9d30-1658a59ac678" xlink:to="loc_srt_CounterpartyNameAxis_4dc0d3b7-70d2-4748-b79f-84d9c247e47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8cbd6369-b149-4003-a1f8-d009fa739f09" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_4dc0d3b7-70d2-4748-b79f-84d9c247e47b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8cbd6369-b149-4003-a1f8-d009fa739f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NovoNordiskASMember_1221b254-4905-4824-b216-95e418d0f851" xlink:href="inpha-20251231.xsd#inpha_NovoNordiskASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8cbd6369-b149-4003-a1f8-d009fa739f09" xlink:to="loc_inpha_NovoNordiskASMember_1221b254-4905-4824-b216-95e418d0f851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_019d2a19-0d61-7167-8e13-17aea65c5338" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_d59f4685-8bcf-4e37-9d30-1658a59ac678" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_019d2a19-0d61-7167-8e13-17aea65c5338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_019d2a19-0d61-7b62-924d-f140bcb3733e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_019d2a19-0d61-7167-8e13-17aea65c5338" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_019d2a19-0d61-7b62-924d-f140bcb3733e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiAventisMember_019d2a19-2a34-7031-8729-26850bcd5221" xlink:href="inpha-20251231.xsd#inpha_SanofiAventisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_019d2a19-0d61-7b62-924d-f140bcb3733e" xlink:to="loc_inpha_SanofiAventisMember_019d2a19-2a34-7031-8729-26850bcd5221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_d59f4685-8bcf-4e37-9d30-1658a59ac678" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfMembersOfTheSupervisoryBoardNotAppointedToTheBoardOfDirectors_019d2a11-3d70-7893-88e3-d97b2256cd0a" xlink:href="inpha-20251231.xsd#inpha_NumberOfMembersOfTheSupervisoryBoardNotAppointedToTheBoardOfDirectors"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_NumberOfMembersOfTheSupervisoryBoardNotAppointedToTheBoardOfDirectors_019d2a11-3d70-7893-88e3-d97b2256cd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfNewMembersAppointedToTheBoardOfDirectors_019d3e1d-5c5d-70f7-a47d-5749a719cadd" xlink:href="inpha-20251231.xsd#inpha_NumberOfNewMembersAppointedToTheBoardOfDirectors"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_NumberOfNewMembersAppointedToTheBoardOfDirectors_019d3e1d-5c5d-70f7-a47d-5749a719cadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfDirectors_019d2a13-7a61-755c-b50f-edfc7a20e1ea" xlink:href="inpha-20251231.xsd#inpha_NumberOfDirectors"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_NumberOfDirectors_019d2a13-7a61-755c-b50f-edfc7a20e1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionForAttendanceFees_e8c385f4-2569-4e1a-aed7-541f92cc037c" xlink:href="inpha-20251231.xsd#inpha_ProvisionForAttendanceFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_ProvisionForAttendanceFees_e8c385f4-2569-4e1a-aed7-541f92cc037c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfLicensingAgreements_f1eeee2d-291c-44ca-9f86-e7c17705f8e3" xlink:href="inpha-20251231.xsd#inpha_NumberOfLicensingAgreements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_NumberOfLicensingAgreements_f1eeee2d-291c-44ca-9f86-e7c17705f8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_7110b216-21dc-4a42-981f-c8648a1f022d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_ifrs-full_Borrowings_7110b216-21dc-4a42-981f-c8648a1f022d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019d2a18-c91d-7278-a685-dc867588159e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_ifrs-full_IssueOfEquity_019d2a18-c91d-7278-a685-dc867588159e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfShareholdingInTheCompany_019d2a19-810f-78b9-bcf4-7ff179816f66" xlink:href="inpha-20251231.xsd#inpha_PercentageOfShareholdingInTheCompany"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_PercentageOfShareholdingInTheCompany_019d2a19-810f-78b9-bcf4-7ff179816f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfCollaborationContracts_019d2a19-ef2c-727b-9786-80eac8a184d2" xlink:href="inpha-20251231.xsd#inpha_NumberOfCollaborationContracts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_NumberOfCollaborationContracts_019d2a19-ef2c-727b-9786-80eac8a184d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialTransactionsRelatedPartyTransactions_019d2a1a-5ab3-705f-b53a-f04690ca85f9" xlink:href="inpha-20251231.xsd#inpha_FinancialTransactionsRelatedPartyTransactions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_36ab4d5c-0f6f-4882-add0-379ed758d7bb" xlink:to="loc_inpha_FinancialTransactionsRelatedPartyTransactions_019d2a1a-5ab3-705f-b53a-f04690ca85f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofTransactionsBetweenRelatedPartiesDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#RelatedpartytransactionsDisclosureofTransactionsBetweenRelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofTransactionsBetweenRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_06aab182-42a5-473d-b5fc-1f1b4834e304" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_06aab182-42a5-473d-b5fc-1f1b4834e304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_aa901a80-24b2-4acd-91da-f172efd04370" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_aa901a80-24b2-4acd-91da-f172efd04370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToRelatedParties_74bf8763-cf77-4db6-bf46-e43b3361f51c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToRelatedParties_74bf8763-cf77-4db6-bf46-e43b3361f51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_16f58350-d708-43b4-b01d-629eee1cd687" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_16f58350-d708-43b4-b01d-629eee1cd687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_aab6a089-f285-4b38-b03b-b816f6e6ea96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_aab6a089-f285-4b38-b03b-b816f6e6ea96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NetAmountsReceivablePayableRelatedPartyTransactions_07f70d3f-ef37-4882-979d-e4f3843524e8" xlink:href="inpha-20251231.xsd#inpha_NetAmountsReceivablePayableRelatedPartyTransactions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_2e2a260c-6a5a-4a1c-ad96-ee9365d8d206" xlink:to="loc_inpha_NetAmountsReceivablePayableRelatedPartyTransactions_07f70d3f-ef37-4882-979d-e4f3843524e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareSummaryofIncomeLossperShareDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomelosspershareSummaryofIncomeLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareSummaryofIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:href="inpha-20251231.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_a6061c84-d453-4e43-ac62-dad26973537f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:to="loc_ifrs-full_ProfitLoss_a6061c84-d453-4e43-ac62-dad26973537f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_49d0a09f-4981-4079-8f02-3a23a11b952d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:to="loc_ifrs-full_WeightedAverageShares_49d0a09f-4981-4079-8f02-3a23a11b952d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_518a553a-2ccb-4a95-ae30-8d05ccfb7a95" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_518a553a-2ccb-4a95-ae30-8d05ccfb7a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_f035a3c1-1368-4064-8a4f-a3e1c867ea64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_f035a3c1-1368-4064-8a4f-a3e1c867ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_a3600859-efef-4c7f-94bc-c8e01fa907dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_572f4982-d5ee-475b-8307-791a26680604" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_a3600859-efef-4c7f-94bc-c8e01fa907dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20251231.xsd#IncomelosspershareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_b4144e2e-3bb4-4798-8c20-de9a9ce356be" xlink:href="inpha-20251231.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare_9342df22-b3e2-41e4-8814-a9939d68a5f7" xlink:href="inpha-20251231.xsd#inpha_NumberOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_b4144e2e-3bb4-4798-8c20-de9a9ce356be" xlink:to="loc_inpha_NumberOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare_9342df22-b3e2-41e4-8814-a9939d68a5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
